ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0001048.1|Tallysomycin_1 # 267 # 788 # 1 # ID=1_1;partial=00;start_type=GTG;rbs_motif=GGG;rbs_spacer=5bp;gc_cont=0.699	BGC0001048.1|Tallysomycin_1 	267	788	+	Loose	900	26.9498	lsaD	33.33	3005121	protein homolog model	n/a	n/a	lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; pleuromutilin antibiotic	antibiotic target protection	lsa-type ABC-F protein	GTGGGACAGTTCGGCACAGGAGGACATCACGGTCCTTGCACCTACCACATCGTGGCGCTCGGCGGCGGTGTGCTGGCGGCCGTGCTGGTGGTGAGCGGTCTGGTGCTGTTGCTCGCCCGACGACTGGTGAACGGGCGCGTGCGCCGCACCACGACCCGGATGGACAAGGTGCTCTACCTCGTGCTGTCAGCGGTGATCGCGTTCGGCACGGGCGGGACGGTGGGGCGCAACCTGCTCGGCTGCGGGTACGACTACCGGGAGACCATCGCCGTGTGGTTCCGCGGGATCTTCTGGTTCCACCCCGAACCGCGGCTCATGGTCGACGTCCCCCTGGTGTTCCAACTGCACGCGCTGAGCGCGCTCGTGCTGTTCGGGCTGTGGCCGTTCACCAGGCTCGTCCACGTCTGGTCGGTGCCCGTCGCCTACCTCTGGCGCCCCTACGTCCTCTACCGGCACCGGAGGCCTCGGCTCTCGGCGTCGGCGCGACCGGGCGCGGTCGGTGACGGGCGGCGAGGAGCGTGA	MGQFGTGGHHGPCTYHIVALGGGVLAAVLVVSGLVLLLARRLVNGRVRRTTTRMDKVLYLVLSAVIAFGTGGTVGRNLLGCGYDYRETIAVWFRGIFWFHPEPRLMVDVPLVFQLHALSALVLFGLWPFTRLVHVWSVPVAYLWRPYVLYRHRRPRLSASARPGAVGDGRRGA	MSNIKINNLTFGYTDQLIFDNVNINIDDQWKLGLVGRNGRGKTTLLKILLGEVDVHLEIKTNKSFVYFPQTINDKDQLTLFVLQELADFEQWELERELTLMGVDLDTLWRPFNSLSGGEQTKTLLALLFLDEHNYPLIDEPTNHLDKASREKVAAYLSEKKGYILISHDRNFLNKTTDHTLAIERADLQVYAGNFAIYEEEKRLRDLTEKAQDDKLRKEIGRLKQTAREKEAWSRNLEATKSRKKRGFDSETKRVDKGFIGRKAANMMQKSKNLEKRMKEDIADKELLLKNWEEVPGLEMSVLESHQKRLLTVENLAAGFEDFLFEPVSFTLEQGQVLALTGENGRGKSSLMKVLTGEFTGRYVGTFELAHNLVISEVRQLADNRGFLNEFAKKENLELELFLNNLRKLGVERKVFEQKIENMSQGQQRKVELARALSQPAHIYLWDEPLNYLDVFNQEQIIQMIKRSKPSMLVIEHDQYFVDQVADAQIELIKSSV	34.81	gnl|BL_ORD_ID|4773|hsp_num:0	3847			237	336	lincomycin; clindamycin; virginiamycin M1; tiamulin
BGC0001048.1|Tallysomycin_2 # 766 # 1044 # 1 # ID=1_2;partial=00;start_type=GTG;rbs_motif=GGG;rbs_spacer=8bp;gc_cont=0.613	BGC0001048.1|Tallysomycin_2 	766	1044	+	Loose	500	25.0238	NDM-18	52.17	3004861	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam	antibiotic inactivation	NDM beta-lactamase	GTGACGGGCGGCGAGGAGCGTGAGGCCACCCGCGAGTTCGGGGACCTGGTTTTCCTTGCCCCAGGAGCGGGTAAAGAAGAGAAAAGCGTCCTGGTCGGTCCGCTTGATCCCGTTTGTCCCTACCTTGCGCCAGCCTGCCCAAGGGGAGTCTGCGCCGAGCGGTCGGCGGCCACTGGGGCGACGTTTCGCCTGTGGGGCAACGAAAACAGCACAAACCAGCACATAAAGAATATTCATAACACATGCCGCGAAGTGAGTGATCACGCAGCTTCGCGGTGA	MTGGEEREATREFGDLVFLAPGAGKEEKSVLVGPLDPVCPYLAPACPRGVCAERSAATGATFRLWGNENSTNQHIKNIHNTCREVSDHAASR	MELPNIMHPVAKLSTALAAALMLSGCMPGEIRPTIGQQMETGDQRFGDQRFGDLVFRQLAPNVWQHTSYLDMPGFGAVASNGLIVRDGGRVLVVDTAWTDDQTAQILNWIKQEINLPVALAVVTHAHQDKMGGMDALHAAGIATYANALSNQLAPQEGMVAAQHSLTFAANGWVEPATAPNFGPLKVFYPGPGHTSDNITVGIDGTDIAFGGCLIKDSKAKSLGNLGDADTEHYAASARAFGAAFPKASMIVMSHSAPDSRAAITHTARMADKLR	33.45	gnl|BL_ORD_ID|2647|hsp_num:0	3659			114	183	
BGC0001048.1|Tallysomycin_3 # 1198 # 4902 # 1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=GGGGAG;rbs_spacer=12bp;gc_cont=0.714	BGC0001048.1|Tallysomycin_3 	1198	4902	+	Loose	700	27.7202	oleI	28.83	3000866	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	ole glycosyltransferase	ATGTGCGCCCTGCGCAAGTCGTTCGACCCGAGCGGTGTTGAGGATTCGGCCAGTGCGGCCCTGCTGCGCCTGAGCCGCCTGCTCACCCGCTCCGACACCTCACCCGACCTCCGCGCCGTGCACCGGCGCGGGGGTCGCGCGGGGGAGTCCTACTACCGGGATCGTTGGAGCCACGACAAAGTCGTCCCGTCCACCCACGGCGTCAACTGCACCGGCTCATGCCGGTGGAAGGTCTACGTCAAGGACGGGATTATCACCTGGGAGACGCAGGACACCGACTACCCCTCCGTCGGGCCCGACCGCCCGGAGTACGAGCCCCGCGGTTGTCCCCGGGGCGCTTCCTTCTCCTGGTACACCTACTCGCCCCTGCGCGTCCGCTACCCCTACGCGCGCGGCGTCCTGGTCGAGATGTACCGCGTGGCCAAGGAGAAACACGGTGATCCCGTCCGCGCGTGGAAGTCCATCATGGACGATCCGGTCAAGCGCGGCGTGTACCACCGGGCCCGGGGACGTGGCGGGCTGGTGCGGATCGACTGGGACGAGGCGGCCGAACTGGTCGCGGCCGCGCACGTGCACACCATCGCCGAGCACGGCCCGGACCGCGTCGCCGGATTCTCGCCCATCCCGGCCATGTCGATGGTCTCGCACGCCGTCGGGTCCCGGTTCATGGCCCTGCTGGGCGCTCCGATGCTGTCCTTCTACGACTGGTACGCGGACCTTCCCGTGGCCTCGCCCCAGGTGTTCGGCGACCAGACCGACGTGCCCGAGTCGGCGGACTGGTGGGACGCCGCCTACCTGCTGATGTGGGGCTCGAACGTCCCGGTGACCCGCACGCCCGACGCGCACTTCATGACCGAGGCCCGGTACCGGGGCCAGAAGGTCGTGGTGGTCTCCCCGGACTTCGCCGACAACACGAGGTTCGCGGACGAGTGGATGGCGCCGCACCCCGGCACCGACGCCGCGCTGGCGTTGGCGATGGGGCACGTGGTGTTGCGCGAGTTCTTCGTGGACAACGCCACACCCGCGTTCACCGACTACGTCCGCCGCTACACCGACCTGCCGTTCCTGGTCACCCTGCTGGAGCGCGACGGGCACCTGGTCCCGGGCAGGTTCGTCACGGCCGCCGATCTCGGCCGCGTGGAGGAGCACGCCGAGTGGAAACCCGCCCTGCTCGACGACGTCACCGGAAAACCCGTGGTGCCCAACGGTTCCCTGGGCTTTCGCTGGTCCGCTGAGCCCGGCAGGTGGAACCTGGACCTGGCCGGCGTGGAACCGGCGCTCTCCCTGCACGGCCGCGCGGAGGCGGAGCCGGTGGGCGTGGCGCTTCCCCGGTTCGACCAGCCGGACGGAACCGGCGAGGTGCTGCGCCGGGGTGTGCCCGCCGTCCGACTGGGTGCGGAGAAGCGTTGGGTCACCACGGTTTTCGACCTGCTGCTCGCCCAGTACGGCGTCGCGCGGGAAGGTCTGCCCGGCGAGTGGCCGACGGGCTACGACGACGCCGAGGAACCGGCGACTCCGGCGTGGCAGGAGACGATCACCGGGGTCCCGGCGGCGCAGGTGGTGCGCGTCGCGCGCGAGTTCGCCGACACCGCCGTGCGGTCGAAGGGCCGCTGCATGATCATCATGGGGTCGGGGGCGAACCACTGGTTCCACGCGGACCTGATCTACCGGTCGATGCTGGCACTGCTCCAGCTCACCGGGTGCCAGGGCCGCAACGGCGGGGGATGGGCGCACTACGTCGGACAGGAGAAGGTCCGACCGCTGACCGGGTGGGCCACGATGGCCGGCGCGCTGGACTGGTGCCGCCCGCCGCGCCAGATGATCGGGACCGCCTACTGGTACACCCACACCGACCAGTGGCGCTACGACGCGCTCGGCGCCGACGCGCTGTCCTGGCCGCTGGGCGGCGGCCACCTCGCCGGCGCCACCGTCGCCGACCTGCTGGCCCGCTCGGCGCGGATGGGCTGGATGCCCTCGTACCCCACGTTCGACCGCAACCCGCTGGACCTGGTGGCCGAGGCCGACGCCGCCGGCGCCGATCCCGTCGCGCACGTCGTCGAGGAACTGCGGGCCGGGCGGCTGAAGTTCGCGTGCGAGGACCCGGACGCGCCGGAGAACTGGCCGCGCGTGCTCACGGTGTGGCGGGCCAACCTGATCGGCTCCTCGGCGAAGGGCAACGAGTACTTCCTGCGGCACCTGCTCGGCGCCGACACCGAGGTCCGCGCCCAGGAGACGCCCCCGGCGCGCCGGCCGCGTGAGGTGCGCTGGCGTGAGCAGGCGCCACAAGGCAAGCTCGATCTCCTGCTGGCACTGGACTTCCGGATGACCAGCACCACCCTGTACGCCGACGTCGTGCTGCCCGCGGCGACCTGGTACGAGAAGCACGACCTGTCCAGCACGGACATGCACCCGTTCGTCCACTCGTTCAACGCGGCCGTGGACCCGCCGTGGCAGTGCCGCACGGACTTCGACATCTTCCACGGGATCGCCCGCACCTTCAGCGAACTGGCCGCCACCCACCTCGGCGTGCGTCGCGATCTCGTGGTCACCGCGTTGCAGCACGACACCCCCGGCGAGATCGCCCAGCCCGGCGGGACCGCGCGGGACTGGCGTGCCGGGGAGTGCGAACCGATGCCCGGCGCGACGATGCCCGTGTTCACCGTGGTCGAGCGCGACTACCCGGCCGTGGCCGCGCGACTGGCCGCACTGGGCCCGGTCGTGGAGAAAGCGGGCGTCACCACGAAGGGCGTGACCGTGGACGTGGCACGGGAACTGGCCTGGCTGGCCGAGGCCAACGGCACCGCCCCGGCCGGTCCGACCGCTGGTCGGCCCCGGGTCGACACCGACCGCCGGTTCGCTGACGCGATCCTCGCGTTGTCCGGCACCACCAACGGGCGGGTCGCCACCGAGGGGTTCCGCGTGTTGCAGGAGCGGGTTGGTCGCCCGCTGACCCAGTTGTCGGCCGAGTCCGCGCACCACCGGGTCACCTTCGCCGACACGCGCTCCCGCCCGGCCCCGGTGGTGACGAGCTACGAGTGGTCGGGCGACGAGTCGGGCGGGCGGCGGTACTCCCCGTTCACGATCAACGTGGAGCAGCTCAAGCCCTGGCACACGCTGACCGGCCGGCAGCACTTCTTCCTCGACCACGAGTGGCTGGCCGAACTCGGGGAGCAGCTCCCCGTCTACCGGCCGCCGTTGGACATGCACCGCCTCTACGACGAACCGCCGCTGGGGCCCGACGGTCAGCGCCAGGTGGTCGTCCGCTACCTGACGCCGCACTCGAAGTGGTCGATCCACTCGGAGTACCAGGACAACCCGCTGATGCTCACGTTGTCCCGGGGTGGGCCCACGTTCTGGATGAGCCCGGCGGACGCCGACGCGATCGGCGTGCGGGACAACGACTGGGTCGAGGCCGTGAACCGCAACGGCGTCGTGGTGGCGCGAGCCGTCGTGTCCCACCGCATGCCGACCGGCACCGTGTTCATGTACCACGCGCAGGAACGCACGGTGAACGTGCCGCGGAGCGAGACCACCGGCCGGCGGGGCGGGGTCCACAACTCCCTGACCCGCCTGCAGATCAAGCCGACGCACCTGGTCGGCGGCTACGCCCAGCTCTCCTTCGGCTTCAACTACCTGGGGCCGACCGGGAACCAGCGCGACGAGGTCACCGTGATCCGCCGTCGGGGCCAGGAGGTGACCTACTGA	MCALRKSFDPSGVEDSASAALLRLSRLLTRSDTSPDLRAVHRRGGRAGESYYRDRWSHDKVVPSTHGVNCTGSCRWKVYVKDGIITWETQDTDYPSVGPDRPEYEPRGCPRGASFSWYTYSPLRVRYPYARGVLVEMYRVAKEKHGDPVRAWKSIMDDPVKRGVYHRARGRGGLVRIDWDEAAELVAAAHVHTIAEHGPDRVAGFSPIPAMSMVSHAVGSRFMALLGAPMLSFYDWYADLPVASPQVFGDQTDVPESADWWDAAYLLMWGSNVPVTRTPDAHFMTEARYRGQKVVVVSPDFADNTRFADEWMAPHPGTDAALALAMGHVVLREFFVDNATPAFTDYVRRYTDLPFLVTLLERDGHLVPGRFVTAADLGRVEEHAEWKPALLDDVTGKPVVPNGSLGFRWSAEPGRWNLDLAGVEPALSLHGRAEAEPVGVALPRFDQPDGTGEVLRRGVPAVRLGAEKRWVTTVFDLLLAQYGVAREGLPGEWPTGYDDAEEPATPAWQETITGVPAAQVVRVAREFADTAVRSKGRCMIIMGSGANHWFHADLIYRSMLALLQLTGCQGRNGGGWAHYVGQEKVRPLTGWATMAGALDWCRPPRQMIGTAYWYTHTDQWRYDALGADALSWPLGGGHLAGATVADLLARSARMGWMPSYPTFDRNPLDLVAEADAAGADPVAHVVEELRAGRLKFACEDPDAPENWPRVLTVWRANLIGSSAKGNEYFLRHLLGADTEVRAQETPPARRPREVRWREQAPQGKLDLLLALDFRMTSTTLYADVVLPAATWYEKHDLSSTDMHPFVHSFNAAVDPPWQCRTDFDIFHGIARTFSELAATHLGVRRDLVVTALQHDTPGEIAQPGGTARDWRAGECEPMPGATMPVFTVVERDYPAVAARLAALGPVVEKAGVTTKGVTVDVARELAWLAEANGTAPAGPTAGRPRVDTDRRFADAILALSGTTNGRVATEGFRVLQERVGRPLTQLSAESAHHRVTFADTRSRPAPVVTSYEWSGDESGGRRYSPFTINVEQLKPWHTLTGRQHFFLDHEWLAELGEQLPVYRPPLDMHRLYDEPPLGPDGQRQVVVRYLTPHSKWSIHSEYQDNPLMLTLSRGGPTFWMSPADADAIGVRDNDWVEAVNRNGVVVARAVVSHRMPTGTVFMYHAQERTVNVPRSETTGRRGGVHNSLTRLQIKPTHLVGGYAQLSFGFNYLGPTGNQRDEVTVIRRRGQEVTY	MTSEHRSASVTPRHISFFNIPGHGHVNPSLGIVQELVARGHRVSYAITDEFAAQVKAAGATPVVYDSILPKESNPEESWPEDQESAMGLFLDEAVRVLPQLEDAYADDRPDLIVYDIASWPAPVLGRKWDIPFVQLSPTFVAYEGFEEDVPAVQDPTADRGEEAAAPAGTGDAEEGAEAEDGLVRFFTRLSAFLEEHGVDTPATEFLIAPNRCIVALPRTFQIKGDTVGDNYTFVGPTYGDRSHQGTWEGPGDGRPVLLIALGSAFTDHLDFYRTCLSAVDGLDWHVVLSVGRFVDPADLGEVPPNVEVHQWVPQLDILTKASAFITHAGMGSTMEALSNAVPMVAVPQIAEQTMNAERIVELGLGRHIPRDQVTAEKLREAVLAVASDPGVAERLAAVRQEIREAGGARAAADILEGILAEAG	291.04	gnl|BL_ORD_ID|1684|hsp_num:0	1824			660	948	oleandomycin
BGC0001048.1|Tallysomycin_4 # 4902 # 6473 # 1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=AGGAGG;rbs_spacer=10bp;gc_cont=0.695	BGC0001048.1|Tallysomycin_4 	4902	6473	+	Loose	1750	27.7202	amrB	30.88	3002983	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCGGGTCATGGCGCAACTGGCGATGGTGATGAACCTGGACAAGTGCATCGGGTGCCACACCTGCTCGGTCACCTGCAAGCAGACCTGGACCAACCGCGAGGGTGTGGAGTACGTCTGGTTCAACAACGTCGAGACCCGGCCCGGGCAGGGCTATCCCCGGCAGTACGAGGACCAGCGGCGCTGGCGCGGCGGGTGGGAGCTGTCCCGGCGCGGACGACTGCGGCTGCGCGGCGGAAGCCGTCTGCGCCGCCTCGGTTCGCTGTTCGCCAACCCCGATCTCCCCGCGCTCACCGACTACTACGAGCCCTGGACCTACGACTACCGCACGCTCACCACCGCGCCGCTCGGCGACGACAGCCCGGTCGCCCGCCCCGTCTCGGCGGTCACCGGCGCGCCCACAACCATCCACAGTGGACCGAACTGGGACGACAGCCTCGGCGGCGGACCGGAGAACGGCGCGCTGGACCCGGTGGTGGCCAAGCTGCGGGACGAGCTGGGGCACCAGGTGCGGTTCGAGTTCGAGCAGACGTTCATGTTCTACCTGCCCCGCATCTGCGAGCACTGCCTCAATCCGTCCTGTGTGGCCAGTTGCCCCTCGGGAGCCATGTACAAGCGGGTCGAGGACGGCATCGTGCTGGTCGACCAGGACCGGTGCCGGGGCTGGCGGATGTGCGTCAGCGGGTGCCCGTACAAGAAGGTGTACTTCAACCACCGCACCGGCAAGGCCGAGAAGTGCACTTTCTGCTACCCCCGTATGGAGGTCGGCCAACCCACGGTGTGCGCCGAGACCTGCGTGGGCCGGCTGCGCTACATCGGGGTGCTGCTCTACGACGTCGACCGCGTGACCGAGGCGGCGAGCGTCCAGGATGAGAAGGGCCTCTACCCCGCGCAGCTCGACCTCTTCCTCGACCCGGACGACCCCGAGGTCGTCGCGGCCGCCGAACGCTCCGGCGTGCCGCACGAGTGGATCCAGGCGGCGCGGCGCTCCCCGGTGCGCGACCTCATCTGCACCTACCGACTGGCGCTCCCGTTGCACCCGGAGTACCGGACGATGCCCATGGTCTGGTACATCCCGCCGCTGTCGCCGGTGGTGGACGCGTTGGCGAAGACCGGTTTCGACGGGGAGGACGCCGGAAACCTGTTCGGGGCCATCGAGGCGCTGCGGATTCCCGTGGAGTACCTGGCCGAGCTGTTCGCCGCCGGCGACCCCGAGCCGGTTAGGGCCTCGATGCGCCGGTTGGCCGCCATGCGGTCGTTCATGCGGTCGGTGAACCTCGGGGAAGTGCCCGACCAGAACCTGTTGAGCGGCGTCGGGTTGACCGAGGACCAGGTTCGGGCGATGTACCGGCTGCTCGCGGTGGCGAAGTACGACGAGCGTTACGTCATCCCGACCGCCGGTGTCGGTCAGGCCCACGAGTTGGAGGCCGTCGCCACGAAGTGCAGCCTGGACACCGAGGGCGGGCCGGGCATGGGTGGCGGTGGCGGGTCTCGGGGCGGCCCGGTCGAGTTGGTCGTGTGGAACGCGCGGAGCCGCCCGGAAGGGCTCTTCCCCCGGCGAGAGCGGTCATGA	MRVMAQLAMVMNLDKCIGCHTCSVTCKQTWTNREGVEYVWFNNVETRPGQGYPRQYEDQRRWRGGWELSRRGRLRLRGGSRLRRLGSLFANPDLPALTDYYEPWTYDYRTLTTAPLGDDSPVARPVSAVTGAPTTIHSGPNWDDSLGGGPENGALDPVVAKLRDELGHQVRFEFEQTFMFYLPRICEHCLNPSCVASCPSGAMYKRVEDGIVLVDQDRCRGWRMCVSGCPYKKVYFNHRTGKAEKCTFCYPRMEVGQPTVCAETCVGRLRYIGVLLYDVDRVTEAASVQDEKGLYPAQLDLFLDPDDPEVVAAAERSGVPHEWIQAARRSPVRDLICTYRLALPLHPEYRTMPMVWYIPPLSPVVDALAKTGFDGEDAGNLFGAIEALRIPVEYLAELFAAGDPEPVRASMRRLAAMRSFMRSVNLGEVPDQNLLSGVGLTEDQVRAMYRLLAVAKYDERYVIPTAGVGQAHELEAVATKCSLDTEGGPGMGGGGGSRGGPVELVVWNARSRPEGLFPRRERS	MARFFIDRPVFAWVISLFIMLGGIFAIRALPVAQYPDIAPPVVSLYATYPGASAQVVEESVTAVIEREMNGVPGLLYTSATSSAGQASLSLTFKQGVSADLAAVDVQNRLKIVEARLPEPVRRDGISIEKAADNAQIIVSLTSEDGRLSGVELGEYASANVLQALRRVEGVGKVQFWGAEYAMRIWPDPVKMAALGLTASDIASAVRAHNARVTIGDVGRSAVPDSAPIAATVLADAPLTTPDAFGAIALRARADGSTLYLRDVARIEFGGNDYNYPSFVNGKTATGMGIKLAPGSNAVATEKRVRATMEELAKFFPPGVKYQIPYETASFVRVSMSKVVTTLVEAGVLVFAVMFLFMQNFRATLIPTLVVPVALLGTFGAMLAAGFSINVLTMFGMVLAIGILVDDAIVVVENVERLMVEEKLPPYEATVKAMKQISGAIVGITVVLTSVFVPMAFFGGAVGNIYRQFAFALAVSIGFSAFLALSLTPALCATLLKPVADDHHEKDGFFGWFNRFVARSTHRYTRRVGRVLERPLRWLVVYGALTAAAALLITKLPAAFLPDEDQGNFMVMVIRPQGTPLAETMQSVRRVEEYVRTHSPSAYTFALGGYNLYGEGPNGGMIFVTMKDWKERKRARDQVQAIIAEINAHFAGTPNTMVFAINMPALPDLGLTGGFDFRLQDRGGLGYGAFVAAREKLLAEGRKDPVLTDLMFAGTQDAPQLKLDIDRAKASALGVSMEEINATLAVMFGSDYIGDFMHGSQVRRVIVQADGRHRLDAADVTKLRVRNAKGEMVPLAAFATLHWTMGPPQLTRYNGFPSFTINGAASAGHSSGEAMAAIERIASTLPAGTGYAWSGQSYEERLSGAQAPMLFALSVLVVFLALAALYESWSIPFAVMLVVPLGVIGAVAGVTLRGMPNDIYFKVGLIATIGLSAKNAILIVEVAKDLVAQRMSLADAALEAARLRLRPIVMTSLAFGVGVLPLAFATGAASGAQIAIGTGVLGGVISATLFAIFLVPLFFVCVGRVFDVVPRRRGGAQAALEAK	50.14	gnl|BL_ORD_ID|428|hsp_num:0	476			2640	2832	
BGC0001048.1|Tallysomycin_5 # 6470 # 7135 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=7bp;gc_cont=0.707	BGC0001048.1|Tallysomycin_5 	6470	7135	+	Loose	800	27.7202	msrA	27.03	3000251	protein homolog model	n/a	n/a	macrolide antibiotic; streptogramin antibiotic; streptogramin B antibiotic	antibiotic target protection	msr-type ABC-F protein	ATGAGACCGTGGCGCCGCCGCGCTCCGCGACCGGACGAGCACGGGACGTCCGTGATCAGGCAGGCCGCCGCCTGGTGCCTGCACTACCCGGATGTTGAGCTGCGGCAACGAGTTCCGCTCCTGCGGTCGGCGTTGGGTGAACTGGCCACCGCTCCGGCCTCGCTGCTGCTCGACGTCGTGGAGTACCTCGCGACCACCCCGGTGGTGGAAGCCGCGCGGCACTACGTCGAGGTCTTCGACAGCCGGCCCCGGCTCTGCCTCTACCTGAGCTGGTACACCGACGGGGACACCCGGCGTCGCGGCGCCTCCCTGGCCGAGTTCAAACAGCTCTACCGCGACCACGGTTTCCTCCCCGGTCGGGGAGAGCTCCCGGACTACCTGCCGATGTTGTTGGAGTTCACGGCCACTGGCGGCCCCCAGGCCCGCGCGGCCGGCGAGGAGATGTTGACCAGGTACCGCCCGGCGCTGGAACTGCTCGCCGGCGGACTGGACCGCTGTGGCACACCGTATGTCCACTGTGTACGAGCCGTGTTGGCCTCCCTGCCACCGGCCCCGCCCACGACGAAGGGCGAACACGCCGCCAGCACCACACCTCCCCACGAACTCGTCGGCCTGGGCCTGCCCGGTTTCGGCCGACCGGAGAGCGAGCCGGAAGGCGCCCGATGA	MRPWRRRAPRPDEHGTSVIRQAAAWCLHYPDVELRQRVPLLRSALGELATAPASLLLDVVEYLATTPVVEAARHYVEVFDSRPRLCLYLSWYTDGDTRRRGASLAEFKQLYRDHGFLPGRGELPDYLPMLLEFTATGGPQARAAGEEMLTRYRPALELLAGGLDRCGTPYVHCVRAVLASLPPAPPTTKGEHAASTTPPHELVGLGLPGFGRPESEPEGAR	MEQYTIKFNQINHKLTDLRSLNIDHLYAYQFEKIALIGGNGTGKTTLLNMIAQKTKPESGTVETNGEIQYFEQLNMDVENDFNTLDGSLMSELHIPMHTTDSMSGGEKAKYKLRNVISNYSPILLLDEPTNHLDKIGKDYLNNILKYYYGTLIIVSHDRALIDQIADTIWDIQEDGTIRVFKGNYTQYQNQYEQEQLEQQRKYEQYISEKQRLSQASKAKRNQAQQMAQASSKQKNKSIAPDRLSASKEKGTVEKAAQKQAKHIEKRMEHLEEVEKPQSYHEFNFPQNKIYDIHNNYPIIAQNLTLVKGSQKLLTQVRFQIPYGKNIALVGANGVGKTTLLEAIYHQIEGIDCSPKVQMAYYRQLAYEDMRDVSLLQYLMDETDSSESFSRAILNNLGLNEALERSCNVLSGGERTKLSLAVLFSTKANMLILDEPTNFLDIKTLEALEMFMNKYPGIILFTSHDTRFVKHVSDKKWELTGQSIHDIT	45.29	gnl|BL_ORD_ID|1105|hsp_num:0	1200			210	432	erythromycin; quinupristin
BGC0001048.1|Tallysomycin_6 # 7132 # 7875 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=GGAAGG;rbs_spacer=6bp;gc_cont=0.684	BGC0001048.1|Tallysomycin_6 	7132	7875	+	Loose	800	25.409	lsaE	25.26	3003206	protein homolog model	n/a	n/a	lincosamide antibiotic; streptogramin antibiotic; pleuromutilin antibiotic	antibiotic target protection	lsa-type ABC-F protein	ATGACCAGCCCACTCGACCTGCTGCTCTGGGCCGTGCTGCCCTACGTGACGATCGCCGTCCTGGTGGGCGGCACGCTGTGGCGGTTCCGCTACGACCGGTTCGGTCTGAGCACGCGCAGCTCCCAGCTCCACGAGTCCCGGTTGCTGCGCACCGCGAGCCCGCTGTTCCACTTCGGACTGTTGTTCGTGGCCGCCGGGCACGTCTTCGGGCTGCTCGTGCCCAAGAGCCTCACGAGCTTTCTCGGCGTGAGCGAGGAGATGTACCACCTCGGGGCGTTGGTGATGGGAGCCCTCGCCGGCTGCGCCACCGTCGCGGGATTGGCCATCCTGATGTGGCGTCGCTGGCGCACGCCGGCCGTCCGGGGCGCCACCACGCGAAACGACCGCCTGACCTACGTCCTGCTCGGCGTGGTGCTGTTGGCCGGCATGTCCACCACCGTCCTCACCAACGGTGTGATGGGGAAGTACGACTACCGCGAGACCATCTCACCGTGGTTCCGCGGAATCCTTCTGCTGCAACCTGATCCGGCGCTGATGGAGTCGGTTCCGCTCACCTACAAGGCGCACATCCTGGGCGCGATGGCGTTGTTCTGCCTGTGGCCCTTCAGCCGGCTGGTCCACGCCTTCACTGCTCCGGTTCAGTACCTGCTGCGGCCCTACGTGGTCTACCGCAGCCGGGGCGAGGGACTGGGCACCCGGGAGCTGGGCGCCCGGGAGCGGCGGCGGGAGAGGCAGGGCCTGTGA	MTSPLDLLLWAVLPYVTIAVLVGGTLWRFRYDRFGLSTRSSQLHESRLLRTASPLFHFGLLFVAAGHVFGLLVPKSLTSFLGVSEEMYHLGALVMGALAGCATVAGLAILMWRRWRTPAVRGATTRNDRLTYVLLGVVLLAGMSTTVLTNGVMGKYDYRETISPWFRGILLLQPDPALMESVPLTYKAHILGAMALFCLWPFSRLVHAFTAPVQYLLRPYVVYRSRGEGLGTRELGARERRRERQGL	MSLINVSNLTFSYEGSYDNIFENVSFQIDTDWKLGFIGRNGRGKTTFLNLLLGKYAYSGNISSTVKFEYFPYDVEDKSLYTIEVMKSICTECMDWEIFREISLLDVQEDALYRPFNTLSNGEQTKVLLAALFLTASCFLLIDEPTNHLDIDARNVVQNYLKRKKGFILVSHDRSLLDQCVDHILSINKTNIEIQKGNFTSWWENKTLQDNFELAENKKLLKEIGRLSYAAKRSSNWSNKVEKSKYGTTNSGSKLDKGYVGHKAAKAMKRAKNIESRHQEAVLQKSELLHNIEQYDDLKISPLEFHKECLIEANDLSLSYGDKEVCSNLNFRVNIGDRVAIIGKNGSGKSSILKLINGDDIKFTGNFMLASGLKISYISQDTSYLKGNLSEFAYNNKIDETLFKTILRKLDFNREQFDKNMVDFSAGQKKKVLIAKSLCESAHLYIWDEPLNYIDIFSRIQIEKMILEYCPTLLFVEHDDAFCNNICTKNINLGL	50.00	gnl|BL_ORD_ID|236|hsp_num:0	264			99	366	lincomycin; pleuromutilin
BGC0001048.1|Tallysomycin_7 # 7872 # 8438 # 1 # ID=1_7;partial=00;start_type=GTG;rbs_motif=GGGAG;rbs_spacer=11bp;gc_cont=0.728	BGC0001048.1|Tallysomycin_7 	7872	8438	+	Loose	1280	25.7942	macB	32.69	3000535	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	GTGAGCCGACCGAGCCCGCGCGTCGGCGGCGTGCTCGGGGAGCGCCCTCGGTCCCGACCACGCAGGGCCGCCTACTCCGCGATCAACTCCTTCCTCTCGCTGGCCCTCATCGGCGTCGCCGCCCTGCTCTCCGGGGAGCCGCTGCTGTTCCCCTCGCTCGGCCCCACGGCGTTCCTGCTGTTCGCCGCACCGCTCACCCCGGCCGCGTGCCCGCGCAACACGCTCGTCGGCCACCTCGTCGGCGTGCTCTCCGGCGCGTTCGCGTTGCTCGTCACCGGCCTGCACGACCAACCCCCGGACCTCAACCACGTCACGGGCGCCCGGATGGCCGCCGCCGCCATCGCCCTGGGACTCACCTGCGGCTTGATGCCGTTGCTGGACCGGGCGCACCCACCGGCGGGTGCGACGACGTTGATCGTGGCCCTGGGATTGCTGCGCACGCCCGAACAACTGGTCATGGTGATGGTCGGCGTCATCCTGATCACCGCGCAGGGCGTGGTGATCAACCGGCTCGCCGGCATTCGGTACCCGTGGTGGAGCCCGGCCCCGCGCCGTGACTCCCGGTGA	MSRPSPRVGGVLGERPRSRPRRAAYSAINSFLSLALIGVAALLSGEPLLFPSLGPTAFLLFAAPLTPAACPRNTLVGHLVGVLSGAFALLVTGLHDQPPDLNHVTGARMAAAAIALGLTCGLMPLLDRAHPPAGATTLIVALGLLRTPEQLVMVMVGVILITAQGVVINRLAGIRYPWWSPAPRRDSR	MSLIECKNINRYFGSGENRVHILKDISLSIEKGDFVAIIGQSGSGKSTLMNILGCLDTAGSGSYRIDGIETAKMQPDELAALRRERFGFIFQRYNLLSSLTARDNVALPAVYMGMGGKERSARADKLLQDLGLASKEGNKPGELSGGQQQRVSIARALMNGGEIIFADEPTGALDTASGKNVMEIIRRLHEAGHTVIMVTHDPGIAANANRVIEIRDGEIISDTSKNPEIPASNVGRIQEKASWSFYYDQFVEAFRMSVQAVLAHKMRSLLTMLGIIIGIASVVSVVALGNGSQKKILEDISSMGTNTISIFPGRGFGDRRSGKIKTLTIDDAKIIAKQSYVASATPMTSSGGTLTYRNTDLTASLYGVGEQYFDVRGLKLETGRLFDENDVKEDAQVVVIDQNVKDKLFADSDPLGKTILFRKRPLTVIGVMKKDENAFGNSDVLMLWSPYTTVMHQITGESHTNSITVKIKDNANTRVAEKGLAELLKARHGTEDFFMNNSDSIRQMVESTTGTMKLLISSIALISLVVGGIGVMNIMLVSVTERTKEIGIRMAIGARRGNILQQFLIEAVLICIIGGLVGVGLSAAVSLVFNHFVTDFPMDISAASVIGAVACSTGIGIAFGFMPANKAAKLNPIDALAQD	29.19	gnl|BL_ORD_ID|446|hsp_num:0	487			1728	1884	erythromycin
BGC0001048.1|Tallysomycin_8 # 8527 # 9582 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=8bp;gc_cont=0.731	BGC0001048.1|Tallysomycin_8 	8527	9582	+	Loose	750	33.4982	tet(X6)	41.18	3005056	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic inactivation	tetracycline inactivation enzyme	ATGCGTGCCTTGACGGTGGACCCTCGGCAGGCCGGGTCGTTGCGCGTGGCCGAGGTCCCCGACCCGGAGCCCGCGCCGGGCGAGCTGCTGGTCGACGGGCTGGCGCTCGGGGTCTGCGGCACCGACCGGGAGATCGCGCGTGCCGAGTACGGCTGGTCGCCGCCGGGCAGGCCCTGGCTGGTGCTGGGGCACGAGTCGCTGGGCCGGGTGCGCCAGGCGTCGCCGGGCAGCGGCTTCACGCCCGGTGACCTGGTGGTCGGCGTCGTGCGCCGGCCCGACCCGGTGCCGTGTGGGGCGTGCGCGCGCGGTGAGTTCGACATGTGCCGCAACGGCCAGTACACCGAGCGCGGCATCAAGGAGATCGACGGGTACGGCAGCCAGGTCTGGTGCGTGGAGCCCGACTACGCGGTGACGCTCGACCCGCGACTGGAGCGCGTCGGCATGTTGATGGAGCCGACGACCGTGGTGGCCAAGGCGTGGGACCAGGTGCGGCGCGTGGGCGAGCGAGCGTGGTTCGAGCCGAGGCGCGTGCTGGTCACGGGCGCCGGCCCGATCGGCCTGCTCGCCGCGCTGCTCGGCGCGCAACGCGGCCTGGACGTGCACGTCCTGGACCGGGTCACCGACGGCCCCAAACCCCGCCTGGTCCGGGACCTGGGCGCGACCTACCACAGCGATCCGATCGACACCGTGGCGTCCCGACTCCAACCCGACGTCGTCATCGAGGCCACCGGCGTGGGCAGTGTCGTCTTCGGCGCGATCGAGCACACCGCGCCGTACGGCATCGTCTGCCTGACCGGCGTGTCACCCTCGGGCCGTGCGCTGCCGATCGACGCGGGCGCGCTCAACCGGTCGCTGGTGCTGGAGAACGACGTCATCATCGGCTCGGTCAACGCCAACCTCGACCACTACCGCCAGGCGGCCGAGGCGTTGGCGAGGGCGGACCTGGACTGGCTGGACCGCGTGATCACCCGCCGCGTCCCGCTCACCCGGTTCGCCGAGGCGTTCGCCGCCGAACCCGACGACGTCAAGGTCGTCATCACCCTCGACGAGGCATGA	MRALTVDPRQAGSLRVAEVPDPEPAPGELLVDGLALGVCGTDREIARAEYGWSPPGRPWLVLGHESLGRVRQASPGSGFTPGDLVVGVVRRPDPVPCGACARGEFDMCRNGQYTERGIKEIDGYGSQVWCVEPDYAVTLDPRLERVGMLMEPTTVVAKAWDQVRRVGERAWFEPRRVLVTGAGPIGLLAALLGAQRGLDVHVLDRVTDGPKPRLVRDLGATYHSDPIDTVASRLQPDVVIEATGVGSVVFGAIEHTAPYGIVCLTGVSPSGRALPIDAGALNRSLVLENDVIIGSVNANLDHYRQAAEALARADLDWLDRVITRRVPLTRFAEAFAAEPDDVKVVITLDEA	MTLLKHKKITIIGAGPVGLTMARLLQQNGVDITVYERDKDQDARIFGGTLDLHRDSGQEAMKRAGLLQTYYDLALPMGVNIVDEKGNILTTKNVRPENRFDNPEINRNDLRTILLNSLQNDTVIWDRKLVTLEPDKEKWILTFEDKSSETADLVIIANGGMSKVRKFVTDTEVEETGTFNIQADIHQPEVNCPGFFQLCNGNRLMAAHQGNLLFANPNNNGALHFGISFKTPDEWKSKTRVDFQDRNSVVDFLLKKFSDWDERYKELIRLTSSFVGLATRIFPLDKSWKSKRPLPITMIGDAAHLMPPFAGQGVNSGLMDALILSDNLTNGKFNSIEEAIENYEQQMFAYGREAQAESIINETEMFSLDFSFQKLMNL	92.86	gnl|BL_ORD_ID|4802|hsp_num:0	3797			18	120	tetracycline; minocycline; oxytetracycline
BGC0001048.1|Tallysomycin_9 # 9602 # 10963 # -1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=GGGAGG;rbs_spacer=4bp;gc_cont=0.711	BGC0001048.1|Tallysomycin_9 	9602	10963	-	Loose	500	28.4906	LlmA 23S ribosomal RNA methyltransferase	30.43	3003982	protein homolog model	n/a	n/a	lincosamide antibiotic	antibiotic target alteration	Llm 23S ribosomal RNA methyltransferase	ATGACAGGGCGGCCGGCGGAGTTCCCCGAGGGACGCCTGTCCGTCCGGGGTCGGCTGGCTCACGACAAGGCCAGCAGGTCTGCCGCCGGCCAGGACTTCGGGCGCGTCGTCCGACAGGAGCCGTGGGCGGTGTTCCGGCCGGAGTCCGCCGAGGACGTCAGCGCGCTCGTCCGGTTCGCGGCCGCTCAGCGACGCGCGGTGGCGCCCCGGGGTCGGGGGCACTCGACCTTCGGACAGGCCCAGGCCGCCGACGGGATCGTCCTCGACCTGAGCGGTCTGCGCGCGGTCCACGAGGTCGGCCCGGACTTCATGGACGTGGACGCGGGCGCCTCCTGGCGGTCCGTCGTGCTCGCGACGGTGCCCCGCGGGCTGACTCCCCCGGTGCTCACCGACTACCTCGGGCTGTCCGTGGGCGGCACGCTCTCGGTGGGCGGCGTCGGTGGCGCGACCCACCGGCACGGCATGCAGACCGACAACGTCCTGCGACTCGACGTCGTCACCGGCGACGGCGTGGCGCGGACCTGCTCCGCGCACACCGAGAGCACGTTGTTCCACGCGGTTCTCGGCGGGCTGGGCCAGTGCGGTGTCATCACCCGCGCCAGACTTCGCCTCGTTCCGGCTCCTGCCCGCGTCCGCCGCTACAAGCTGTACTACGCCACACCGCGCAGGCTCACCGCCGACCAGCGCCGCCTCCTGGCCTCCGACCGCTTCCCCTACCTCGAAGGACAGCTGAAGCCCGACGCGAGCGGATGGCGTCCGAGGTTGGAAGCCGCTGCCTTCTTCTCGCCGCCGGAGCTCCCCCTCGACGAGTCGCTGTTGGACGATCTGGGACACGAGCGCGGAAGCGAGGAAATCGAAGATCTGTCCTATGTGGACTTCGTGGACAGGCTGACGTGCAGCGAGGCCGACCTGCGCGCCACGGGCGAGTGGTTCCACCCCCACCCGTGGTGGAACGCGTTCCTCCCCGGCTCCACTGTGGACGATCTGGTCGAGGAGGTCGCCGCCCGAGTCACACCCGACGACATCGGCGCGGGCGGTGCGTTGCTCCTCTACCCCTTCACGCGGCGACGCCTGACCACACCGATCGTGCGCACCCCTGACGATCCTGTCGTCTTCCTCTTCGCGATCCTGCGCACCGCTCCCCCGGACCAGCCGACGGCGGTAGAGGAGATCATCCGTCTCAACCGCGCCCTGTACGAGCAGGTTCGTGCCGCCGGCGGAACCCGGTACCCCGTCGGGACGGTGCCGTTCGACCGTGCCGACTGGGTGCGGCACTTCGGCACCGCGTGGCCCTCGTTGCACGAAGCCAAGGAACGGTACGACCCGCACCACGTCCTCACACCCGGCCAGGGAATCTTCTGA	MTGRPAEFPEGRLSVRGRLAHDKASRSAAGQDFGRVVRQEPWAVFRPESAEDVSALVRFAAAQRRAVAPRGRGHSTFGQAQAADGIVLDLSGLRAVHEVGPDFMDVDAGASWRSVVLATVPRGLTPPVLTDYLGLSVGGTLSVGGVGGATHRHGMQTDNVLRLDVVTGDGVARTCSAHTESTLFHAVLGGLGQCGVITRARLRLVPAPARVRRYKLYYATPRRLTADQRRLLASDRFPYLEGQLKPDASGWRPRLEAAAFFSPPELPLDESLLDDLGHERGSEEIEDLSYVDFVDRLTCSEADLRATGEWFHPHPWWNAFLPGSTVDDLVEEVAARVTPDDIGAGGALLLYPFTRRRLTTPIVRTPDDPVVFLFAILRTAPPDQPTAVEEIIRLNRALYEQVRAAGGTRYPVGTVPFDRADWVRHFGTAWPSLHEAKERYDPHHVLTPGQGIF	MYVAQDWQDYEVIDTGGGEKLERWGDVILRRPDPQIIWPIEREDGQWRSVHGHYHRSSSGGGQWDMKKQLPDRWTISYDQLKFHIRPTNFKHTGLFPEQAANWRWMMDKIASAGRPVSVLNLFAYTGGATVAAASAGAQVVHVDAAKGMVQWAKENAALSGLADRPIRYITDDVFKFVQREQRRGNKYDAIIMDPPSYGRGPSGETWKLEQSLYPFLESCMSIVSDNPLFMLINSYTTGISPTVLNNMLTMTMKPKYGGTISAGEIGLPITRSGMNLPCGILGRWES	157.84	gnl|BL_ORD_ID|2227|hsp_num:0	2519			690	828	clindamycin
BGC0001048.1|Tallysomycin_10 # 11023 # 11865 # -1 # ID=1_10;partial=00;start_type=GTG;rbs_motif=AGGAGG;rbs_spacer=8bp;gc_cont=0.731	BGC0001048.1|Tallysomycin_10 	11023	11865	-	Loose	500	26.5646	ErmF	31.67	3000498	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; streptogramin B antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	GTGCGGGATCAGGACGGTGACCCCGGCTCCGGGGTGACGACGGCGCGGGAGGGCGGAGTGGATCTCAGCCGGCCGAACCCGGCCCGCATGTACGACTACTACCTCGGCGGGGTGCACAACTTCGCGGTCGACCGCAGGGCCGCGGCCGACGTGCTGTCGATCCTGCCCGAGACCCGCGACTTCGCCCTGCGCAACCGGGCGTTCCTCCGCCGCGTGGTGCGCCACCTCGCCGCCGAGGCCGGCATCGTCCAGTTCCTCGACCTGGGCTCGGGCATCCCGACCGTGGGCAACGTGCACGAGATCGCCCAGGACGTGAACCCCGCCTGCCGCGTGGTCTACGTCGACCACGAGCCCGTCGCCGTGGCCCACTCGCGCAAGCTGTTGGAGGGCAACGACAACGCGGCCGTCATCCAGGCCGACGTCCGCGACGCCGCGACGGTGCTGTCCCACCCGGACACCCGTCGGCTGCTGGACTTCGAGCGGCCGCTCGCCGTGCTGATGCTCCAGGTGCTGCCCTTCGTCCCCGAGGCGGACAACCCCGGGGGCATCGTGGCCGCCTACCGGGCGGCCTGCGTGCCCGGCAGCTATCTGGCCCTGGCGCACAGCCTCACGCCGGAGTTCTGGCCGGGCAACGTCGACCAGGCCATCGAGCTGTACCGGTCGAGCACCCACCCCCTGCACCTGCGCACCCCCGAGCAGGTGGCGGCGCTGTTCGAGGGGTACGAGCTGGTCGAGCCCGGCGTCGTCTTCACCGCGGCCTGGCGGCCGGACCGGCCGATCCACCAACAGGACGCGATCAGCAGCCGAGCCGTCGCCGGCCTCGGCCGCCTCCCCTCCCGCTAG	MRDQDGDPGSGVTTAREGGVDLSRPNPARMYDYYLGGVHNFAVDRRAAADVLSILPETRDFALRNRAFLRRVVRHLAAEAGIVQFLDLGSGIPTVGNVHEIAQDVNPACRVVYVDHEPVAVAHSRKLLEGNDNAAVIQADVRDAATVLSHPDTRRLLDFERPLAVLMLQVLPFVPEADNPGGIVAAYRAACVPGSYLALAHSLTPEFWPGNVDQAIELYRSSTHPLHLRTPEQVAALFEGYELVEPGVVFTAAWRPDRPIHQQDAISSRAVAGLGRLPSR	MTKKKLPVRFTGQHFTIDKVLIKDAIRQANISNQDTVLDIGAGKGFLTVHLLKIANNVVAIENDTALVEHLRKLFSDARNVQVVGCDFRNFAVPKFPFKVVSNIPYGITSDIFKILMFESLGNFLGGSIVLQLEPTQKLFSRKLYNPYTVFYHTFFDLKLVYEVGPESFLPPPTVKSALLNIKRKHLFFDFKFKAKYLAFISYLLEKPDLSVKTALKSIFRKSQVRSISEKFGLNLNAQIVCLSPSQWLNCFLEMLEVVPEKFHPS	105.26	gnl|BL_ORD_ID|568|hsp_num:0	621			111	276	erythromycin; roxithromycin; lincomycin; telithromycin; clarithromycin; clindamycin; tylosin; spiramycin; azithromycin; dirithromycin; pristinamycin IA; quinupristin; virginiamycin M1; madumycin II; griseoviridin; dalfopristin; pristinamycin IB; virginiamycin S2; pristinamycin IC; vernamycin C; patricin A; patricin B; ostreogrycin B3; oleandomycin
BGC0001048.1|Tallysomycin_11 # 12315 # 14114 # 1 # ID=1_11;partial=00;start_type=GTG;rbs_motif=AGGAG;rbs_spacer=7bp;gc_cont=0.734	BGC0001048.1|Tallysomycin_11 	12315	14114	+	Loose	1000	222.246	msbA	29.54	3003950	protein homolog model	n/a	n/a	nitroimidazole antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	GTGAACGACCAACGCGGCCGGACCGGGGCCACGAGGGTGCTGTGGTCCTACACCCACGACATGCGCGCCGCGCTGATGTGGTTGTTACTCCTGGAGCTGGTGTCCAACGGAGCCGCGCTGGCCCAGCCGCTGGTGGTGCGCGCCGTGGTCGACCGGTTGGGGGCGGGGGAGAGCCTGGTCGGGCCGGTGGTGCTGCTCGTGGTGATCGCGGCCACCGGCCTGGTGCTCACCTGGTTGTCCACCTACCTGATGGAACGGTTCGGCCAACGCATCGTGCTGACCGTGCGGCAACGGCTGGTGCGCCGCATCCTCGGGGCTTCGGTGTCCACAGTGGAGGAACGACCGGTCGGGGACTTCCTGTCGCGGGTCAGCGGCGACACGACGGTGCTGCGGCACACGGTCACCGGGATGCTGGTGCACGGCGCGGCGGCGCCGCTGACCATCGCGGCCGCGGTGGTGGTCATGGCCAGCATCGACCTGGTCCTGCTGGCGATCGTGGTCGCGATGTTCGGCCTGTCGATGGTGGCCGCCAAGTGGGCGCTGGACCGGGTGGGCCGGGCCAGCGAGGAGGCCCAGGGCCACCTCGGTGGGCTCACCAGCGTGCTCCAGCGTGCGTTGGTGGCCTTCCGCACCGTCAAGGCGTCGGGCACCGAGGAGTGGGAGCGCCGACTGGCCGACGAGGCGGCCGGCTCCTCCTACCGGGCCGCCGTCCGCGCGGGCCGGGCCGAGGCGACGGTGGACGTCATCGCGGTGACCGGCATCGAGCTGTCCTTCATCGTGGTGCTGGTGGTCGGCGCGGCCAGGGCCACCTCCGGCGCCCTCACGCTGAGCGACCTGATCGCCTTCCTGCTCTACGTGGTCTACCTGCGCGGACCGGTGGGGACGCTGGCCATGGTCGGGTCCTCCTTCGCCGAGGGCCTGGCGGCGGTGCGCCGGGTGCGGGAGCTGGAGCTCCTCCCCGCCGAGGCCGGGGACCGGCCGGCGACCACCGCCCCGCGCGCGGAGCAGAACGGCGGGCGGAACGGGGAGCCGTCGCTCCGGCTGGACGACGTGTGGTTCGGCTACGAGGGGCAGCCCCTCCTGCGCGGGGTCACCCTGGACGTGCCGCGCGGGCTGACGGTGCTGGTCGGCCCGTCGGGCACGGGGAAGACGACGGTGCTCAGCCTGGTCGAGCGCTTCGCCGACGTGGACCGCGGGCGCATCCTGCTGGACGGGGTGGACCTGCGGGAGATCGACCGGGGCGCGCTCCGGCAGAGGCTGGGCTACGTCCAGCAGGACGCCCCGTTGCTGGGCGACACCATCGGGGCGGCCGTGCGCTACGGCGTGCCCGACCCGGACGGGGCGGACGTGGTTGAGGCGTTGCGCACGGTCGGGCTGTGGTCGTGGGTCAGCGGCCTTCCGTCCGGTGTGGACACTCCGGTCGGGGAGCGCGGGGTGGCGATCTCGGGCGGGCAGCGGCAGCGGCTGGCGGTCGCCAGGGCCCTGCTCCGCGACCCCGCGGTGTTGTTGCTGGACGAGGCGACCAGCCAGCTCGACGCCCGCAGCGAGCGCGTCCTGATGCGCGCGGTCGTCGAGCAGGCCGCGCACCGGGTCGTGCTCGCGGTCACCCACCGGGGCGTGGTGGCCGGCCTCGCCGACCAGGTGGCGTTGCTGGACGGGGGTCGGGTGCGCGCCGTGGGTCGGCACGAGGAGTTGTTGTCCTCCGACACGCTCTACCGGGAGCTGCTGGCGGTTCCCGAGTTCCCGTCCGCACCGGAGCGCGGGAAGCGAGAAGAAAGATCGGTAATCTCCGCGGATTAG	MNDQRGRTGATRVLWSYTHDMRAALMWLLLLELVSNGAALAQPLVVRAVVDRLGAGESLVGPVVLLVVIAATGLVLTWLSTYLMERFGQRIVLTVRQRLVRRILGASVSTVEERPVGDFLSRVSGDTTVLRHTVTGMLVHGAAAPLTIAAAVVVMASIDLVLLAIVVAMFGLSMVAAKWALDRVGRASEEAQGHLGGLTSVLQRALVAFRTVKASGTEEWERRLADEAAGSSYRAAVRAGRAEATVDVIAVTGIELSFIVVLVVGAARATSGALTLSDLIAFLLYVVYLRGPVGTLAMVGSSFAEGLAAVRRVRELELLPAEAGDRPATTAPRAEQNGGRNGEPSLRLDDVWFGYEGQPLLRGVTLDVPRGLTVLVGPSGTGKTTVLSLVERFADVDRGRILLDGVDLREIDRGALRQRLGYVQQDAPLLGDTIGAAVRYGVPDPDGADVVEALRTVGLWSWVSGLPSGVDTPVGERGVAISGGQRQRLAVARALLRDPAVLLLDEATSQLDARSERVLMRAVVEQAAHRVVLAVTHRGVVAGLADQVALLDGGRVRAVGRHEELLSSDTLYRELLAVPEFPSAPERGKREERSVISAD	MHNDKDLSTWQTFRRLWPTIAPFKAGLIVAGVALILNAASDTFMLSLLKPLLDDGFGKTDRSVLVWMPLVVIGLMILRGITSYVSSYCISWVSGKVVMTMRRRLFGHMMGMPVSFFDKQSTGTLLSRITYDSEQVASSSSGALITVVREGASIIGLFIMMFYYSWQLSIILIVLAPIVSIAIRVVSKRFRNISKNMQNTMGQVTTSAEQMLKGHKEVLIFGGQEVETKRFDKVSNRMRLQGMKMVSASSISDPIIQLIASLALAFVLYAASFPSVMDSLTAGTITVVFSSMIALMRPLKSLTNVNAQFQRGMAACQTLFTILDSEQEKDEGKRVIERATGDVEFRNVTFTYPGRDVPALRNINLKIPAGKTVALVGRSGSGKSTIASLITRFYDIDEGEILMDGHDLREYTLASLRNQVALVSQNVHLFNDTVANNIAYARTEQYSREQIEEAARMAYAMDFINKMDNGLDTVIGENGVLLSGGQRQRIAIARALLRDSPILILDEATSALDTESERAIQAALDELQKNRTSLVIAHRLSTIEKADEIVVVEDGVIVERGTHNDLLEHRGVYAQLHKMQFGQ	102.92	gnl|BL_ORD_ID|2185|hsp_num:0	2423			201	1725	metronidazole
BGC0001048.1|Tallysomycin_12 # 14669 # 14971 # 1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=AGGAGG;rbs_spacer=9bp;gc_cont=0.789	BGC0001048.1|Tallysomycin_12 	14669	14971	+	Loose	1700	24.6386	AxyY	34.88	3004144	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; cephalosporin	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCGTCGTCCCGACCGGTCCGCCGTGCTCCCGGCGGCCACCGCCGTCTCGGCGGCCGTGGTTGACGCGCCGGACCCGTCCGCCCTGGACCCGGACCGCGACGAGGCGTCCGGGAACGCCTCCGCCATCTCCACCAGCTCCGTCGTCTCCGGGCCTCGCCCGGTGACCCCGCGCGGCCGCACCGGGCCGCGTCGGGGCGCGTCCCGCCTCGCGCGGCGCGCGCACCCTCGGGGGCCTGTTCGTCCACAGTGGCGCGAGCGTCCTCCGGACCGGGGGGCTCGTCAGCCGCAGTCTCGCTCCTAG	MRRPDRSAVLPAATAVSAAVVDAPDPSALDPDRDEASGNASAISTSSVVSGPRPVTPRGRTGPRRGASRLARRAHPRGPVRPQWRERPPDRGARQPQSRS	MARFFIDRPVFAWVISLLIALVGLLSIRALPVAQYPDIAPPVVNIGASYPGASAKVVEEAVTAIIEREMNGAPGLMYTSSSSDSTGWASINLTFKQGTNPDIAAVEVQNRLKAVEPRLPESVRRDGVRVEKAADNIQLVVSLKSDGSLDDMQLGELAASNVLQALRRVEGVGKVQSFGAEAAMRIWPDPAKLTALSLTPGDIVSALRSHNARVTIGELGNQAVPKDAPLNASIVAGESLHTPEQFANIPLRALPDGATLRLKDVARVELGGTDYMYLSRVNGLTGTGLGIKLAPGSNAVETTRRIRETMRELAQYFPPGVTWDIPYETSTFVEISIKKVLMTLLEAVALVFCVMYLFMQNLRATLIPTLVVPVALLGTLGVMLGLGYSINVLTMFGMVLAIGILVDDAIVVVENVERIMAEEGLSPHDATVKAMGQISGAIVGITVVLVSVFVPMAFFDGAVGNIYRQFAVTLAVSIAFSAFLALSLTPALCASLLKPVPAGHHEKRGFFGWFNRAFARLTTRYTARVAGVLARPVRFGLAYALVIGVAALLFARLPSSFLPDEDQGSFMAMVILPQGSPQAETMAVVKDVERYMMEHEPVQYVYSVNGFSQYGSGPNSAMFFVTLKDWKERRDASQHVDAVVKRINKAFADRKNLMVFALNSPPLPDLGSTSGFDFRLQDRGGLGYEALTQARQKLLAKAAEHPALTDVVFAGQEEAPQLQLRVDRDKAQAMGVPIDEINTALAVMYGSDYIGDFMLNGQVRRVMVQADGKRRVDVDDISRLHVRNLQGQMVPLSAFATLTWSMGPPQLNRYNGFPSFTINGSAARGHSSGEAMRAMETLAAELPRGIGFDWSGQSYEERLSGNQAPVLFALSVLIVFLALAALYESWSIPLAVILVVPLGVIGALLGVTVRGMPNDIYFKVGLIATIGLSAKNAILIVEVAKDLVRDGQGILSATLEAARLRLRPIVMTSLAFGVGVLPLALATGAASGAQAAIGTGVLGGIITATVLAVFLVPLFFLIVGRMVGMRARPARPDGREPLETTP	9.57	gnl|BL_ORD_ID|2411|hsp_num:0	2799			1593	1722	erythromycin; cefepime
BGC0001048.1|Tallysomycin_14 # 16093 # 22491 # 1 # ID=1_14;partial=00;start_type=GTG;rbs_motif=GGGAG;rbs_spacer=7bp;gc_cont=0.735	BGC0001048.1|Tallysomycin_14 	16093	22491	+	Loose	1000	122.865	almE	26.65	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	GTGTCCGAAACGGCGAATGCTGGCTACCGCGTTTCCCCGCTCCAGCGCCATAGGTGGGCCCGGCGGCTCGACGGCCGCGAGCAGCCGTACGCGCAGCTGGGAGTCCGGCTGGAGGGACCGGTCGACGCCGAGCGACTCGCCGCCGCGACCGCCGCCGTCGTGGCCAGGCACGAGTCGCTGCGCACCAGCTTCGTCGGACTGGCCGGCCGCGCCGCGCCGCTCCAGGTCGTCGGCGAGCCGGGGCCGTCGCCGTTACGGGTCGTCGAGGCGCCCGACGCCACGGTCGAGGCGCTGTGCCGCGACGAGCGCGCCGGCCTCGACCCCGTCGACGGGCCGACCTTCCGGGCCGTCCTGACCAGGGTGGCCCCGGACCGGGCGCTGTTCGTGCTGACCGCGCACGCCCTGGTCGGCGACCGGGGCTCGCTGCGGACCGTGCTCGCCGAGATCGCCGCCGCGTACCGGGGCGACGCCGCGTCGTCGGAGCTCCCGATGCAGTACGCGGACTTCGCCGCCTGGCACGACGAGCTGCTCACCGGTGAGGACGGGGCGGCGGAGCGCGCGGCGTGGGCCGGGCAGCTCACCGCCGAGCTGTTCGAGCCGGTGCTGGGCCTGGCGCGGCGCGCCGACGGCGCTGCCAGTGCTGCCAGTGCCGCCAGTGCTGGCAGCGCTGACGGGGCCGGCGGGTGGCGGACGCACCGGACCGAGGTGGACGCCGAGCTGACCCGCCGGGTCGCCGAGTTCGCCGCCGCCGCGTCGGGCACGCCGGCAGACGTGCTCGCCGCCCTGTTCGAGGTCCTGGTCTGGCGGTTCTGCGGGGAGCGGGACGTCCTGGTCGCCGAGGTCGCCCCCGGGCGGTCCTACGACAGCCTGCGCGGCGCGGTCGGCGCGTTCGAGCGCGAGGTCCCGGTCGCCTGCCGGCTCAGCGCCGACACCCCGTTCCGCGAGCTGGTCGCCGAGAGCGCGCGGCGTCGCGCGGAGTGGGTGGACCGCGTCGACCACCTCGATCCGGAGAAGGTGGTGGACCACGCCGGAAAACCCGCGGCCCCGTTCTTCGCCTTCCACTTCGCCAACGCGTCGGAATCGCTGGTCGCCGACCAGGTCACCTTCGTTCCGGTGCTTGAGGCCGCGACGTCGGACGCCGCGTTCCGGCTCACCTGCACCGAGCGCGACAACCGACTCGTCGTCGAGATCGGATACGACGAGGAACGCGTCGACCCGGCCCAGCCCGAGCGTGTCGCGGAATGCTTCGCCGTCCTGCTGCGGAATGCCATGGCGAATCCCGCGACCCCGGTCGGGGAAATCGACATGCTGTCCGACGCCGAGCGCGAGCGCGTGGTGGCGCTCAGCCGGGGGCCGGTCGTCGACTCCCCGGTCGTCCCGGTGCACCAGGCGTTCGCGGCGCAGGCGCGGCGCACGCCCGACGCGGTGGCCGTCGTCGCCGACGGCGTCGAGATCACCTACGCCGCGCTCGACGCCCGCGCCGGACGGCTGGCCCAACGGCTCGTCCAGCTCGGCGTGCGCCAGGGCGACCCGGTCGTCATCTCCGTGGGCCGGTCGGTGGAACTGCTCGTCGGCGTCCTGGGGGTGCTGAAGGCCGGGGCGGCGTTCGTGCCGGTCGACGTCGCCTACCCGTTGCGCCGCCTGGAGTTCGTGCTGGAGGAGACGGCGGCGCCGGTGCTCCTGGGCACCAGTGAGCTGCGCGACCGGTTGGGCGAGTGCCGGGCGATTCTCCTGGCGCTGGACGAGGACGAAGACGGCGACGAACCGGTCGTCGGCAAAGAGTCCACTGTGGACGCTGAGTCGACCGACCTGGCCTACGTCATGTACACCTCCGGCACCACCGGCTCCCCCAACGGCGTTCGGGTGACCCACGGCGGTCTGGCCAACTACCTGCACTGGGCCGCCGATGCGTACCAGCTGCGGGAGGGCACCGGCGCGGTGGTCCACTCCTCGATCAGCTTCGACCTCACGCTGACCGCGCTGCTCGCGCCGCTGCTGGTCGGGCAGCGGGTCGTCCTGCTGTCCGAGACGGCCGGCGTGACCGGTCTGGTCGCCACGCTGCGCACCAGCCGCGACCTCAGCCTGGTCAAGCTGACCCCGACCCACCTGGACGTGGTCAACCAGCTGCTGGAGCCCGAGCAGGTCGCCGGCAGCGTCCGCACCCTGGTCGTGGGCGGCGAGGCGCTGCACGCGCGCAGCGTCGCGCCCTTCCGCGCGGCCGGCACGCGGATCGTGAACGAGTACGGCCCGACCGAGACCGTCGTCGGCAGCGTCGCCCACGTCGTCGACGAGAGCACCCCGCACGCGGGACCGGTCCCCATCGGCGTGCCGATCGCCAACACGCAGGCGTACCTGCTCGACCCGAGGCGCCAGCCGGTGGCCGACGGGGTCGTCGGCGAGGTCTACCTCGGTGGCGCCGGCGTCGCACTCGGCTACCTGAACCGCCCCGAGCTGACCGAGCAGCGGTTCCTGCCCAACCCCTTCGGTGACGGGCGGCTGTACCGCACCGGCGACCTCGCCCGCCGCCGGGCCGACGGCACCCTGGAGTACCTGGGCCGGGCCGACGAGCAGGTGAAGATCCGCGGTGTCCGGATCGAGCCGGCCGAGATCGAGAACGTGTTGCTGCGGCACGGTTCCGTGGGCCAGGTCGCGGTCGTGGCCCGGCGGGACGAGGACCCCGGCCGGTCCTCCCCGCTGGTCGCCGAGCTGACGCTCGTGGCCTACGTCGTGCCCGCCGACCAGGCGGCCGCGCCCGGCGTCGCCGACCTCGCCGAGCACTGCCGGGCGCACCTGCCCGAGCACCTGGTGCCGGCCGCGTTCGTGGTCATGGACGCGCTGCCGGTGACCGCCAACGGCAAGCTGGACCGCGCCGCGCTGCCCCGGCCCGCCGGCCACACGCCGGTCGTCGCCGACTACGTGCCGCCCAGGACCGGCACCGAGGAGATCCTGGCCGCCGCGATCGCGACCGTGCTCGGCGTGAGCCGGGTCGGCATCGACGACAACTACTTCGCGCTCGGCGGCGACTCCATCCGCAGCGTCATGATCGCCAGCCGGGCCCAGGCCAGCGGCGTGGAGGTCTCCGTCGCCGACCTCCACCGGCTGCCCACGGTCCGCCAGTGCGCCGCGCACCTGGACGCCCGCGAGGAGCCGGTGGAGCCGCCGCGCACCGAACCGTTCGCGTTGGTGCGCGAGGAGGACCGGCCGCTGATCCCGGCCGAGGTGGAGGACGCCTTCCCGCTGAACCTGTTGCAGGAGGGCATGATCTTCCACCGCGACTTCGCGGCGAAGTCGGCGGTGTACCACGCGATCGCGTCGGTGCGGCTGCGCGCGCCGTTCGACCTGGACGTGATGCGCATGGTGGTGCGCCAGCTCCTGGAGCGGCACCCGATGCTGCGCACCTCGTTCGACATGGGCACCTTCAGCCAGCCGCTGCAGCTCGTGCACACCGAGTACGAGACCCCGCTGTACCACGAGGACCTGCGGGGGCTGCCGGCCGAGGAGCAGGACTCCCGGGTCGAGGCGTGGATCGAGCACGAGAAGGAGCGCGGCTTCGAGCTGCACGAGTACCCGCTGATCCGGTTCATGGTCCACCGGATCGCCGACGACGTCTTCCAGTTCACCTACGGCTTCCACCACGAGATCGTGGACGGCTGGAGCGAGGCGCTGATGATCGCCGAGCTGTTCAGCCACTACTTCTCGGTGGTCTACGACGAGCCGATCGCGATCCGGCCGCCCACCTCGACCATGCGGGACGCGGTCGCGCTGGAGCTGGAGGCGTTGGAGGACCGGCGCAACTACGAGTTCTGGGACTCCTACCTGGCCGACGCCACGCTCATGCGGCTGCCCAGGCTGGGCTCGGGGCCCCGGGCCGACAAGGGCGACCGGGAGATCGTGCGGATCGCCGTCCCGGTCTCGGTCGAGTTGTCCGACCGGCTCAAGGAACTGGCCCTGGCCAACGCCGTTCCGCTCAAGACCGTGCTGATGGCCGCGCACATGGCGGTGATGTCCACCTACGGCGGGCACACCGACACACTGACCTACACCGTCACCAACGGTCGTCCCGAGACCGCGGACGGCAGCACGGCGATCGGCCTGTTCGTCAACAGCCTGGCGCTGCGGGTGCGGATGGCCGGCGGGACCTGGCGGGACCTCATCCTGGCGACGCTGGAGTCCGAGCGGGCCTCCCTACCGTACCGGCGGCTGCCGATGGCGGAGCTCAAGCGGCACCAGGGCAACGAGCCGCTGGCCGAGGCGCTGTTCTTCTTCACCAACTACCACGTCTTCGGCGTGCTGGACCGGTGGAAGGACCGCGGCGTCGAGCACGTCGCCAACGAGCTGTACGGCGAGTCCACCTTCCCGTTCTGCGGCATCTTCCGGTTGAACCGGGAAACCGGTCACCTGGAGGTGCGGATGGAGTACGACAGCCTCCAGTTCTCCGCCGAGCTGATGGACAGCATCCGGGACTGCTACGCGCGGGTCATGGAGACGATGGTCGCCGACCCGCGGGGCCGCTACGACACCCGGGCGTTCCTGTCCGACCGCGACCGGGAGCTGTTGGCCTCGTACGTCTCCGGCCCCACCGCGCACCACGACGACCTGTGCCTGCACGAGCTGATCGAGGACCGCGCCAGCGAGCGGCCGGACGCCGTGGCGGTGCAGCTCGACGACGCGGTGCTGACCTACCGGGAGCTGAACCGCGGGGCGAACCGGTTGGCCCACGTGCTCCGCCGGCACGGCGTCGGTCCGGAGTGGACGGTCGGCGTGCTGGCCGAGCGCTCCGTCGAGCAGATCGTGTCGCTGCTCGCGGTGCTCAAGGCCGGCGGCGCCTACCTGCCGCTGGACCCCAGCCAGCCGGACGAGCGGATCAACGCCCTGGTGCGCGCCAGCGGGGTCACGGTGGTGCTCGCGCAGGAGCACCTCGTCTCCCGGGTTCCGGCCGGCCCCACGACGATCGGGGTGAACCCGAGCGCCGGGACGGGCGAGGACGCGCCCGACACCAACCCGGTCAGCGGGGTCGTGCCCGCGAACCCGGCCTACGTCATGTTCACCTCCGGGTCCACCGGACAGCCCAAGGGCGTGGTCGTCGAGCACCGCAACGTCGTGGCCTCGCTCGCCGCGCGGGCGGCGGCCTACGAGGGCGAGGTCGAGCGGTTCCTGCTGCTGTCGTCGTTCGCCTTCGACAGCTCGGTCGCGGGCATCTTCTGGACCCTCACGCAGGGCGGCACCCTGGTGCTTCCCCGCGAGGGCCAGCAGATGGAGCCCGCGGGCCTGGTCGAGACCATCGCCCGCCAGCGGCCCACCCACACCCTGGGCATCCCGTCGCTGCTCGCGCCCGTGGTGGAACAGGCCAACCCGGGCGAGCTCTCCTCGCTGCGCCTGGTGGTCGCGGCCGGCGAGCCCTGCCCCACCGCGCTGGCGCGGGCCTGCGCGACGGCCGTCCCGGAGTGCGTGCTGGCCAACGAGTACGGGCCGACCGAGGCGACGGTGTGGGCCACGATGTGGTCCGCCGCCGAGGCCCCGGACCGACCGCAGTTGCCGATCGGCTCGCCGGTGGCCAACACGCGGGTGGAGGTGCTCAACCCGCACGGCCTGCCGGTGCCGATCGGGGTCTCCGGCGAGCTGCACCTCGGCGGCGCCGGCGTCGCCCGGGGCTACCTGGGCCGGCCGGCCGAGACCGCGGCCAGCTTCCGGCCGGACCCGGCGTCGCCGGGCCGCCGCCGCTACGCCAGCGGCGACCTCGGCCGCTACCTGGCCGACGGCGAGCTGGAGTTCCTGGGCCGGGCCGACCACCAGGTGAAGGTGCGCGGGTTCCGGGTCGAGCCGGGCGAGGTCGAGGCGGTCCTGGAGACCCACCCGGACCTCCAGCGGGTGATCGTCGTGGCCAGGGGGGAGAACGCCGCGGACAAGGTGCTCGTGGCGTACGTGCTCCCCGTGCCGGGGCAACGGCCCGACCCCGCCGACCTCCAGCAGTACGTGCGGGACCGGCTGCCGAAGTACATGGTGCCCAGCGCGTGCGTCGTGCTCGACGCCGTGCCGCTCACCGCGACCGGGAAGGTGGACCGGGCGTCGCTGCCGGAGCCGACCCGCGCCGAGCTGACCGGCGGTCGCGGCTACCAGCCGCCGCGCACCGAGACCGAGCAGGCCCTCGCCGCGATCTGGGCCGACGTGCTCAAGCTGGACCGGGTCGGGATCGCCGACCGGTTCTTCGACCTGGGCGGCGAGTCGTTGCGCGCCATGCAGGTCACCGCCGCGACCAACCGGATGTTCGGCATCAAGCTGTCGGTGCGGCGGCTGTTCGACGCGCCGACCATCGCCGAGTTCGCCCTCGGGGTGGACGAGGCGCGGCTGGCGCGGGAAGGGGCCGGCGCGGCCACCGGGGACGGGGCTGGCCGCGCATGA	MSETANAGYRVSPLQRHRWARRLDGREQPYAQLGVRLEGPVDAERLAAATAAVVARHESLRTSFVGLAGRAAPLQVVGEPGPSPLRVVEAPDATVEALCRDERAGLDPVDGPTFRAVLTRVAPDRALFVLTAHALVGDRGSLRTVLAEIAAAYRGDAASSELPMQYADFAAWHDELLTGEDGAAERAAWAGQLTAELFEPVLGLARRADGAASAASAASAGSADGAGGWRTHRTEVDAELTRRVAEFAAAASGTPADVLAALFEVLVWRFCGERDVLVAEVAPGRSYDSLRGAVGAFEREVPVACRLSADTPFRELVAESARRRAEWVDRVDHLDPEKVVDHAGKPAAPFFAFHFANASESLVADQVTFVPVLEAATSDAAFRLTCTERDNRLVVEIGYDEERVDPAQPERVAECFAVLLRNAMANPATPVGEIDMLSDAERERVVALSRGPVVDSPVVPVHQAFAAQARRTPDAVAVVADGVEITYAALDARAGRLAQRLVQLGVRQGDPVVISVGRSVELLVGVLGVLKAGAAFVPVDVAYPLRRLEFVLEETAAPVLLGTSELRDRLGECRAILLALDEDEDGDEPVVGKESTVDAESTDLAYVMYTSGTTGSPNGVRVTHGGLANYLHWAADAYQLREGTGAVVHSSISFDLTLTALLAPLLVGQRVVLLSETAGVTGLVATLRTSRDLSLVKLTPTHLDVVNQLLEPEQVAGSVRTLVVGGEALHARSVAPFRAAGTRIVNEYGPTETVVGSVAHVVDESTPHAGPVPIGVPIANTQAYLLDPRRQPVADGVVGEVYLGGAGVALGYLNRPELTEQRFLPNPFGDGRLYRTGDLARRRADGTLEYLGRADEQVKIRGVRIEPAEIENVLLRHGSVGQVAVVARRDEDPGRSSPLVAELTLVAYVVPADQAAAPGVADLAEHCRAHLPEHLVPAAFVVMDALPVTANGKLDRAALPRPAGHTPVVADYVPPRTGTEEILAAAIATVLGVSRVGIDDNYFALGGDSIRSVMIASRAQASGVEVSVADLHRLPTVRQCAAHLDAREEPVEPPRTEPFALVREEDRPLIPAEVEDAFPLNLLQEGMIFHRDFAAKSAVYHAIASVRLRAPFDLDVMRMVVRQLLERHPMLRTSFDMGTFSQPLQLVHTEYETPLYHEDLRGLPAEEQDSRVEAWIEHEKERGFELHEYPLIRFMVHRIADDVFQFTYGFHHEIVDGWSEALMIAELFSHYFSVVYDEPIAIRPPTSTMRDAVALELEALEDRRNYEFWDSYLADATLMRLPRLGSGPRADKGDREIVRIAVPVSVELSDRLKELALANAVPLKTVLMAAHMAVMSTYGGHTDTLTYTVTNGRPETADGSTAIGLFVNSLALRVRMAGGTWRDLILATLESERASLPYRRLPMAELKRHQGNEPLAEALFFFTNYHVFGVLDRWKDRGVEHVANELYGESTFPFCGIFRLNRETGHLEVRMEYDSLQFSAELMDSIRDCYARVMETMVADPRGRYDTRAFLSDRDRELLASYVSGPTAHHDDLCLHELIEDRASERPDAVAVQLDDAVLTYRELNRGANRLAHVLRRHGVGPEWTVGVLAERSVEQIVSLLAVLKAGGAYLPLDPSQPDERINALVRASGVTVVLAQEHLVSRVPAGPTTIGVNPSAGTGEDAPDTNPVSGVVPANPAYVMFTSGSTGQPKGVVVEHRNVVASLAARAAAYEGEVERFLLLSSFAFDSSVAGIFWTLTQGGTLVLPREGQQMEPAGLVETIARQRPTHTLGIPSLLAPVVEQANPGELSSLRLVVAAGEPCPTALARACATAVPECVLANEYGPTEATVWATMWSAAEAPDRPQLPIGSPVANTRVEVLNPHGLPVPIGVSGELHLGGAGVARGYLGRPAETAASFRPDPASPGRRRYASGDLGRYLADGELEFLGRADHQVKVRGFRVEPGEVEAVLETHPDLQRVIVVARGENAADKVLVAYVLPVPGQRPDPADLQQYVRDRLPKYMVPSACVVLDAVPLTATGKVDRASLPEPTRAELTGGRGYQPPRTETEQALAAIWADVLKLDRVGIADRFFDLGGESLRAMQVTAATNRMFGIKLSVRRLFDAPTIAEFALGVDEARLAREGAGAATGDGAGRA	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	383.45	gnl|BL_ORD_ID|4935|hsp_num:0	5928			135	1635	colistin A; colistin B
BGC0001048.1|Tallysomycin_15 # 22488 # 25754 # 1 # ID=1_15;partial=00;start_type=ATG;rbs_motif=GGGG;rbs_spacer=10bp;gc_cont=0.747	BGC0001048.1|Tallysomycin_15 	22488	25754	+	Loose	1000	149.058	almE	28.54	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGACGACGACGGCGTGCGGTGGGACCGGGGTCGGGGGCGCTGGCGCGCCCCTGGCCTCGGCCCAGCGCCGGCTGTGGTTCCTGCACCAGCTCGCACCCGGCAGCGCGGCGTACAACATCTGCACCGCCATCGAGCTGACCGGCCGGCTGGACCTGGCCGCGCTGCGGGACGCCGTCCTGCGGCTCGGCCGGCGGCACGAGGTCCTGCGGGCCACCTTCGGCGTGGTGGACGACGAACCGCGGCAGTGGTTCGACTCGCCGGCGGTGGCGCCGACCCTGGTCGATCTGTCCGGAGTGGACGGTGGCGGCTGGTCGGAGGTCGAGCGGCGGATGCGGGAGATCGCCGCTCGGCCGTTCGACCTGGCGGCCGGCCCGCCGGTCGCCTGGCTGCTGTTCCGCCTCACGCCCGAGCGGCACGTCCTGGTGTTCTCCGTGCACCACATCGTGTTCGACGGCGGGTCCCTCGCCGTGGTCTGCGCCGAGCTGGAGGCCGCCTACCGCGCGAGCCGTGAGGGGCGTCCGGACGGTCTGCCCGACGGGATTCCGGGCTACAGCGACCTGATCGGCCTGGAGAGCACACTGGCCGACGAGGACAGTGTGGACTTCTGGCGCGAGACGTTGCGGGACGCGCCGGCCCGCAGCGCGGTGTTCGGAACCCACCGTGCTCCTGCCGCTGCGCCGGCGCAGCTCGTGGACCGCCGCGCGGTCACCGACTGGGACGCCTTCGACGCGCTGTGCCGGCGCGAGGGCGTCACCCACTACGTGACGTTGTTGGCCGCCCTGGGCTGCCTGGTCGCCCGCTACTCCGGTCAGCGGGACGTCGTTCTCGGCTCCCCGGTGGCCCTGCGCGGGCACGAGGCACTGTCCTCTGTGGTCGGAATGCTGACCAACACGCTGCCGTTGCGGCTCCGGCTCGACGGCGACCCCACGTTCCGCCAGGTGCTGGCGCGCGCCAGGGACAGCGTGATGGACGCGCTCGAACACCAGCTCACGCCGTTCGAGGAGATCGTGGACGCGCTGGAGGTGGCGCGCGATCCCCAGGTGAGCCCGCTGTTCCAGGTGTTGTTCGCCTACCAGCGGCGACCGGAGGCCCCCGCCCTGCCCGAGGTCGCCAGCCGACTCGTGCCGGTGCCCACGGCGGCGGCCAAGTACGAGTTGACGGTCACCGCCACCGAGTTTGCCACCGGGTCCGACACCGGGTCCGGTACCGGGTCCGGTACCGGGTCCGTCTCCGGGCTCGAACTGGCCTTCGAGGCCGACCCCGGCCACTGCGGGGACGCGGAACTGCGGGCGTTCTCCCGGCACTTCCGCACCCTGCTCGACACGGCGGTGCGGAAACCGGACACCCCGCTGAGCGCGCTGCCACTGCTGTCCGAAGTGGAGCGTCAGCGCCTGGCCCCGCTGACCCGACCGCGCGAGCGCACGCCGGCGGCGCGTCCGGTGCACCACCTGGTGGAGCGGGTGGCGCGGGAGCGACCGGACGCGATCGCGTTGGTGTGCGGGCAGGAGCACGTCAGCTACCGCGAGCTGAACCGCCGAGCCAACCGACTGGCCAGGGAACTGCGCCACCGGGGCTGCGGCCAGGACGAGATCGTGGCCGTCCGGATGCGCCGCCGGCCCGACCTCGTGGTCGCGATCCTCGCGGTGCTCAAGGCGGGCGCCGCCTACCTCCCGATCGACCTCGCGCATCCCGTCGAGCGCGTTCGCGGAACACTGCGCGACGCCGCCGCCCGCCTCGTGATCACCGAGCCGGAGCTGCGCTCCGACCTCGACGGCACGGCCGTCCCGGCCGTCCTGCCGGACGACCCCGACCTGGCCCGGCACTCCGACGGCGACCTCGGCGTGCCCGTCGCCCCGACGGCCCTGGCCTACGTGCTCTCCACGTCCGGCTCGACCGGCCGGCCGAAGGGCGTGGCCATCCAGCACGACAGCGCCGTCGCCTTCCTCGGGTGGGTCGCGGACGCCTTCCCCGGCGACGACCTCGCCGCCGTCCTGGCGACGACGTCCGTCGGGTTCGACCTGTCGGTCTTCGAGCTGTTCGGGCCGCTCACCACCGGGGGTTCCGTGGTGCTGGCCGACAGCGCCCTCCAGGTGCCGGAACTCGCGGCGGCGCGCGCCGCGACCCTGCTCAACACCGTGCCCTCGGCCGCCGAGGCGCTGCTCGACGTCGACGGGTTGCCCACGTCGTTGCGCGCGGTCAACCTGGCCGGCGAGCCGTTGCACCGCGACCTCGTCCGCCGCATCCAGGACCGGCTGCCGGGCGTGGTCGCCCGCAACCTCTACGGCCCCTCGGAGGCCACCACCTACGCCACCGCGACGGCACTGTCCACAGAGGACGACCAGCAGCCCACCATCGGAACCGCCATCTCCCCGGCCGCCGCCTGGGTGGCGGGGGAGGCCGGAGAGCCGGAACCCGCCCACGTCGTCGGCGAACTGGTCATCGGCGGCCCCACCGTGGCGCGCGGGTACCTCGGGCGACCGGGGCTGACCGCCGCGAGCTTCCGGCCCGACCCGCGCGGCGGTGGGAGCCGGATCTACCGCACCGGCGACCTCGCGCGCCGGCGTGGCGACGGCCACCTGGTGTTCCTGGGCCGAACCGACGACCAGGTCAAGGTGCGGGGTGTCCGGATCGAGCTGGGCGAGGTGGAGGCCGTGCTGCGCGAGATCGCCGGTGTCCGGGCGGCCGTGGCCGTCCCGACCGGTCGCGGCGCCGCCGACCGCCAGCTCGTCGGCTTCGTGACGCCCGAGCCCGGCGCGGCGATCGTGCCGGAGGAGGTGCTGTCGACGCTGCGGACCCGACTGCCCGCCGTGATGGTGCCCACCCGGTTGACCGTGCTGGAGGCGTTGCCGCTCAACGACAACGGCAAGATCGACCGGGGCGCGCTCGTCCGGATGGCCGAGCTGGCGCGACCGCAGGCCAGCCCCCCGGTTCCGCCCCGCACCACGCTGGAACGGCTCATCGCCGAGGCGTGGCGCGAGGTGCTGGGCCTGGACCAGGTCGGGGTGCACGACGGCTTCTTCGAGGCCGGCGGCACCTCGCTGACGCTGCTCCGGCTGCACAGCGCGCTGTCCAGGAAGGTGCGGCCGGCGCCGAGCCTGGTGGACCTGTTCCGGTTCCCCACCATCGCCGCGCTCGCGGTCTTCCTGACGCAGCGGGACACCGCGCCGGACGCGGCCCACAACGAGCTGTCCGCGCGGGCGCGGGAGCGGGGCGCGCGCCGCCGCGCCGTCGCCGCCCGCCGACCGGCGGGGGAGGTGGACGCGTGA	MTTTACGGTGVGGAGAPLASAQRRLWFLHQLAPGSAAYNICTAIELTGRLDLAALRDAVLRLGRRHEVLRATFGVVDDEPRQWFDSPAVAPTLVDLSGVDGGGWSEVERRMREIAARPFDLAAGPPVAWLLFRLTPERHVLVFSVHHIVFDGGSLAVVCAELEAAYRASREGRPDGLPDGIPGYSDLIGLESTLADEDSVDFWRETLRDAPARSAVFGTHRAPAAAPAQLVDRRAVTDWDAFDALCRREGVTHYVTLLAALGCLVARYSGQRDVVLGSPVALRGHEALSSVVGMLTNTLPLRLRLDGDPTFRQVLARARDSVMDALEHQLTPFEEIVDALEVARDPQVSPLFQVLFAYQRRPEAPALPEVASRLVPVPTAAAKYELTVTATEFATGSDTGSGTGSGTGSVSGLELAFEADPGHCGDAELRAFSRHFRTLLDTAVRKPDTPLSALPLLSEVERQRLAPLTRPRERTPAARPVHHLVERVARERPDAIALVCGQEHVSYRELNRRANRLARELRHRGCGQDEIVAVRMRRRPDLVVAILAVLKAGAAYLPIDLAHPVERVRGTLRDAAARLVITEPELRSDLDGTAVPAVLPDDPDLARHSDGDLGVPVAPTALAYVLSTSGSTGRPKGVAIQHDSAVAFLGWVADAFPGDDLAAVLATTSVGFDLSVFELFGPLTTGGSVVLADSALQVPELAAARAATLLNTVPSAAEALLDVDGLPTSLRAVNLAGEPLHRDLVRRIQDRLPGVVARNLYGPSEATTYATATALSTEDDQQPTIGTAISPAAAWVAGEAGEPEPAHVVGELVIGGPTVARGYLGRPGLTAASFRPDPRGGGSRIYRTGDLARRRGDGHLVFLGRTDDQVKVRGVRIELGEVEAVLREIAGVRAAVAVPTGRGAADRQLVGFVTPEPGAAIVPEEVLSTLRTRLPAVMVPTRLTVLEALPLNDNGKIDRGALVRMAELARPQASPPVPPRTTLERLIAEAWREVLGLDQVGVHDGFFEAGGTSLTLLRLHSALSRKVRPAPSLVDLFRFPTIAALAVFLTQRDTAPDAAHNELSARARERGARRRAVAARRPAGEVDA	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	195.68	gnl|BL_ORD_ID|4935|hsp_num:0	5928			141	1629	colistin A; colistin B
BGC0001048.1|Tallysomycin_16 # 25751 # 30352 # 1 # ID=1_16;partial=00;start_type=GTG;rbs_motif=GGGGGA;rbs_spacer=9bp;gc_cont=0.737	BGC0001048.1|Tallysomycin_16 	25751	30352	+	Loose	750	73.559	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid	29.29	3003463	protein variant model	G387D	n/a	isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant kasA	GTGAGCGACGACGCGCCCGAGCCGATCGCCATCGTCTCCCTGGCGGGACGTTTCCCCGGCGCGGACGACGTGCCGACCTTCTGGGAGAACCTGCGCGCCGGCGAGGAGAGCATCCGCCGGTACACGCGCGAGGAACTCCTGGCGCTGGGCCGGGATCCCGCGCTGGTCGACCACCCCCGCTTCGTCGGGGCGGAGGGCGTGCTCGGCGACATCGCGGGCTTCGACGCCGACTTCTTCGGCTACTCCCCGCGCGAGGCCGAGATCATGGACCCGCAGCACCGGCTCTGCCTGGAGACGGCCTGGGCCGCGTTCGACTCGGCCGGCTACGACCCGGCGGCGCTGACCGAGCCGGTCGGGGTGTTCCTCGCGACCAGCCTCAGCTCTTACCTGGTGCGCAACCTCCTGTCCGATCCCGGTCTGGCCCGTGGAATCGGCGGATTTCCCCTGCTGATCCACAACGACAAGGACTTCGCCGCCACCACCGTCTCGCACAAGCTGGGCCTGACCGGCCCCAGCTACGCCGTCGGCTCCGCCTGCTCCTCGTCGCTGGTCGCGGTCCACCTCGCCTGCCAGAGCCTCCAGTCGCACGAGTGCGACATGGCGTTGGCCGGCGGGGTCTCCCTCCAGGTGCCGCAGGGCCAGGGCTACGTGTACGCCGAGGACGGCATCTACTCGCCGGACGGCCGGTGCGCGGCCTTCGACGCCTCCGCCGGCGGCACGGTCGGCGGCAGCGGCGTGGGACTGGTGCTGCTCAAGCGACTGTCCGACGCCGTCCGCGACCGGGACCAGGTGCACGCGCTGGTTCTCGGCACCGCGGTCAACAACGACGGCGCGAACAAGGTCGGCTACACCGCGCCCAGTGTGGACGGACAGAGCGCGGTGATCGTCGAGGCGCACGCCGTTGCCGGGATCAGCGCGGACACCGTCGGCTACGTCGAGGCGCACGGAACCGGCACCAGCCTGGGCGATCCGATCGAGGTCACCGCGCTGACCCAGGCCTTCCGCGCCAGCACCGACCGGACCGGGTTCTGCGCGCTGGGCTCGGTGAAGACCAACATCGGGCACCTGGACGCCGCCGCCGGGATCGCCGGCCTGGTGAAGGCCGCGCTCGCCGTGCGCGACGGGATCATCCCCGCCAGCCTGAACTTCCGCGAGCCGAACCCGCGCATCAACTTCGCCGCCACGCCGTTCCACGTCGCGGACACGACGCGGCCGTGGCGGGCCGAGGGCGCGCCGCGCCGGGCCGGCGTCAGCTCGTTCGGGATCGGCGGCACGAACGTCCACGTGGTGCTCGAACAACCGCCGGCGCCCCCGCTCCGGGCGAAGCGTCGTCGGGCGGCGCAACCGCTGGTGTTGTCGGCTCGCACCGGGGAGGCGCTGGCCGAGGCCGCCCGCGATCTCGCCGAGCGACTTCGCCGGGACCCCGGGGTCGATCTGGCCGACGTGGCCGCCACCCTGGCCAGCCGTCGGGCCTTCCCCCACCGGAAGACCGTGGTGTGCCGCGATGTCAGCAGTGCGATCAGTGCTCTCGACCTGCCGAACGCGCCCGCGCGAGTCGCGGACGCCGAGCGCCCCGTGGTGTTCCTGTTCCCCGGACAGGGAGCCGCCTACCCGGGGATGGCCCGGGAGCTGGCCCGCGAGGACGTCACGTTCCGGGCGCATCTCGACGAGTGCGCCGACCTCCTGGCGGGACTGGGCGTCGAGCTGGACGCGGCGTTGGACTGTCCACCCGGGACTGTCGAGGCGACCCGGCTCGGCCAGCCGGCGCTGTTCGCGGTCGAGTACGCCCTGGCCCGCGCGCTCCAGGACTGGGGGCTCACGCCGACCGCGATGCTCGGGCACAGCCTGGGCGAGTACGTGGCCGCGACCCTGGCCGGTGTTCTCTCCCTGCCGGACGCCCTGCGGCTGGTGTCGGCCCGGGGACGGGTGCAGGCCGCGATGGCACCGGGTCGGATGCTCGCCGTGTCCCTGCCCGAGGACCGCCTCCGCCCACTGCTGGCCAGCGGGCTGTCCGTGTCAGCCGTGAACGCGTCGGACCGGTGCGTGGTCGGCGGAGAGCCCTCAGCGGTGGCCGACCTGGCGAAAGCCCTTGGTGGGCAAGGAATTCCCACTCAGATGCTTCCCACGGCGCACGCCTTCCACTCCACCGCCGTGGAACCGGTGCTGGACCGGTTCCGCGAGGTGTTGGCCGAGGTCGAGTTCCGCGCGCCGTCGGCGCGGTACGCGTCGAACCTGACCGGGAACTGGGTGCGCCCCGAAGAGGCGTGCGACCCGGACTACTGGTTGGCCCACATGCGTCAGCCGGTGCGGTTCGGGGACGGCCTCGCCCGTTGCCTGGAGCTGGGGCCGGTGTCCCTGGTCGAGGTCGGCCCGTCCGCCGGTCTCACCGGCCTGGTCCGCCGGCATCCGCTCGCGAGCGGGGACCACCGCGCGGTGCGGACCATTCCCGGGGCGCGCGACTCGGGCGAAAAGTCCGAAGTGGACAGTGTGGTGACGGCGGTGGCGGAGCTGTGGGCCGAGGGCTGCGCCGTCCGCTGGGACGCGTTCCACCGCCAGCAGGAGCCGCGCCGGGTGGCCGTTCCCGCGTACCCCTTCCAACGCGAGCGGTACTGGGTCGAGCCAGCTGCGACGACGAGTGGCGGGAGCGACCTCGCCGCGCCGGTCGCGTCCCGCCCGGAGGGCACCGGTGATCGGGACTGGCCGGAGAAGCGGCCCGACATCGGGAGCTGGGGGTACCGACCCGGCTGGCGGCACGCGCCGACGCCGGTTCCCGACCGCGAGGCCGTGGCCGGGCGGTGTCTCCTGTTCTCCTCCGGCCCGTTGGGACACGCCGTCGAACGCCGGCTGGTGGCCGCTGGGGTGGATGTGGAACGGGTTCCCGCCGACCCCGCGATCTGCTTCGACCCCGACCGCCCCGAGCACTACCGCGAGCTGGTCGCGGGGCGCGGCGGCGCGCCGCGACTCGTCGTGCACCTCTGGGCGTTGGAGGACGCGCTCGCCCGGGGTGGCGCCGCGCCCTCCGGCCTGATGCCCGAGGTCCAGCGGCGGGGACTGCACAGCCTCCTCCACCTGGCCAGGGCGCTCGGCGCGGCCGAGAACGGCGGTCCGACGCGGCTCGTGGCCGTCACCGGAGGGGCACAGGAGGTGCTCGGCGACGACCTGCGCCACCCGGAGCACGCCACCGCGCTCGCCGCCGTCAAGATCATTCCTCGGGAGTACCCGGGGATGGCCTGCACCGCGGTGGACCTCGACCTCACGCGGCTGGACCGGGACCTGGACTGGTTGGCCGAGCGCGTGGTCGACGAGCTCCTGGCCGCCAGGGAGTCCACTGTGGTCGCCTACCGCGGTCGACGTCGGTTCCGGCTCGACCACGCGCCCTGTCCGCTGGAGCCGGGCGACCCGGCCGTGGGACCGCGCCCCGGCGGGGTGTACCTGGTCTGCGGCGGGCTCGGCGGGATCGGCCTGAACCTCGCCGAGGACCTCGGCCGGCTCCCGGCGAAGGTGGTCCTGACCCACCGGCGTCCGTTCCCGGCCGCCGAGGACTGGGCCGACCACCTCGCCACCCACCCGGCGGACGACCCGACCAGCGTCGCGATCAACCGCCTGCGGGGGATCATCGAGGCCGGCGGCGAGGTCCTCGTGGCACCGGCCGACCTCACCGATTCGGACGCGGTCCGCGCGGTGGTGGCCGAGGCGGAGCGCCGTTTCGGTCCGCTCACCGGAGCGGTGCACGCCGCCGGTGTGCCCGACACCGCCGGGGTGATCCACCGCCGCACCACCGCCGACACCGAGGCCGCCATCGCGGCCAAGGTGCACGGCACCGCGGTGCTCGACGAGGTGCTGGGTGACCGGCCGCTCGACTTCTTCGTGCTGTGCTCGTCCATCGGCTCGGTGCTGCACAAGCTGAAGTTCGGCGAGGTCGGCTACGTCGCTGGGAACGACTACCTGAACGCCTACGCCGCCTACCGCGCGGCCCGCCGGCCGGGGATCACGACCGCGATCGCGTGGACGGACTGGCTGGAGTCCGGGATGTCGGCCGTCGCCCAGGAACGGCTCGTCGACCGCTACGACACGGGTGGCACACAGTCCACAGTAGACAGTGCGTCGGTCGGGCCGGCTGGCGACCTGCTCGGCGCGCTGACCCGGGACGAGGGCGTCGAGGTGTTCCGGCGCGTGCTGCGCGCCGGTCTCGGCCCCCAGGTGCTGGTGTCCACACAGGACCTGGACGCCCTGCTCGCCAGGCACGACGCCTACACCACGGGCGACCACCTCGCGGTGGTGAGCGGGCTGAGCGCACACGGCGGCCGGTCCCGGGCGCGGTTGAGCACCGCGTACGCGGCCCCGCGGTCCGACCTCGAACGCACGCTCGCCGGCTGGTACGCCGAACTGCTCGGCTACGACCAGATCGGCCGCGACGACGACTTCTTCGAACTGGGCGGCGACTCGCTGCTGGCGCTGCGGCTGCGGTCGATGGTGCGCTCCGGATACGGCGTGGAGGTGTCGGTGGCGCAACTGTTCGACGCGCCCACCGTCACCGGACTCGCCACCCTCGTCGGACACGCGGTCGGCGGCGACCCCGACCGGCAGGAGGTGGTGTTGTGA	MSDDAPEPIAIVSLAGRFPGADDVPTFWENLRAGEESIRRYTREELLALGRDPALVDHPRFVGAEGVLGDIAGFDADFFGYSPREAEIMDPQHRLCLETAWAAFDSAGYDPAALTEPVGVFLATSLSSYLVRNLLSDPGLARGIGGFPLLIHNDKDFAATTVSHKLGLTGPSYAVGSACSSSLVAVHLACQSLQSHECDMALAGGVSLQVPQGQGYVYAEDGIYSPDGRCAAFDASAGGTVGGSGVGLVLLKRLSDAVRDRDQVHALVLGTAVNNDGANKVGYTAPSVDGQSAVIVEAHAVAGISADTVGYVEAHGTGTSLGDPIEVTALTQAFRASTDRTGFCALGSVKTNIGHLDAAAGIAGLVKAALAVRDGIIPASLNFREPNPRINFAATPFHVADTTRPWRAEGAPRRAGVSSFGIGGTNVHVVLEQPPAPPLRAKRRRAAQPLVLSARTGEALAEAARDLAERLRRDPGVDLADVAATLASRRAFPHRKTVVCRDVSSAISALDLPNAPARVADAERPVVFLFPGQGAAYPGMARELAREDVTFRAHLDECADLLAGLGVELDAALDCPPGTVEATRLGQPALFAVEYALARALQDWGLTPTAMLGHSLGEYVAATLAGVLSLPDALRLVSARGRVQAAMAPGRMLAVSLPEDRLRPLLASGLSVSAVNASDRCVVGGEPSAVADLAKALGGQGIPTQMLPTAHAFHSTAVEPVLDRFREVLAEVEFRAPSARYASNLTGNWVRPEEACDPDYWLAHMRQPVRFGDGLARCLELGPVSLVEVGPSAGLTGLVRRHPLASGDHRAVRTIPGARDSGEKSEVDSVVTAVAELWAEGCAVRWDAFHRQQEPRRVAVPAYPFQRERYWVEPAATTSGGSDLAAPVASRPEGTGDRDWPEKRPDIGSWGYRPGWRHAPTPVPDREAVAGRCLLFSSGPLGHAVERRLVAAGVDVERVPADPAICFDPDRPEHYRELVAGRGGAPRLVVHLWALEDALARGGAAPSGLMPEVQRRGLHSLLHLARALGAAENGGPTRLVAVTGGAQEVLGDDLRHPEHATALAAVKIIPREYPGMACTAVDLDLTRLDRDLDWLAERVVDELLAARESTVVAYRGRRRFRLDHAPCPLEPGDPAVGPRPGGVYLVCGGLGGIGLNLAEDLGRLPAKVVLTHRRPFPAAEDWADHLATHPADDPTSVAINRLRGIIEAGGEVLVAPADLTDSDAVRAVVAEAERRFGPLTGAVHAAGVPDTAGVIHRRTTADTEAAIAAKVHGTAVLDEVLGDRPLDFFVLCSSIGSVLHKLKFGEVGYVAGNDYLNAYAAYRAARRPGITTAIAWTDWLESGMSAVAQERLVDRYDTGGTQSTVDSASVGPAGDLLGALTRDEGVEVFRRVLRAGLGPQVLVSTQDLDALLARHDAYTTGDHLAVVSGLSAHGGRSRARLSTAYAAPRSDLERTLAGWYAELLGYDQIGRDDDFFELGGDSLLALRLRSMVRSGYGVEVSVAQLFDAPTVTGLATLVGHAVGGDPDRQEVVL	MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY	368.51	gnl|BL_ORD_ID|1968|hsp_num:0	1943			447	1227	isoniazid
BGC0001048.1|Tallysomycin_17 # 30349 # 33774 # 1 # ID=1_17;partial=00;start_type=GTG;rbs_motif=AGGAGG;rbs_spacer=7bp;gc_cont=0.739	BGC0001048.1|Tallysomycin_17 	30349	33774	+	Loose	1000	114.39	almE	26.88	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	GTGACCATCGCCGGATTCCTCGCGGACCTGCGGGCCCGTCAGGTCCTGGTCACCGCGGACGGGGACCAGCTCCGGTGCAGCGCGCCGGCGGGCGTCCTCACCGACGACCTGCTCGACGCGATCCGCGGCCGCAAGGCGGAGATCCTGCGCCACCTGGGCCGCCAGGCGCTCATCCCCCGGCACGAGGGGACGCCTCCGCTGTCCTACGCGCAGGAGCGGTTCTGGCTGCTGCACCAGTTCCACCCCGACGACAACGCCTACAACATCCCGCTGGCGATCCGGCTGCGCGGCGAACTGGACCCGGCCGCGCTGCGTCAGGCGATCGGACAGGTGATCCGCCGCCACGACGTGCTGCGCACCCGGTACGTCACGCGCCGCGGTCGCCCGGAACCGGTCGTCGACCCGGCCGCCGCGCCGGATCTTCCCCTGGTGGACCTCACCGGCCTGCCCGAGGCGGAGCGCGAGGCGACGCGCCGTGAGCTCACGGAAGCCGAGGCGCGACGGCCCTTCGACCTCGCCAGCGGGCCCGTCCTGCGCTCGTGGTTGTTGCGCGAGAGCCGCGACGAGCACGTCCTCCTGTTGACCCGGCACCACATCGCCAGCGACGGCTGGTCGTTGGGGCCGCTGCTCACGGAGCTGGGCGCGCTGTACGAGGCGTGTCGCGGTGGTCGGCCCTGTCCGTTGCCGGAACTTTCCGTCCGCTACGGGGATTTCGCCGCGTGGCAACGCGCCGCCGACCACACCCGTGATCTCGACCGGTGGGGGCACCTGACCGACGCTCCGCCCACTGTGGACCTGTTGACGAGCGTGGACGCCGACGCGCCGCAGCGTCCGGTCGAGGTCCGGCGCGCGGTGCTGGAACCCGCGCTGGTCGATCGGTTGCGGGAGTGGGCCGGGCGTGAGCGCGTGACCCTCTTCTCGGTGCTGCTCACCGGCTACGCGCTGGTGCTGTCCAGCCTGTCCGGGCAGCGGGAACTGGTGATCGGCAGCCCGGTCGCCGGCCGCACCCGCCCGGAACTGGACGGACTGATCGGCTGTTTCGTGAACATGCTGCCGCTGCGCCTGGACCTCTCCGGCCACGGCACCGCGAGCGAGCTGGTGCGACGGGCCAACGCGGTGGTGCGGGACGGGCTCGCCGGTCAGGACGTGCCCTTCGAGAAGCTCGTGGAGGCGTTCCGACCGGAGCGCGACCTGACCGAGAACCCGTTGTTCCAGGCCGCCTTCGCCTTCCAGAACACGCCAGCCGCCGACGTGCGACTGTCCGATGTGGAGGCTTCGGTCGAGCCGTCGGCGTCGGTCGCGCCGAAGTTCCCGCTCACCCTCACCGCCACGGACCGGGCAGGGGCGCTCGACCTGGACCTGGAGTTCGACCCCCGCCGGCTGGTGCCCGACCTCGCCGGGGAGATCCTGCGGCGGCTGCGGGAAGTTCTGCTGGCGGGCGCCGCGGAACCGGACATCACGGCGGCCCGACTGCGGCACCGGCTCGCCCTCGGCGAGGACGCCGCTCCGGCGGTGGCTGTCGAGGAGACCACGCTTCCCCGACTCGTCGCGGAGATCACCGCTGCCCGACCGGACGCGATCGCGGTGTCCCACAACGGCCACCACCTGACCTACCGCGCTCTCCAGGAGCGGGCGGACCGGGTGGCGGCCGCGCTGCGCGCCCGTGGCGTCGGGCCGGACACCCTGGTCGGCCTGTGCGTCGAGCCCGGCGTGGACCTCGTCGTGGGAGCACTGGGAATTCTCCGGTCCGGCGGCGCCTACCTCCCCCTGGACCCGACCGATCCGGTGGACCGGATGCGTGCCGTGGCCGGGGACGCGGGCCTGCGCCTGGTCGTGACTCGCGGGGACGTGCCCGCGCCGCCGGTCGAGCGGATCGATCTCGGCGATCTCGGTGATCTCGACGACGCCGGTGGTCTCGGCGCGCCGGCGCACCCCGGGCTGGCCCAACCCGTTCCGGCCAACCTCGCCTACGTCATCTACACCTCGGGCTCCACCGGGCGGCCCAAGGGAGTCGCGGTCAGCCACGGCAACGTCACCGGGTTGCTGGCGGCCTGCCGCCGGGCGCTGCCGGTGACCGACGAACCCCAGGTGTGGGCGCTGACCCACTCCGCGGCCTTCGACTTCTCGGTGTGGGAGATGTGGGGCGCGCTGACCTCGGGCGGCCGCCTGGTGATCGTGCCGCCGGACGTCCTCCGCAAGCCCGACGAGCTGTGGGAGCTGCTGCGCGCCGAGCGGGTGGCCGTCCTCGGCCAGACGCCGAGCGCGTGCCGGCACCTCCTGCCCGCCGCGCTGGCCGACGACCCGCGGCGCGCCGCGCTCGCGCTGGTGGTGCTGGGCGGCGAGTCCTGCGAGGTCGCCACGCTGGGGCCCTGGTTCGAGGCGATGGACCACAGTGGACCAGAGCTGGTGAACATGTACGGGATCACCGAGACCTGCGTGCACGTGACGGTGCGGCCGCTGCGCGCGGCGGACGTCGACGGCGCGGCGCGCAGCCCCATCGGCGGACCTCTGCCGGGACAGCGGATCGCGGTGGTCGACCAGAACGGCGTCCGGGTTCCCGTGGGCGGCCAGGGCGAGTTGTTCGTGGGCGGCGTCGGCGTCGCCCGCGGCTACCTCGGCCAGCCGGCCCTGACCGCTGACCGGTTCCGGCCGGACCCGGCTCGCCCCGGCGCGCGCGGTTACCGGTCCGGCGACCTGGCCAGGGCGCTGCCCGACGGTGAGCTGGACTACCGGGGACGCCTGGACAAACAGGTCAAACTCCGCGGCTACCGCATCGAACCCGGCGAGGTGGAGGCGGCGGCGCTGGCCCATCCCTCGGTCCGCGCGGGCGTGGTCGTGCCGCGCACCGACGGCGGGCGGACGTACCTGGCCGCCTATCTGGTGCTGGCGGACGGAACCCGGGACCAGCACGCGGCGGCGGACGCGGCGCGGGCAGAACTGCGCGCGTTCCTCGCCGAGCGCCTTCCCCGGCACATGGTCCCGGCGGCCTTCGTGTTCGTCGACCGGATTCCGCTCACCCGCAACGGAAAGCTCGACGAGGCCGCGCTGCCCGAGCCGTCGGCCGGCCACCGCCCGGTGAGCCGACCTCCCCAGACGCCCACCGAGTGGCGGATCGCCGGCATCCTGGCCGAGGTGCTCGGCCTCGGCGGCCCGGAGAACGTGGGCGCGCAGGACAACTTCTTCGACCTGGGCGGCGACTCGCTGCTGCTCATCCAGTTCCACTCCAGGGTGGTCGCGGCGTTCGACATCGACCTCCCGGTCCGGCAGGTCTACCAGGTGCTCGACGTCGCCACCCTCGCCAGCACCGTGGAGACCTTCCGCGCCCGCGCGGACGAGGAGGCCCTCCGCGCCGCGCTCGCCGTGGTGGAGGCCGCGGAGCTCCCCGGAGATCCGACCGCACCGGAGTCAGTGGAGGGAGACCAGTGA	MTIAGFLADLRARQVLVTADGDQLRCSAPAGVLTDDLLDAIRGRKAEILRHLGRQALIPRHEGTPPLSYAQERFWLLHQFHPDDNAYNIPLAIRLRGELDPAALRQAIGQVIRRHDVLRTRYVTRRGRPEPVVDPAAAPDLPLVDLTGLPEAEREATRRELTEAEARRPFDLASGPVLRSWLLRESRDEHVLLLTRHHIASDGWSLGPLLTELGALYEACRGGRPCPLPELSVRYGDFAAWQRAADHTRDLDRWGHLTDAPPTVDLLTSVDADAPQRPVEVRRAVLEPALVDRLREWAGRERVTLFSVLLTGYALVLSSLSGQRELVIGSPVAGRTRPELDGLIGCFVNMLPLRLDLSGHGTASELVRRANAVVRDGLAGQDVPFEKLVEAFRPERDLTENPLFQAAFAFQNTPAADVRLSDVEASVEPSASVAPKFPLTLTATDRAGALDLDLEFDPRRLVPDLAGEILRRLREVLLAGAAEPDITAARLRHRLALGEDAAPAVAVEETTLPRLVAEITAARPDAIAVSHNGHHLTYRALQERADRVAAALRARGVGPDTLVGLCVEPGVDLVVGALGILRSGGAYLPLDPTDPVDRMRAVAGDAGLRLVVTRGDVPAPPVERIDLGDLGDLDDAGGLGAPAHPGLAQPVPANLAYVIYTSGSTGRPKGVAVSHGNVTGLLAACRRALPVTDEPQVWALTHSAAFDFSVWEMWGALTSGGRLVIVPPDVLRKPDELWELLRAERVAVLGQTPSACRHLLPAALADDPRRAALALVVLGGESCEVATLGPWFEAMDHSGPELVNMYGITETCVHVTVRPLRAADVDGAARSPIGGPLPGQRIAVVDQNGVRVPVGGQGELFVGGVGVARGYLGQPALTADRFRPDPARPGARGYRSGDLARALPDGELDYRGRLDKQVKLRGYRIEPGEVEAAALAHPSVRAGVVVPRTDGGRTYLAAYLVLADGTRDQHAAADAARAELRAFLAERLPRHMVPAAFVFVDRIPLTRNGKLDEAALPEPSAGHRPVSRPPQTPTEWRIAGILAEVLGLGGPENVGAQDNFFDLGGDSLLLIQFHSRVVAAFDIDLPVRQVYQVLDVATLASTVETFRARADEEALRAALAVVEAAELPGDPTAPESVEGDQ	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	205.22	gnl|BL_ORD_ID|4935|hsp_num:0	5928			588	1647	colistin A; colistin B
BGC0001048.1|Tallysomycin_18 # 33771 # 41999 # 1 # ID=1_18;partial=00;start_type=GTG;rbs_motif=GGAGG;rbs_spacer=7bp;gc_cont=0.726	BGC0001048.1|Tallysomycin_18 	33771	41999	+	Loose	1000	145.591	almE	31.93	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	GTGACGTCGACCCGAGCGCGCTCCGCCCGCACCATCGTGGACGTGGCCCGGCACCACGCCGAGACCACGCCGTCCCGTCCCGCCTACGTGTTCCTGCCGGACGGCGAGACCGAGTCCGAGCGGTTCGACTTCGCCGGCATCGACCTGCGTGCCCGCGCGATCGCCGTGGCCCTGCGGGAGCGGGGCATGGTCGGGGAACGCGTCCTGATCGCCTACCCGTCGGGCTCCGCCTACGTCCAGGCGATCCTGGGATGCCTGTACGCGGGCGCGATCGCCGTGCCGTGCGACGCCCCCGAGCGAGCGTCCAGTGTGGAGCGACTGACGGCCGTGGCCGGCGACGCCGCTCCCGCGCTGACGCTGGCGGCGGCCGACGGGCCGTTGGCCGGGCGGATGCCGCTGTTCGACATCACGACGGTGTCCGACGAGGCGGCCGAGAGCTGGAGCGCGCCAACGCTCGACGTCGACGCTCCGGCCTTCCTCCAGTACACCTCGGGATCGACCCGCACCCCGCGCGGCGTCATGGTCAGCCACGCCAACCTCCTGGCGAACGAGGAGGCGATCCGCCGGACCTGCGGCCACGACCAGGACTCGACGTTCGTGGGCTGGCTGCCGCTGTTCCACGACATGGGCCTGGTGGCGAACGTCCTCCAGCCGCTGTTCCTCGGATCGCTGTCGGTGCTGATGCCGCCGTCCGCCGTCCTGCGGCATCCCATCCGCTGGTTGCGCGCGGTCACCCGGTACCGCGCGCACACCAGCGGTGGACCGAACTTCGGCTACGAGCTGTGCGTGGAGCGGACGAGCCCGGAGGAGCGCGCCGAGCTGGACCTGTCCTCGTGGCTGGTCGCCTACAACGGCGCGGAACCGGTGCGGGCGGCCACCCTCCGGCGGTTCGCCGAGGTCTTCACGCCGCATGGTTTCGCCTCCACCGCGCACTTCCCGTGCTACGGCCTGGCGGAGGCCACCCTCCTGGTTTCCGGCACCCCCAAGGCGGAGGCACCGTTGGTGCTCACCGTCGACCCGGCGGAGCTGCGGCAGGGTCGGGTGACGCCGGCCGTGGAACCGGCCCCGGGCACGGAGTCGGTGGGCACCGGATCGTTGGGCACCGGATCGTTGGGCACTGAGTTGGTGAGCTGCGGGAAGGTCGCTGTGGACACCGAGGTCCGGGTCGTCGACCCGGAGACGGCGCGTCCGGTGGCCGACGGCCAGGTGGGCGAGGTGTGGGTCCGCGGACCCGGCGTGTCCGGTGGTTACTGGCGCGATCCGGACGAGTCGGACAAGGTGATGCACGCCCGGCTCGGCGAGGAGGGGCCGTACCTCCGCACGGGCGACCTCGGCTGTCTGCTGGACGGCCAGCTCTACCTGACCGGCCGGCGCAAGGACCTGCTCGTCGTGCGGGGGCAGAACCACTACCCGCACGACCTGGAGTGGACGGCCGAACAGGCGCACCCGGCGCTCCGGCCGAGCTGCGGGGCGGCCTTCGCCGTGGACGACGGCGACCGGGAACGGCTGGTGCTCTGCTACGAGCTGCGCGCCCCGGTGTCGGACCTCGCCGACGTGGCCGAGGCCGTGCGCCGGGAACTGTCCCGCCGACACGGGATCGAGCCGCACGAGCTCGTCTTCCTGGAGCGCGGCGGTGTCCCGAAGACGACGAGCGGCAAGGTCCGCCGCCAGAGCTGCCGACAGTCCTACGTGGACGGGAAGTTGCCGGTGCTGGCCGTGGTCCCGCTGGCCGTCGGGGACGCCCGGTCGGACATGGCCCTGCCCTCGCTGGCGGATCTGGCCGAGCTGGACCCGGCACAGCGGGTTCTGGTTCTCGCGTCCGCGCTCCGCGACGCTCTGATCGCCCGCGCGGGCGTCGCCGGTGCTCCTCCGGCGCTGGACGAGCCGCTCTCCGCGATGGGCGTGGACTCCCTGGCCCTGATGGAACTGGGCCACCACGTCGAGGCGTGCTACGGCGTCGTTCTGGGGCCGGGCGTGTTGTTGGGTGACACCGGAGTCCGCGAGGTGGCACAGCGGATTCTCGATGCCGCCGAGGAAGTCTCGGAGAGCTCCGCGCCCACCCCACCCGTGGCCGACCCGACGTGGCTTCCGCTCACGGGCGGACAGCGCGCGTTGTGGTTCGAGCAGGCGTTGGCGCCCGAGTCCGGGGCCTACCACCTCGCGCGCGCGATGCGGATCGAGGGACGGTTGGACGTCGCCGCGTTCACCCGCGCCTTCGACCGGCTGGTCGCCCGCCACGCCGCGCTGCGGACCCGTTTCGCCGTCCACGACGGCCAACCCGTGTGCCGTGTCGATGACCGGGGACCGCGTCTGGTCATCACCGAGGTGGGACCGGCGGGGGACAGCGCACTGGCCCGGCAACTCACCACGTTGGCCGACGAGCCGTTCGACCTGCTGGCCGGACCGCCGGTGCGGGCCGTGCTGTTCCGACGCGACGCCGAGGCGTCCGTCCTGTTTCTGATGGTGCACCACCTGCTCGCCGACTTCTGGTCGTTCGTCGTGGTGATGCGGGACCTGGCCGCGCTCTACCGCGAGGAGACCGGCGGAGACGCGGCGGACCTCCCGCCCCTGCGGGTGGGGCACGCCGACCTCGTGCGGGCCGAGAACCTGGCCGCGGACTCGCCCTCGGCCGAGCGCCAGATCCGGTTCTGGCGCGACACTCTCGCGGCGGCGCCGGCCGCCCTCGACCTTCCCACCGAGCGGCCAGAACCGACGCGCCGGACGTTCGAGGGCGCGACCCAGACGTTCCGCGTGCCGGCCGAGCTGACCGACCGCCTCCGGGACCTGGCTCGCGCCGAGCGCTGCACGCTCTTCACCACCCTGCTGACCGGATACCAACTCCTGCTCCACCGGTACGCCGCGCAGCAGGACATCGTGGTGGGCACGTTGCTGGCGCGCAGGGAGCGCGCCGAGCTCGCCAACCTGGTGGGGTACCTGGTCAACCCCCTGCCGATCCGCTCCCGGTTCGAGGCCACCGAGCCGTTCCGGGCGCTGCTGCTGCGCACTCGTCGGTCCATTGTGGACGCCATGGAGCACGCCGACGTCCCGTTCGACCGGTTGGTCGGTGAGGTGGCCCCGGTCCGACTCCCGGGCCGCGCGCCGCTGGTGCAGAGCCTCTTCGTGATGCAGCGGGAGTACGGCCCCGCCGCCGACGGCTTCCGCGCGTTGGCACTCGGGGTTCCCGGGAAGCTCCCGCTGGGCGACGTCGCCGTGGAGACGGTCCCGGTTCCGCGTCGGTGGGCGCAGCTCGACCTGACGCTGTCCATGGCCGAGGTCGATGGCGAACTGGTCGGTGTGTGGGAGTACCGCACGGATGTCCTGGCGGAGCCCGCTGTCTCGGCGATGACCCGGCACTTCCTGCGGCTGCTCTCGGAAGCCGTGGCCGAACCCGACCAGCCCGCCGGGAATCTCGACCTGCTGTCCACAGAGGAGCGTGGTGAAGTCCGGCGCGGCGCGACCGGGCCGGAACGCCCTCGCGACGGTGCTTCCCTGCACGATCTCGTGGCGCGCGCCGCGGCCCAGCGACCCGACGCCGTGGCGGTGATCGCCGACGACGCGAGCGGCGTCCCGGTTCAGATCAGTTACCGGGCGCTCCAGCGCGCGGCGACCCGGATCGCGGCGCGACTGGGGGAGCGGGGTGTCCAGCCCGAGGAGCCGGTGGCGCTGCTGGTGGAGCGGGGTTCCGCCCTTCCCCTCGGATACCTCGGCGTGCTCAACGCGGGCGCCGTCGTGCTCCCGCTCAATCCGGAGGACCCGGACCACCGCCTGTCGACGGTGCTCGCCGACAGTGGTGCGCGCACCGTGCTCACGCGGCGATCGCTGGTGGATCGCGCCGGCGGGCTCGGCGCGCACGCCGTGGCTGTGGAGGATCTGCTGACGGCCGACGGGGACGGCCACACCCGCGGTGTCCATCCCGAACAGGCGGCCTACCTGCTCTACACGTCCGGATCGACCGGGAAGCCGAAGGGCGTCCTGGTGCCGCAGCGCGGCATCGTGAACCGGATTCTCTGGATGCAGGAGGAGTACCAGCTCGGTCCGGGCGAGCGGGTCCTGCACAAGACCCCGGTCACCTTCGACGTGTCGTTGTGGGAGCTGTTCTGGCCGCTGGTCGCCGGCGGCTGCCTGGTGATCGCGCGTCCCGGCGGGCACCGCGATCCCGCGTACCTGCACGCGCTCATCGCGCGGCACCAGGTGTCCACCGCGCACTTCGTGCCGTCGATGCTGGGGCCGTTCGTGGCGGAGCGGGCGCGGGGAGAGGCGTTGCCGTCCCTGCGGCGGGTGGTGTGCAGCGGTGAGGTTCTTTCGCCGGAGCTGTGCCGGCGGTTCGCCGCGCTGTTCGACGCGGAGCTGCACAACCTCTATGGGCCAACCGAGGCATCGGTCGACGTCACGGCCTGGCGTTGCTCCGCGCGCGAAACCGGGACCGTCCCCATCGGACACCCCATCGCCAACACGACATGCGTGGTGCTCGACGAGCGCCTGCGTGTCCTGCCCGCCGGAGTGACGGGCGAACTCCACCTCGGCGGGGTCGGGCTGGCCCGCGGCTACCTGAACCGCCCGGAGCTGACGGCCGCGAGCTTCGTGCCCGACCCGGACGGGACCGGGGAACGGCTCTACCGCAGCGGAGACCTCGCCAGGAGCCGGGCCAACGGGGTCCTGGAGTACCGGGGGCGGCGCGACGACCAGACCAAGATCGCCGGCAACCGGGTGGAGCCGGGCGAGGTGGCCGAGGTGCTGTGCGGGCAGCCCGAGATCACCGACGCGGCCGTGGTGGCGCGGGACCAACGCCTCGTCGGCTACGTCGTGGCGGACCGGCCGGTGTCGGCCGAGGCGCTGCGGGCCAGGCTCCGGGATCTCCTGCCCGTCTTCCTGGTTCCCGCCGCCATCGTCCAACTCGACCAGCTTCCGCTCACCAGCAGCGGAAAGCTGGACGCCCGCGCTCTGCCCGTGCCGGTGGAGCGCGCCGCTGACAGCGAGCCACCCCGTGGCGACACCGAGCACCGCCTGGCGGAGATCTGGCGGGAGCAGCTCGGTGTGAGCGGCCTGGGCGTCACCGACGACTACTTCACCCTCGGCGGCGACTCCATCCGCGCCATTCGGGTCGTCTCCGCCGCCAGGGACGCCGGTCTCGACCTGACGGTCACGGATCTGCTGCACCACCGCACGGTCCGGGACCTGGCGCATTACCTCGACCGTCGCGCCGAGCCACGTCCGGACACAGTGGACGTTTCGGAGGTGGTCCCACCCTTCGCGCTGTGTCCGGCCGCCGCCGGCAGAGAAGGTGTGGCGGACGCCTACCCGATCTCGATGGCCCAACGCGCGCTGTTGTTCCACAAGGAGAACAACCCCGGGTACGAGGTCTATGTCACCAGCGTCGCCGTGCACGGCCCGCTCGACCGGGAGCGGATGGCCGAAGCCGTCGCCGGGGTGATGCGGCGACACGCCTATCTCCGCTCCTTCTTCGACCTCACCAGCTACGACGAGCCCGTTCAGCTCGTCATGGCGGACGTGCCCACCCCACTGCACGTCATCGATGTCCGCGACCTTCCGGCGGCGGAGCGGCAGACCGCGTTCCAGCGCTGGTTGCACGCCGAGCGCCAGCGCCACTTCGACGTCGACCACGGGCCGCTGGTCCGGTTCACCGCCCACGACGCCGGAACGGAGTTCCGCCTGACCGTCAGCAGCTTCGGCCTGGACGGCTGGTGCGTGGCGATCGTGCTCACCGAGCTGCTCCGCCACCACCGCGAAGGCGCGGCGGGACACGCGATCCACGAGGCCGAGCACGTGGGCTACGCGGACTTCGTCGCGCTGGAACGCCAGGCCATGTCCTCTGAGGAGCATCGACGCTTCTGGATGACGGAGTTGTCAGGGGCGGAGGAGTGCCTCCTACCGCGTTCTCCTGGTTTCCCGAGGAAACGGACAGCGGAAGCCCGCCAGCACCGGCACATCGTCGAGGTGGACGCCGACGTGCACGCGAAGCTGACCGACCTCGCGGCGACGCTGGGCGTCGGGCTGAAACACGTCCTGCTCGCCGCCCACCTCCGCGTGGTCCGGACCTGGACAGGTCACAGCGACACCGTGACCGGCCTGGAGTGCAACGGTCGGCCGGAGCGGCGAGGCGGCGACCGCGTCGTCGGGGTGTTCAACAACATCGTTCCGCTGCGGCTCGACACGAGCGAACCGCGGAGCTGGGCGGAGTTGGCCAGGGCCGCGCACGCCGCCGAGGTCCGCCTCTCCCCGTTCCGCCGCTACCCGCTGGCCCAACTGCACCGCGAGCACGGAGCGGGGCGGCTCTTCGACACGCTGTTCGTCTTCACCCACTTCCACCTCTACGAGGAACTGGCCGAGGCGGGCGTGTCGGATCTCCAGGCCCCGGACCAGACCTACGTGCCGCTGACCGCGCACTTCAACCTCGACGCCTGGTCGGGGCGGTTGCGCCTGTTGCTCGACTTCGACCCGGCCGAACTGGCCGAGGACCAGATCGCCGCCCTGGCCGACAGTTACTCGCGCGCGGTCGAGGCGATGGCCACCGAGCCCGAGCGGCACCCCGCCGCGACCGCCCTGGCCGAGGCCAGTGCTGACGCCGACGGTGGCTCGGGATTCGAGCGGCCGGACAGCGTCGCGGACCTTGTGCACGACACCGTGCGACGGACTCCGGACCACGTCGCGCTCTCGGAGGGCAGCTGTCACCTGAGCTATGCCGGTCTCTGGTCCCGCGCCGGCGCACTGGCCGCCGCGCTGCGTTCCGTCGGTGTCGGACCGGAGTCGGTGGTCGGGCTGTTCGCCCCGCGCCGGCTCGACACCGTCGTGGCGATGGTGGCGATCCTGCGGGCGGGCGGCGCCTATCTGCCCCTGGACCCCACGTCTCCGCCGCACCGGCTGCGCCAACTGCTCACGGAGTCCGGAGCTTCCGTGGTGGTGCTGCCACCGTCGACGGCTCAGCAGGCCCAGCCGGAGTGGGCGGAGGGAATGACGGTCGTCCACGCCGACGCGAGGACGGAAACCCGGTCGCCCGTCCGGAGAACCCACCGGGACGCGCTCGCCTGCGTCATGCCGACCTCCGGGTCCACAGGCGTCCCGAAACTGGTCGGCGTCCCGCACCGGGGGATGGTCAACTACCTGCGCTGGGCCGTGGAGCGGTACGGCATCGACGCGCGGACCGTCGCGCCGGTGGCCTCCTCCCCGGCGTTCGACCTCACCGTCACCTCCCTGCTCGCCCCGCTCGTCGGCGGGGGAACAGCCGAGCTGCTTCCTGCCGACGCGCCAACCACTCTCGGCGACGCGCTGGCACGGGGCCGCCACACCCTGGTCAAGCTCACCCCGGCCCATCTGGCGGCGGTGGCCGAGCAACTCGCCGCGCACGGCGGGCGGTCGAGCCTGCGCACAGTGGTGGTGGGCGGTGAGCAACTCCACGCCGGACACGTCCGTGCACTGTGGACAGTGGCTCCGGAGGCGGTCGTGGTGAACGAGTACGGGCCGACCGAAACCGTGGTCGGTTGCAGTGTCCACCAGGTCGCCGACCTTCCCTCGGAGGGGCCGGTTCCGATCGGGCGGGCGATCTCGGGCGCCAGCGTTCGGGCCGTCGACGAGTACGCATCTGGTTTTGGTGCGACGGAAGCCGCCCCCGGTGTCCTCGGCGAACTGCACGTGGGCGGAGCGGGCGTCACGCGCGGATACCTCGGCCGTCCCGCCGACACCGCCGCGGCCTTCGTCCCCGACCCCCATCGGGAGGGCGCACGGCGGTACCGGACGGGAGACCTCGCGCGCCGCCTTCCCCACGGTGATCTGGTCTTCGTCGGCCGCGCCGACCGCCAGGTGAAGATCCGGGGCCACCGGGTCGAACTCGGGGAGCTGGAGCACACCCTGGCCGCGCATCCCGCCGTGCGCCAGGTCGCGGCGGTGACCCGCCCGGGGCCGGGCGGCCGGCTCCGCCTCACGGCCTACTGGGTGCCCGCACCCGGGACCGAGGCCGCCACGGCCGAACTCCAGAACTGGCTGGCCCATCGGCTGCCCGCCCACCTCGTCCCGGACGCCCTGGTGCGGATGCCGGCCCTGCCGATGACCGCCAACGGCAAGGTGGACCAGAGCCGACTGCCGGACGGCGCGGACCGCGTCGCGGCGGTGCTGGAGCGGATCGAGGAACTGTCGGACGCCGAGGTGGAACGGTTGCTGGCCAACGCCCGCACGGCCGCAGGGCCGTCCCCGACCGAAGGAGGCGCGCGTGGCTGA	MTSTRARSARTIVDVARHHAETTPSRPAYVFLPDGETESERFDFAGIDLRARAIAVALRERGMVGERVLIAYPSGSAYVQAILGCLYAGAIAVPCDAPERASSVERLTAVAGDAAPALTLAAADGPLAGRMPLFDITTVSDEAAESWSAPTLDVDAPAFLQYTSGSTRTPRGVMVSHANLLANEEAIRRTCGHDQDSTFVGWLPLFHDMGLVANVLQPLFLGSLSVLMPPSAVLRHPIRWLRAVTRYRAHTSGGPNFGYELCVERTSPEERAELDLSSWLVAYNGAEPVRAATLRRFAEVFTPHGFASTAHFPCYGLAEATLLVSGTPKAEAPLVLTVDPAELRQGRVTPAVEPAPGTESVGTGSLGTGSLGTELVSCGKVAVDTEVRVVDPETARPVADGQVGEVWVRGPGVSGGYWRDPDESDKVMHARLGEEGPYLRTGDLGCLLDGQLYLTGRRKDLLVVRGQNHYPHDLEWTAEQAHPALRPSCGAAFAVDDGDRERLVLCYELRAPVSDLADVAEAVRRELSRRHGIEPHELVFLERGGVPKTTSGKVRRQSCRQSYVDGKLPVLAVVPLAVGDARSDMALPSLADLAELDPAQRVLVLASALRDALIARAGVAGAPPALDEPLSAMGVDSLALMELGHHVEACYGVVLGPGVLLGDTGVREVAQRILDAAEEVSESSAPTPPVADPTWLPLTGGQRALWFEQALAPESGAYHLARAMRIEGRLDVAAFTRAFDRLVARHAALRTRFAVHDGQPVCRVDDRGPRLVITEVGPAGDSALARQLTTLADEPFDLLAGPPVRAVLFRRDAEASVLFLMVHHLLADFWSFVVVMRDLAALYREETGGDAADLPPLRVGHADLVRAENLAADSPSAERQIRFWRDTLAAAPAALDLPTERPEPTRRTFEGATQTFRVPAELTDRLRDLARAERCTLFTTLLTGYQLLLHRYAAQQDIVVGTLLARRERAELANLVGYLVNPLPIRSRFEATEPFRALLLRTRRSIVDAMEHADVPFDRLVGEVAPVRLPGRAPLVQSLFVMQREYGPAADGFRALALGVPGKLPLGDVAVETVPVPRRWAQLDLTLSMAEVDGELVGVWEYRTDVLAEPAVSAMTRHFLRLLSEAVAEPDQPAGNLDLLSTEERGEVRRGATGPERPRDGASLHDLVARAAAQRPDAVAVIADDASGVPVQISYRALQRAATRIAARLGERGVQPEEPVALLVERGSALPLGYLGVLNAGAVVLPLNPEDPDHRLSTVLADSGARTVLTRRSLVDRAGGLGAHAVAVEDLLTADGDGHTRGVHPEQAAYLLYTSGSTGKPKGVLVPQRGIVNRILWMQEEYQLGPGERVLHKTPVTFDVSLWELFWPLVAGGCLVIARPGGHRDPAYLHALIARHQVSTAHFVPSMLGPFVAERARGEALPSLRRVVCSGEVLSPELCRRFAALFDAELHNLYGPTEASVDVTAWRCSARETGTVPIGHPIANTTCVVLDERLRVLPAGVTGELHLGGVGLARGYLNRPELTAASFVPDPDGTGERLYRSGDLARSRANGVLEYRGRRDDQTKIAGNRVEPGEVAEVLCGQPEITDAAVVARDQRLVGYVVADRPVSAEALRARLRDLLPVFLVPAAIVQLDQLPLTSSGKLDARALPVPVERAADSEPPRGDTEHRLAEIWREQLGVSGLGVTDDYFTLGGDSIRAIRVVSAARDAGLDLTVTDLLHHRTVRDLAHYLDRRAEPRPDTVDVSEVVPPFALCPAAAGREGVADAYPISMAQRALLFHKENNPGYEVYVTSVAVHGPLDRERMAEAVAGVMRRHAYLRSFFDLTSYDEPVQLVMADVPTPLHVIDVRDLPAAERQTAFQRWLHAERQRHFDVDHGPLVRFTAHDAGTEFRLTVSSFGLDGWCVAIVLTELLRHHREGAAGHAIHEAEHVGYADFVALERQAMSSEEHRRFWMTELSGAEECLLPRSPGFPRKRTAEARQHRHIVEVDADVHAKLTDLAATLGVGLKHVLLAAHLRVVRTWTGHSDTVTGLECNGRPERRGGDRVVGVFNNIVPLRLDTSEPRSWAELARAAHAAEVRLSPFRRYPLAQLHREHGAGRLFDTLFVFTHFHLYEELAEAGVSDLQAPDQTYVPLTAHFNLDAWSGRLRLLLDFDPAELAEDQIAALADSYSRAVEAMATEPERHPAATALAEASADADGGSGFERPDSVADLVHDTVRRTPDHVALSEGSCHLSYAGLWSRAGALAAALRSVGVGPESVVGLFAPRRLDTVVAMVAILRAGGAYLPLDPTSPPHRLRQLLTESGASVVVLPPSTAQQAQPEWAEGMTVVHADARTETRSPVRRTHRDALACVMPTSGSTGVPKLVGVPHRGMVNYLRWAVERYGIDARTVAPVASSPAFDLTVTSLLAPLVGGGTAELLPADAPTTLGDALARGRHTLVKLTPAHLAAVAEQLAAHGGRSSLRTVVVGGEQLHAGHVRALWTVAPEAVVVNEYGPTETVVGCSVHQVADLPSEGPVPIGRAISGASVRAVDEYASGFGATEAAPGVLGELHVGGAGVTRGYLGRPADTAAAFVPDPHREGARRYRTGDLARRLPHGDLVFVGRADRQVKIRGHRVELGELEHTLAAHPAVRQVAAVTRPGPGGRLRLTAYWVPAPGTEAATAELQNWLAHRLPAHLVPDALVRMPALPMTANGKVDQSRLPDGADRVAAVLERIEELSDAEVERLLANARTAAGPSPTEGGARG	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	493.17	gnl|BL_ORD_ID|4935|hsp_num:0	5928			582	1629	colistin A; colistin B
BGC0001048.1|Tallysomycin_20 # 43812 # 44804 # 1 # ID=1_20;partial=00;start_type=ATG;rbs_motif=AGGAGG;rbs_spacer=9bp;gc_cont=0.707	BGC0001048.1|Tallysomycin_20 	43812	44804	+	Loose	1200	39.2762	arnA	24.72	3002985	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	ATGCGGACCGTGGTCACCGGGGCCGGTGGGTTCATCGGAGCCCACCTGGTGCGCTTCCTCGCACAGCAGGGCTGCCACGTGCGCGGCGTCGACCTGCGGCACCCGGAGTTCGCCCCCTCGGCGGCCGACGAGTTCGTCACGGCCGACCTTCGCGACCCGGCCGCCGCGGCGGACGCGGTCGCCGGCGCCGACGTGGTCTTCGCCCTGGCGGCCAACATGGGCGGCATCGGCTGGACGCACGCCGCCCCGGCCGAGATCCTGCGGGACAACCTGCTGATCTCCACCAACACCGTGGAGGCGTGCCGTGCGGCCGGTGTGGGCAAGGTGGTCTACACGTCCTCCGCGTGCGTGTACCCCGGGTACCTCCAGCGGAACCCGGACGACCCGCCGTTGCGGGAGGACCGGGTTTTCCCCGCCGAACCCGACATGGAGTACGGCTGGGAAAAGCTGACCACCGAGATCCTGTGCGCCACCTACCGCCGGACCTACCGGATGGACATCAAGGTCGCCCGGCTGCACGCGATCTACGGCCCCTGGGGCAGCTACGAGGGCTTGCGGGCCAAGTCGCTGTCGATGCTGTGCGGCAAGGTGGCGCGAATCCCCGACCAGGCGGGGGAGATCGAGGTGTGGGGGGACGGGACCCAGACCCGCTCCTACTGCTACGTCGACGACTGCGTCGAGGGGCTCTGGCGGCTGTCCAAGTCCACTGTGGACACGCCGGTCAACCTCGGGTCCGAGGAGCGGGTGACGATCGCCGAGCTGGTCGACCGGATCGCGGTGGTCGCGGGGAAGACCGTGACCTCCCGCTACCTGACGGACAAACCGGTCGGCCCCCGTGGCCGCAGCTCGGACAACACCCTGTGCCGCGAGCTGTTGGGGTGGGCGCCGGAGACGAGCCTGGACGAGGGCCTGCGCCGCACCTACGCCTGGATCGAACAGCACCTGGCGGCAGGGGATTCGACGGCCGATGTCGTGAGGAGCACCGATGGCTGA	MRTVVTGAGGFIGAHLVRFLAQQGCHVRGVDLRHPEFAPSAADEFVTADLRDPAAAADAVAGADVVFALAANMGGIGWTHAAPAEILRDNLLISTNTVEACRAAGVGKVVYTSSACVYPGYLQRNPDDPPLREDRVFPAEPDMEYGWEKLTTEILCATYRRTYRMDIKVARLHAIYGPWGSYEGLRAKSLSMLCGKVARIPDQAGEIEVWGDGTQTRSYCYVDDCVEGLWRLSKSTVDTPVNLGSEERVTIAELVDRIAVVAGKTVTSRYLTDKPVGPRGRSSDNTLCRELLGWAPETSLDEGLRRTYAWIEQHLAAGDSTADVVRSTDG	MTSKAVVFAYHDIGCTGIEALLNAGYEIAAVFTHADDPRENTFYASVARLCAERGIPLHAPEDVNHPLWLERIRQLRPDFLFSFYYRRLLGAELLACAARGAYNLHGSLLPRYRGRAPANWVLVNGETQTGVTLHRMIERADAGPILAQQAVAIDPEDTALSLHGKLRKAAGALLRDSLPLLALGVLPEVEQDESQASHFGRRTPADGLLDWHRPARQLYDLVRAVTQPYPGAFCQVGEQKLIVWSAEVVAGNHGREPGSVLSCDPLRIACGEDSLVLRFGQRGERGLYLAGTQLATELGLVEGARLRGAACSPQRRTRVLILGVNGFIGNHLSERLLRDGRYEVHGMDIGSDAIERLKADPHFHFVEGDIGIHSEWLEYHVKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLRIVRYCVKYGKRVVFPSTSEVYGMCQDPDFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYGQQGLRFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDVDDGIEALARIIDNRDGRCDGQIVNIGNPDNEASIRQLGEELLRQFEAHPLRAQFPPFAGFREVESRSFYGDGYQDVAHRKPSIDNARRLLDWQPTIELRETIGKTLDFFLHEALREREAQA	49.85	gnl|BL_ORD_ID|1513|hsp_num:0	1643			954	1950	polymyxin B
BGC0001048.1|Tallysomycin_22 # 46702 # 48588 # 1 # ID=1_22;partial=00;start_type=ATG;rbs_motif=GGGGG;rbs_spacer=8bp;gc_cont=0.733	BGC0001048.1|Tallysomycin_22 	46702	48588	+	Loose	500	28.8758	PNGM-1	28.21	3004571	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	PNGM beta-lactamase	ATGTGCGGAATCGTCGCGATCCACGCGCCGGACGGCGGGCTCGCCGAGGCGGACGCGCTGCCGGGCATGGCGGCGCTGCGCGCCCGCGGGCCCGACGGGTCCGGCGTGTGGTGCTCGCCCACCGGACGGGCGGTCCTCGGCCACACCCGGCTCGCGGTGATCGACCCGGACGGCGGGCGCCAGCCGATCGCCGACGAGGAGGGACACCGCCACCTCGTGGCCAACGGCGAGTTCTACGACTACCGCCGGATTCGCCGGGAGCTCGCCGACGCCGGACACGTGTTCCGGACGCGAGGTGACAGCGAGATCGCGCTGCACCTGCACGCCAGGGAGGGCCACCACGCGCTCGACCGGCTCCGGGGCGAGTTCGCCTTCGTCATCTGGGACGAGCGCACGGGTGAGCTGTTCGCGGCGCGCGACCGCTTCGGCGTCAAACCCCTGTACTACGCCCGGCACCAGGGCCGTCTGCTGATCGCCTCGGAGATCAAGGCGTTGTTGGCCTGCGGGGTGCCCGCCCGCTGGGACACCGCCGCGTTCGCCGCCCACCTCCAGGTCGCGCCACCTCCGGACCGCACCCTCTTCGCCGGGATTTCCCAGCTCCCGCCCGGCTGTTACCTCGTCGCCGGGTCGCAGGGCGTCGCCGTCCGCCGTTACTGGGACCTCGACTACCCGTTGGCGGCGGATCTGGAGCAGGGGGACGAGCACTGGGAGAGCCACGTCGAGGAGGTGCGCGCCGCGATCGAGGAGGCGGTCCGGGTCCGGATGATCGCCGACGTCCCGGTCGCCTACCACCTCAGCGGCGGGCTCGACTCGACCAGCGTGGTCGCCACCGCGGCGCGCCACGACACCGTCACCGCCTTCACCGTCCGGTTCGACGACCCCGCGTACGACGAGAGCGAGGTCGCCGAGCGCACCGCGCGTCGGCTCGGGGTCCGGCACCACCAGATCGACTCCCACCGCGCCGACTTCGCCCACCACCTGCGGGAAACGGTGTGGGCGGGGGAGAGCGTCCAGGAGAACGCCCACGGGATCGCGCGGTACCTGCACAGCAGGGCGATCCGGGGACACGGCTTCAAGGTCGTGCTGGGCGGCGAGGGCGGCGACGAGATCTTCGCCGGATATCCCCAGTTCCAGAAGGACCTGGCGCTCGGGCTGTCTCCGGACCTGTTCGCGGAGACGCGCCGCGGCTACCGCAAGCTCGTGGCCGCCGGCGCACCCCAGCACCTGCGCACCCTGTTGGACGAACTGGGGTTCGTGCCGAGCTGGGTGCTCGACCGGTACCTGTCGGTCACCTCGCCGGTGATGCCGTTGCTGCGCCCGGAGTTCGCCGCCGAGGTGTCGGTCACCGACGCCTGCGCGCCGCTGCTGGCCGCGACCGGGGACCAGCTCGCCGGCCGCGCGACGTTGCACCAGTCCACGTACCTGTTCGCGAAGAGCTGGCTGCCCCACTACATCCTCGCGTCGGAGCGGTTGGACGCCGCCCAGGCCGTCGAGGCCAGGCTGCCGTTCTTCGACCATCACCTGTTCGCCGTCGCCCGCCGGACCCCGTTGCACTGGTACACCCGTGCTGGCGCCACGAAGTACCCCCTGCGCGCCGCGATGGCCGACCGGCTGCCGGCCGAGGTCAGCGCGGGGCGCAAGCGCGGGTTCTTCGCGCCACCGGTGGTCGGCGACGACGGGATGGTCGCCGCGGTGCGGGACCTGGCCCGCGGATCGGCGTTGCGGGACAACCCGTTCTTCCGGCCGGAGGCGGTCGTGCGGCTCGTCGACCGGCTGGCCGACCGACCGCCCGCCCAACGGGCGACCGCGGAGCGCCTGGTCCAACTGGTGGGCTCGGTCGGCGCGCTGGCGGAGGAGTTCGGCCTGACGGGAGGGGGAACGCCGTGA	MCGIVAIHAPDGGLAEADALPGMAALRARGPDGSGVWCSPTGRAVLGHTRLAVIDPDGGRQPIADEEGHRHLVANGEFYDYRRIRRELADAGHVFRTRGDSEIALHLHAREGHHALDRLRGEFAFVIWDERTGELFAARDRFGVKPLYYARHQGRLLIASEIKALLACGVPARWDTAAFAAHLQVAPPPDRTLFAGISQLPPGCYLVAGSQGVAVRRYWDLDYPLAADLEQGDEHWESHVEEVRAAIEEAVRVRMIADVPVAYHLSGGLDSTSVVATAARHDTVTAFTVRFDDPAYDESEVAERTARRLGVRHHQIDSHRADFAHHLRETVWAGESVQENAHGIARYLHSRAIRGHGFKVVLGGEGGDEIFAGYPQFQKDLALGLSPDLFAETRRGYRKLVAAGAPQHLRTLLDELGFVPSWVLDRYLSVTSPVMPLLRPEFAAEVSVTDACAPLLAATGDQLAGRATLHQSTYLFAKSWLPHYILASERLDAAQAVEARLPFFDHHLFAVARRTPLHWYTRAGATKYPLRAAMADRLPAEVSAGRKRGFFAPPVVGDDGMVAAVRDLARGSALRDNPFFRPEAVVRLVDRLADRPPAQRATAERLVQLVGSVGALAEEFGLTGGGTP	MAGGKVTSSTGIAPKRYVYYPGSEELGPDEIRVIACGTGMPTARRAQAAAAWVVELGNGDKFIVDIGSGSMANIQSLMIPANYLTKIFLTHLHTDHWGDLVSMWAGGWTAGRTDPLEVWGPSGSREDMGTKYAVEHMLKAYNWDYMTRAVTINPRPGDINVHEFDYRALNEVVYQENGVTFRSWPCIHAGDGPVSFALEWNGYKVVFGGDTAPNIWYPEYAKGADLAIHECWMTSDQMMTKYNQPAQLALRINLDFHTSAQSFGQIMNMVQPRHAVAYHFFNDDDTRYDIYTGVRENYAGPLSMATDMMVWNITRDAVTERMAVSPDHAWDVAGPSEDLAPDRNRASEYTQYILDGRLNVDEANAHWKQEFMGRTGLTTEDLGVGS	162.69	gnl|BL_ORD_ID|2715|hsp_num:0	3272			363	684	
BGC0001048.1|Tallysomycin_23 # 48585 # 56447 # 1 # ID=1_23;partial=00;start_type=GTG;rbs_motif=GGGGGA;rbs_spacer=5bp;gc_cont=0.728	BGC0001048.1|Tallysomycin_23 	48585	56447	+	Loose	1000	143.665	almE	30.3	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	GTGAACGGAGAACAGCGCGGTTCCGACGAACTCGCCCGCAGGATCGCCGCACTGCCGCCGGAGCGGCGGGCGATGCTGGAGGAGGTGCTGCGCCGGCAGTCCGGCGCCCGCACCGGAATCCCCCGGCTCGGCCCCGACGAGCCGGCCCCGCTGTCGTTCGCCCAGCAACGGATGTGGGTCCTCCAGGGCCTCACCCCCGCCGCCTGCAACTACGCCTCCGCCATCCGGCTGCGCGGCCCGCTCAACACGACCGCGTTGCGCGCCGCGCTGCGCCAGGTCGTCCAGCGGCACGAGGTGTTGCGCACCAGCTTCGTCCTGGATGGCGACGAGATCCGCAACACCGTCCACTCCTGCGCCGAGCCGCCCTTCCGGCTCGTCGACCTGAGTGGGGTGGGCGCGTCGGAGGACGCCCTCGCGGCGCTGCTGCGGGAGGAGTCCCGTCGTCCGTTCGACCTCACCGCCGCCGCGCCGACGATGCGGGTCACCGTGTTCCGGCTCGCGGCCGACAACCACCTGGTGCTGCTGGTCTTCCACCACATCGCCATCGACGGCTGGTCCAACGGTGTTCTGGTCCAGGAGCTCTCCGCGCTCTACCAGGACCAGGTGCTCGGCCAACCGTGCGCACTGCCCGCGCCGCCGGTCCAGTACGGCGACTACGCGGCATGGCAACGGAACCGGCTCAGCGGCCCGGAACTGGAGGCCCTGACCGAGTTCTGGGCCGAGCAGGTGCGGGATCTGCCCCGGCTGGACCTGCCCACCGACCGGCCGCGCGCGGACGCACCGCGAGGTGAGGGCGCGAACCACCACTTCGTCCTGTCACCGGAGGCCACCCGCCGACTCGGCGAGGTGCGGCAGCGCGAGGGCGGTTCGCTGTTCATGCTCGTGCTGGCGGCTTTCGTGGCGGTGCTGCGAACCGTGACCGACCAGCGAGACGTCGTCCTCGGCACTCTCGTGGCCGGGCGGAACCGCGCGGAACTGGAACGGCTCGTCGGCTACTTCGTCAACGTCGTCCTGCTCCGGTTCACAGTGGACGACCAGGCCGACTTCCGGGAGCTGTGGCGTCACGTGCGGGACCGCGTCCTGGCCGCGCACGCTCACCAGGAACTGCCGTACGAGAAGCTGGTCGAGCTGCTGCGCGCGAACGGCCACGCGGACAACGAACCGCCGATCAGGGTCGTGTGCGTGGCACACCAGACCCCGCCGCCGGTCGACCTCGCCGGACTCGCGGCCGAGGTGGCGGACGTCGACCTCGGCACCACCCAGTTCGACCTCGTGGTCGAGGTGCGGGAGAAACCGGAGGGGTTGCAGGTCGCCTTCCAGTACGACGTCGACCTCTTCGCCCCCGCCACGGTGCGGCTTCTCGCCGACCACCTCCGCACCGCCCTGGAACGCGTCGGCGAGTCCCCCGACCGGCACCCCGCCGAGCTGCTCCGGGCCGCGCCCGTGGCGGTCGCGGAGACGGCGGTGGAGCACGACGCCACCCTGCACGGACTGTTCGAGGACCGCGTCGCGCGGACGCCGGACTCCGTGGCGCTCCTGGCGGCGGGGCACCAGATCACCTACCGGCAGCTCAACGCGCGGGCGAACCAGCTCGCCCGCCGGTTGCGCGCGCGAGGAGTGCGGGCAGAGGACCGGGTCGCCCTGTTCCTGCCCCGGTCCCTGGACTCGGTGACCGCGATGCTCGGGATTCTCAAGGCCGGTGGGGCGTACGTCCCGCTGGACCCCGACCACCCGAGCACCAGGCTGTCCGCGGTGATCGCCGACGCCGCCCCAACGCTTCTGGTCACCACCAAGGAGATCCAGGACCGCTGCCCGGAGTACCGGGGACCGGTGCTGCTGCTGGACAGCGAGCGCGACGCACTGTCCACAGAGGACACCGCCGACCTGCGTCTGCCGGTCCGGGCCGACAACCTCGCGTACGTGCTGCACACCTCGGGCTCCACCGGACGACCCAAGGGCGTGCTCGGTCTGCACCGCGGCGCGGTCAACCGCGCGGCGTGGTGGGAGAAGGTCTACCCGTTCCAGCCGGGCGAGGTCTGCGCGGCCCGCACCGCGTTGGGCTTCGTCGACTCGGTGTGGGAAACCTTCGGGCCGCTGATCGCCGGCGTGCCGTTGCTCGTGTTGTCCCCGGACGAGGTCGCCGATCCGGTGCGGTTGGTGGACCGGCTGGCCGCGCACCGGGTGACGCGCCTGGTCGGGGTGCCGTCGCTGGCCACCCTGTTGCTGGACGAGCTGCCGGACCTGGACCAGCGGTTGCCGGAGCTGAGGTTCTGGGTGCTCAGCGGGGAGTCCCTGTCCGGCGGTCTGGCCCGCCGCTTCCACGAGCGGCTGCCCGGCCGGACCCTGCTGAACCTGTACGGCTCGTCGGAAGCGTCGGCCGACGCCACCGCCGCCGAGATTCCGCACAGCGCGACGGAGTCCCGAGTGCCGATCGGCCGGCCGATCAGCGGCGTCGCGGTCCAGGTGCGCGATTCGGCGCTGCGCGCCCTGCCGGCGCTCGCGCCGGGCGAGCTGCACGTGGGCGGCGAGTGCCTGGCCCGGGGATACCACCGGCGCCCGGCCGAGACCGCGGCGGTGTTCCTGCCCGCGCCGGACGGGCCGCCGGGATCTCGGGCCTTCCGCACCGGAGACGCCGCGCGGTGGCGCCCGGACGGCCAACTCGACTACCTGGGCCGGCTCGACGGACAGGTTCAGGTGCGCGGCCACCGCGTGGAACCCGGTGAGGTCGAGCAAGCGCTGTCGGGCCACCCCGACGTGCGCGCCGCCGCCGTCGTCGCCCGCCCCGACTCCACGGGATCCACCGCCCTGGTCGGATATCTCGTGGCGGACCGCAACCTGGATCTCGCCCAGGTCCGCGACTTCCTGCGTCAGCGCCTCCCGGGCTACCTGGTGCCGAGCCTGCTCACCCAGGTGCCGGCCCTGCCGATGACGCCGAGCGGCAAGGTGGACCGACTGCGGCTCCCGGAGCCGGACACCACGGCAGGCGAAGGGATCGAGCGGGTCGTCTCGCCACGCACGCGGACGGAGGCCGTGGTCGCCGAGGTCTTCGCCGAGCTGCTGCCGGGACAGCGCCAACCCGGCCCGCACGACGACTTCTTCGTCCTGGGTGGACACTCCGTCCTGGCCGCGCGGGTGGCGGCCCGGCTGCGCGAGCGGTGCGGCGTCGACATCGGACTGCGCGACCTGTTCGCGGCCCCCACGGTGGCCGGCCTGGCCGCGCGGGTCGACGAGCGCGACCCGTCCCGGCAGACCCGGCCGGGCCGGCTGGTGCCCGCGCCCGAGTCGCTGACCGAACCGTTCCCGCTGACCGACGTGCAGCAGGCGTACTACGTCGGACGGGACGACAGTCTCGACCTCGGCGAGGTCTCCACCCACGCCTACCTGGAACTGTCGGCGCCCGAGCTGGACCTCGACCGGTTCCAGACCGCCCTGCGCGGCGTCATCGAGCGGCATCCCATGTTGCGCGCGGTGGTGCGGCCCGACGGGCGGCAGCAGGTGCTGGCGTCCGTTCCGCCGTACCAGGTCGCCGTGCAGGACCTGCGGGACGTCTCCGAGGCCACCGAGCGGCGGCGACTGCTGGCGGTGCGCGAGGAGATGTCGCACCAGGTGCTGCCCGCCGACGTGTGGCCGCTCTTCGAGGTGCGCGTCTCCCTGTTGCGGGACGGGGGAGCGTGCGTCCACGTCAGCGTCGACGCCCTGATCTGCGACGCCTACAGCTTCGGCATGGTGTTGTCCGAACTGGGCCTGCGCTACCAGGACCCCGCGCGGGAGCTGCCACCGCTGGAGGTCAGCTTCCGCGACTACGTCCTCGCCGACCGGGAGCGCCGAGCCTCCGACGAGTACGCCGCCGCGCTGGACTACTGGCGCGAGCGGATCGCCGACCTGCCGCCGGGACCTGACCTGCCGCTCGCGGTGACACCCGAGTCGCTGGGCAAACCTCGGTTCGAGCGCCGCTCCGGCCGGATCGCCGCTCCGGAGTGGACAGTCCTGAAGGGACTCGCCGCGTCGGTCGGACTCACCCCGTCCGGCCTGCTGCTGGCGGTCTTCGCCGAGACGTTGACGACATGGAGCCGTCGGCCGCACTACTCCCTGATGCTGACGGTGTTCCAGCGGGAGCCCGTGCACCCCCAGGTCGGCGAGATCGTCGGTGACTTCACCTCGCTGACCGTGCTGGAGGTGGACCACACCCGCGCCGGCGGTTTCGTCGACCGCGCGCGTGCGCTGCAACAACGGCTGTGGGACGACCTGGACCGGTCCGTCGTCAGCGGCGTGACCGTGATGCGGGAGTGGGTCGCGCGGCACGGCGGCCGACCCCGGCTGGTCACGCCCGTGGTGTTCACCTCCAACCTGCCGTTGGCCGACAACGCGACCAGCGCCGACGCCGCCGAGGAGTGGGCACTGGGCTCCACGACCTACGGCATCACCCAGACTCCGCAGGTCCACCTGGACCACCAGGTCAGCGAGCAGCAGGGCGAGCTGGTGTTCAACTGGGACGCGGTGGGCGAGCTGTTCGAGCCCGGCGTGCTGGACGACATGTTCGCCGCCTACCAGGACTTCCTGGCCCGACTCGCGGCGCAGCCCCACGCCTGGCAGCAGCCGATCCGTGTTCCATTGCCCGACGCGCAACGAAACCGCCGCGCCGAGGTCAACAGCACAGCCGTGCCCCTGCCCGACCGCTGCCTGCACGAGACCGTTTTCGAGGCGGCGCAACGTTTCCCGGAGCACACCGCTGTGGTCGACGGGGACGTGCGCGTGACCTACCGCGAGCTGGCCGCGCGCTCCCACCGGGTCGCCCGCGCCCTCCGCCGGCTCGGGGCCAAGCCGGGCGAACTCGTCGCGATCGTGGCCCGCAAGGGATGGCAGCAGGTCGTGGCCGCGCTCGGTGTCCTGGAGTCCGGGGCGGCGTTCGTGCCGGTGGACCCGGACCTTCCGGCGGCCCGCCTGACCCACCTCCTTCACAGGGCCGAGGCGCGGATCGCGCTCACCCACCTCGCCGTCGCCGAGGAGGTCCCGTTCCCGGACGACCTGAGCGTCCTGGCCGTCGACGACGACAGCGCCCTCCAGGACAACAGCGCCCTCCAGGACAACAGCGCCCTCGACGCCTCCGACGAACCGCTGGACCGCGCCCAGGGGATGGATGACCTCGCCTACGTCATCTTCACGTCCGGCTCGACCGGCGAGCCGAAGGGCGTGATGATCGACCACCGGGGCGCGGCCAACACGATCCGGTGCGTCAACCAGCACTTCGCCGTCGGCCCGCACGACCGGGTGCTGGCGGTCTCCTCGCTGAGCTTCGACCTCGCGATCTACGACCTGTTCGGCGTGCTCGCCGCCGGCGGCACCGTCGTGCTGCCACGGCACTCCCGACGCCGCGACCCCGCGCACTGGGCGGAGCTCGTCGCCACCGAGCGGATCACGTTGTGGAACTCGGTCCCAGCGCTCGCGGAGGTCCTGGTCGGCTACGCCGAGGCGTTGGCGCCCCAGGCGTTGCGCTCCCTGCGCGTGGTCATGCTCAGCGGCGACTGGATTCCCGTCGCGCTGCCGGACCGCCTCCGGCGGCTCGCGCCGGAGACGCACGTCCGCAGCCTCGGCGGCGCGACCGAGGGGTCGATCTGGTCGGTGTGGTACCCGATCGGCGAGGTCGACCCGTCCTGGCGCAGCATCCCCTACGGGATGCCGATGGACAACCAGAGCATGCACGTCCTGGACCGCGGGCTGTCCCCGCGGCCGGACTGGGTCGCGGACGAGCTGTACATCGGCGGCACCGGCGTGGCCCTGGGCTACTGGCGCGACCCGGAGCGGACGGCGAGCAGCTTCCTGACCCACCCCGACACCGGGGAACGCCTCTACCGGACCGGGGACATCGCCCGCTACCTGCCGGACGGGAACCTGGAGTTCCTGGGCAGGGAGGACAACCAGGTCAAGATCAGTGGCTTCCGGGTGGAGCTCGGCGAGATCGAGTCCACTCTGGAGCGTCTGCCCGGGGTGCGGACCGCCGCCGTGGTCGCGGTCGGCGATCCCCGGGGGGAGAAGCGGTTGGCCGGTTACGTGGCGCGCGAACCGGGGGAGCAGGTCGACCCGACCGCGCTGCGCCGTCGCCTCGCGGAGCTGCTGCCCAGCCACTTGGTGCCGCCGACGCTCCACGTCCTGGACCAGCTTCCCCTGACCAACAACGGAAAAGTCGACCGCGCGGAGCTCCGCTCCCGAGCGGAGAAGCGGCCCGCCGTCCGTCAGGAACCACGCGACCGGGACCCGGGGCGCGCGCACGCGCTCGTGCCCGAGATCGTGGCGTTGTGGCGTGAAGTGCTGGAGGTCGACGAGATCGACCCCGACGACGGGTTCTTCGCCCTGGGCGGCACGTCGTTGCAGGCCATCCGGCTGCTCACCCTCATCCAACGCGACCGGGGAATCCGCATCCCGTTGGCGCGCCTGCTCGACGCGCCAACCGTCCTCGCCCTCGCCGAGGCGATCGCCGACGCCGAGAGCGGCCCGGCCGGCCCCGCCGCCGCGCCGGACGAACTGCCCGTGTTGCGGCCCGACCCGGAGCGGCGGCACGATCCCTTCCCCCTCACCGACATCCAGCAGGCGTACTGGCTGGGCAGGCGGACCGCCGCCGGCCTGGGCGGCGTCGCCACCCACAGCTACGTGGAACTGGACGTCGAGGACCTGGACCCGGCCCGGCTGGAGATCGCGGTGCGCCGGCTCGTCGACCGACACGACGCGCTGCGCACCGTCTTCCGGCCCGACGGCCAGCAACAGGTGCTGTCCGAGGTGCCGGCCTTCGAAGTGTCCTCTGTGGACCTTCGAGGGCTGTCGGAGGACGAGGCGGACGCGCGGCTGGCCGCGGTGCGCGAGGAGATGTCCCACGAGGTGCGCGACGCCGCTCGGTGGCCGCTGTTCGAGATGCGCACCCACCGGCTCGACGAGGTCCGCACCCGGTTCCACCTCAGCCTCGACCTGTTGATCGCCGACGCCCACAGCACCCGGGTCCTCACCGGCGAACTGCTGGCCCTGTACCACGACCCCGACACGGCCCTGCCGGAGCTGACCTGTTCCTTCCGCGACTACGTGCTCGCGATGGCGGCGTTCCGCGACAGCGCGACGCACGGCAGGGCGCGGCGGTACTGGGAACAACTCCTGCCCGAGCTGCCTCCAGCGCCGGCCCTGCCCCTTCTCGCCCGACCCGAGGAGCTGGTCCAGCCCCGGTTCGAGCGGCTGGCGACCACAGTGGACGCCGAGGACTGGGCCGCGCTGCGGGCATGGGCCGCCGCCGAGGGGCTCACCCCGTCCGCGGTCGTCTGCGCCGCCTTCGCCCACGTGCTCGGGGCGTGGAGCGCCTCGCCGAGGTTCACCCTCAACCTCACGACGTTCAACCGCTTCCCGCTGCACCCCCAGGTCGACGCGCTCGTCGGGGACTTCACCGCCACGACGCTGCTCGCCGTGGACGCCACCGCGCCCTCGGTGCCGGAGCTGGCCCGCCAGGTGCAGGCCCGGATCTGGCGGGACCTGGAGCACCGGACGGTCAGCGGCGTCGAGGTGCTGCGGATGCTGCGCCGAGATCCCCGCCGCCGCGACGAGGCGCTGATGCCGGTCGTCTTCACCAGCACCCTGCTGCCCGACGGCGTGGCACCACCGGCGCCGCCGAGCCAGTGGCGCGCGCGAGCGGTCTTCGCGGTCAGCCAGACCCCGCAGGTGTTGTTGGACCACCAGGTCGGCGAGGACGCCGGCCGCCTGGTGTGCACGTGGGACCACGTGCCGGCGGCGTTCCCGCCGGGTCTGGTCCCCGCCATGTTCGGCGCCTTCGAGCACGCGCTCGCCGCTCTCGTGGCGGGGGCCAAGCAAACGAAAGGTGGTCAGCCTTGA	MNGEQRGSDELARRIAALPPERRAMLEEVLRRQSGARTGIPRLGPDEPAPLSFAQQRMWVLQGLTPAACNYASAIRLRGPLNTTALRAALRQVVQRHEVLRTSFVLDGDEIRNTVHSCAEPPFRLVDLSGVGASEDALAALLREESRRPFDLTAAAPTMRVTVFRLAADNHLVLLVFHHIAIDGWSNGVLVQELSALYQDQVLGQPCALPAPPVQYGDYAAWQRNRLSGPELEALTEFWAEQVRDLPRLDLPTDRPRADAPRGEGANHHFVLSPEATRRLGEVRQREGGSLFMLVLAAFVAVLRTVTDQRDVVLGTLVAGRNRAELERLVGYFVNVVLLRFTVDDQADFRELWRHVRDRVLAAHAHQELPYEKLVELLRANGHADNEPPIRVVCVAHQTPPPVDLAGLAAEVADVDLGTTQFDLVVEVREKPEGLQVAFQYDVDLFAPATVRLLADHLRTALERVGESPDRHPAELLRAAPVAVAETAVEHDATLHGLFEDRVARTPDSVALLAAGHQITYRQLNARANQLARRLRARGVRAEDRVALFLPRSLDSVTAMLGILKAGGAYVPLDPDHPSTRLSAVIADAAPTLLVTTKEIQDRCPEYRGPVLLLDSERDALSTEDTADLRLPVRADNLAYVLHTSGSTGRPKGVLGLHRGAVNRAAWWEKVYPFQPGEVCAARTALGFVDSVWETFGPLIAGVPLLVLSPDEVADPVRLVDRLAAHRVTRLVGVPSLATLLLDELPDLDQRLPELRFWVLSGESLSGGLARRFHERLPGRTLLNLYGSSEASADATAAEIPHSATESRVPIGRPISGVAVQVRDSALRALPALAPGELHVGGECLARGYHRRPAETAAVFLPAPDGPPGSRAFRTGDAARWRPDGQLDYLGRLDGQVQVRGHRVEPGEVEQALSGHPDVRAAAVVARPDSTGSTALVGYLVADRNLDLAQVRDFLRQRLPGYLVPSLLTQVPALPMTPSGKVDRLRLPEPDTTAGEGIERVVSPRTRTEAVVAEVFAELLPGQRQPGPHDDFFVLGGHSVLAARVAARLRERCGVDIGLRDLFAAPTVAGLAARVDERDPSRQTRPGRLVPAPESLTEPFPLTDVQQAYYVGRDDSLDLGEVSTHAYLELSAPELDLDRFQTALRGVIERHPMLRAVVRPDGRQQVLASVPPYQVAVQDLRDVSEATERRRLLAVREEMSHQVLPADVWPLFEVRVSLLRDGGACVHVSVDALICDAYSFGMVLSELGLRYQDPARELPPLEVSFRDYVLADRERRASDEYAAALDYWRERIADLPPGPDLPLAVTPESLGKPRFERRSGRIAAPEWTVLKGLAASVGLTPSGLLLAVFAETLTTWSRRPHYSLMLTVFQREPVHPQVGEIVGDFTSLTVLEVDHTRAGGFVDRARALQQRLWDDLDRSVVSGVTVMREWVARHGGRPRLVTPVVFTSNLPLADNATSADAAEEWALGSTTYGITQTPQVHLDHQVSEQQGELVFNWDAVGELFEPGVLDDMFAAYQDFLARLAAQPHAWQQPIRVPLPDAQRNRRAEVNSTAVPLPDRCLHETVFEAAQRFPEHTAVVDGDVRVTYRELAARSHRVARALRRLGAKPGELVAIVARKGWQQVVAALGVLESGAAFVPVDPDLPAARLTHLLHRAEARIALTHLAVAEEVPFPDDLSVLAVDDDSALQDNSALQDNSALDASDEPLDRAQGMDDLAYVIFTSGSTGEPKGVMIDHRGAANTIRCVNQHFAVGPHDRVLAVSSLSFDLAIYDLFGVLAAGGTVVLPRHSRRRDPAHWAELVATERITLWNSVPALAEVLVGYAEALAPQALRSLRVVMLSGDWIPVALPDRLRRLAPETHVRSLGGATEGSIWSVWYPIGEVDPSWRSIPYGMPMDNQSMHVLDRGLSPRPDWVADELYIGGTGVALGYWRDPERTASSFLTHPDTGERLYRTGDIARYLPDGNLEFLGREDNQVKISGFRVELGEIESTLERLPGVRTAAVVAVGDPRGEKRLAGYVAREPGEQVDPTALRRRLAELLPSHLVPPTLHVLDQLPLTNNGKVDRAELRSRAEKRPAVRQEPRDRDPGRAHALVPEIVALWREVLEVDEIDPDDGFFALGGTSLQAIRLLTLIQRDRGIRIPLARLLDAPTVLALAEAIADAESGPAGPAAAPDELPVLRPDPERRHDPFPLTDIQQAYWLGRRTAAGLGGVATHSYVELDVEDLDPARLEIAVRRLVDRHDALRTVFRPDGQQQVLSEVPAFEVSSVDLRGLSEDEADARLAAVREEMSHEVRDAARWPLFEMRTHRLDEVRTRFHLSLDLLIADAHSTRVLTGELLALYHDPDTALPELTCSFRDYVLAMAAFRDSATHGRARRYWEQLLPELPPAPALPLLARPEELVQPRFERLATTVDAEDWAALRAWAAAEGLTPSAVVCAAFAHVLGAWSASPRFTLNLTTFNRFPLHPQVDALVGDFTATTLLAVDATAPSVPELARQVQARIWRDLEHRTVSGVEVLRMLRRDPRRRDEALMPVVFTSTLLPDGVAPPAPPSQWRARAVFAVSQTPQVLLDHQVGEDAGRLVCTWDHVPAAFPPGLVPAMFGAFEHALAALVAGAKQTKGGQP	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	471.22	gnl|BL_ORD_ID|4935|hsp_num:0	5928			582	1638	colistin A; colistin B
BGC0001048.1|Tallysomycin_24 # 56444 # 59083 # 1 # ID=1_24;partial=00;start_type=TTG;rbs_motif=AGG;rbs_spacer=9bp;gc_cont=0.741	BGC0001048.1|Tallysomycin_24 	56444	59083	+	Loose	1000	62.3882	almE	20.85	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	TTGACGGCCAGGTCCACAGCGTCGCTGCTTCCCGCCGACCAACAGGAGCTGCTGCGCGCAATCAACGACCAGACCGCGCCGATTCCGGCCGGCCGGCTAGACGAGCTGGTGGCGGCCGGGACCGACGCGGTCCGGGCGGACGCCCCGGCCGTGGTCTCCCCGCGCCGCGTCCTCGACCGCGCCGACCTGCTCGCCCGCGTGGACGCCCTCGCGGCGCGGCTGCTCGCGGCCGGCGTCGCTCCTGGCGACCGCGTGGTGTGCTCGGTCGAGCCCGGCTGGGAACAGGTCGTCGCGCTGCTCGGCGTCCTGCGGGCCGGCGGCGTCCACCTCCCGGTGCCGCCCGGCCTCGGCCAGGTCGCCCGGTGGCAGCGCGTCACGCGTTCCGAGGCGGCGGTCGTGCTCACCCAGTCCTGGCTGGGCGAACGACTGTCCTGGCCGGACTCGGCCACCGTGATCGCCGTGGACGAGGTGGAGCCGGGACCGACTCCGGCCACTGTGGACAGAGCACCGGAGGCCGCGGCCTGCCTGGTGCCCGGCGAGGACGGCCGCGACCACGTCGCCGTGAGCCACCGCGCGATCGTCACCACGCTCACCGAGCTGAACGCCCGCTTCCGCGTCGGGCCGGAGGACCGGGTGCTGGCCCTGTCCTCGCCCGAGTCCGGGTTCGCGCTCTACGAGACGGTCGGCGCGCTGCTGGCCGGGGCGACCGTGGTGTTCGGCGACGATCTCGACGCCCGCGACCCCGCGGCGTGGACGGCGTTGCTGCGGCGGGAGAGGATCACCGTCTGGCACTCGCCGCCCACCCTGCTCGGCATGCTCGTCGACCACCTGGAGGCCAGCGGCGACCGGCTTCCGGCCGAACTCCGGCTGGCGCTCGTCGGTGGCGAGCGGTTCCCCGCCGACCTGGTTCGCCGGCTTCGCGGCGTTGCGGACCCGGCTCCGGTGGTGGCCGCCCTCGGCGCCGCGACCGTCCCCGGGCTCTGGACGACCTGCGCCGAGATCGACGAGATCCCCACCGAGTGGCGTTCGGTGCCGATCGGGCGGCCGTTGCCGAACCACCGCGTCTTCGTGCTGTCGGAGACGATGACGCAGTGTCCGGTCTGGGTGACCGGCCGGCTGCACTTCGGCGGTGTGGCCGCCGAACCCTGCTCCGACAGCGACACCGAGAGCGAGTCCGGGGCGCGGGTGCCGCATCCCGAGACCGGTGAGCCGCTGACGCCCACCGGCCGGTTCGGGCGGGTGCTGCCCGACGGCGTGGTGGAGGTCGTCGGCGACGAGGCCGCCCAGGTGACGGTGCACGGCCGGGCGTTGAACATGCAGGACACCGAGGTGGCGTTGGCCGGCCACGAGGCCGTGCGGGACGCGGTGGTGGTGCCGGTGACCGAGGGCGAGTCGGTGGCGCACGTCCGCCTCGCGCCCGGCGCGCAGGTCGACGGCCCGGCGTTGCTGGACTTCCTGCGCCGCAAGGTCTCGCCCTACCTGCTGCCCACGCGGGTCGAGGTGGTGACCGGGTTCCCCCTCACCTCCGACGGCCGGGTCGACCGCGCCGCGCTGGCCAGCGCCGCGTCTCCGTCCACTGTGGACGATCAGTCCGCGGCGTCGACCGCTCCCGCCGACGACGAGCTGATCCAGCAGGTGACCAGGATCGCCTGCGGCGTGCTCGGGGTCAGCGACATCGAGCCGAACATGAACCTGCTCGACGTGGGCGCCACCTCGATCGAACTGGTCCGCCTGGCCACCCTGGTCGAGGAGGAGCTGGGCATCACCGTCGACGTCGAGGAGCTGCTGCGCTTCCCGTCGATCGCGGTGCTGGTCAGCCGGCAGCTCGGCGAGTCCGAGACCATCCCGTCGGCCGCCCCGGACACGGTGTCCGCCACCGGGTCCGGCACCGAGTCCGACACCCCGCCCGTGCCGGCGACGCCCACTGCGGCGGCCGCCCCGCAGGAGGAGAGCACCTCGGCCAGCATGCCGCTGCTCGTCGGAATCCTGGAACGGCAGGCCTTCAAGGACGCCGCGCACGGAATCCGCCACGAGTACGACGACACCGAGGGCGTCGAGATCACCGGCTCCGCGCCCGAGCGGCTGGTGAACCGCCGCACGCACCGCGGCTTCGACTCCCGCCCGGTGGAGTTCGCCGCGATCTCCGAACTCCTCTCCGCGATGCGGCAGACCCGCCACGGCGGCGAACCGAAGCGCTGGTACCCGTCGGCGGGCAGCGCCTACCCCGTGCAGGCCTACCTGGTCGTGGAGCCGGGCCGGGTCAGGGAACTGCCGTCGGGCAGCTACTACCACCACCCGGCGCGCAACTGCCTGGTGCCCGTGGTTCCCGGCGCCCGCGTCGACGCCTCGGCGCACGCCGAGATCAACCGCAGGAGCCTGCGCGAGTCCGCCTTCTCGCTCTACCTCGTCGCGCGGATGGACGCGATCACCCCGCTGTACGGGAACCTCGCCGCGGACTTCGCGATGTTCGAGGCGGGCGCGATGACCCAACTGCTGATGGAGGTCGCCACCGAGCTGGGACTCGGGCTGTGCCCGGTCGGGGCGATGGAGACCGCGCCGCTGCGCGACGTCCTGCGGCTCGGCGAGAGCGACCGCTTCCTGCACGTGTTGCTCGGCGGCTACCCCGGGGACCGGCGATGA	MTARSTASLLPADQQELLRAINDQTAPIPAGRLDELVAAGTDAVRADAPAVVSPRRVLDRADLLARVDALAARLLAAGVAPGDRVVCSVEPGWEQVVALLGVLRAGGVHLPVPPGLGQVARWQRVTRSEAAVVLTQSWLGERLSWPDSATVIAVDEVEPGPTPATVDRAPEAAACLVPGEDGRDHVAVSHRAIVTTLTELNARFRVGPEDRVLALSSPESGFALYETVGALLAGATVVFGDDLDARDPAAWTALLRRERITVWHSPPTLLGMLVDHLEASGDRLPAELRLALVGGERFPADLVRRLRGVADPAPVVAALGAATVPGLWTTCAEIDEIPTEWRSVPIGRPLPNHRVFVLSETMTQCPVWVTGRLHFGGVAAEPCSDSDTESESGARVPHPETGEPLTPTGRFGRVLPDGVVEVVGDEAAQVTVHGRALNMQDTEVALAGHEAVRDAVVVPVTEGESVAHVRLAPGAQVDGPALLDFLRRKVSPYLLPTRVEVVTGFPLTSDGRVDRAALASAASPSTVDDQSAASTAPADDELIQQVTRIACGVLGVSDIEPNMNLLDVGATSIELVRLATLVEEELGITVDVEELLRFPSIAVLVSRQLGESETIPSAAPDTVSATGSGTESDTPPVPATPTAAAAPQEESTSASMPLLVGILERQAFKDAAHGIRHEYDDTEGVEITGSAPERLVNRRTHRGFDSRPVEFAAISELLSAMRQTRHGGEPKRWYPSAGSAYPVQAYLVVEPGRVRELPSGSYYHHPARNCLVPVVPGARVDASAHAEINRRSLRESAFSLYLVARMDAITPLYGNLAADFAMFEAGAMTQLLMEVATELGLGLCPVGAMETAPLRDVLRLGESDRFLHVLLGGYPGDRR	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	158.09	gnl|BL_ORD_ID|4935|hsp_num:0	5928			525	1659	colistin A; colistin B
BGC0001048.1|Tallysomycin_25 # 59080 # 60126 # 1 # ID=1_25;partial=00;start_type=ATG;rbs_motif=GGGGA;rbs_spacer=6bp;gc_cont=0.722	BGC0001048.1|Tallysomycin_25 	59080	60126	+	Loose	600	25.409	APH(4)-Ia	33.33	3002655	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(4)	ATGAGTGTCCACAGGGGACCGGTCAGTGGCCAGCGCCGCGCCATCGCGCTGGCCACGACCGACTGGGTGCGTCCGGGGGGAACGCCGCCGGGACGGGAACTCCCGCTGGTGCTGCGGCCCAGCCACGACGACGTCGACCTCGCCGCGTGGGCGGGCACCCACGGCGGCCGGGTCCGCTCCTGGCTGCACCGGTACGGGGCGCTGCTGTTCCGCGACTTCCACGTGGCGCAGGAGGACTTCGGCGAGGTGGTGCGCGCCCTCGCCGGGGAGCCGCTCGCGTACGTGGAGCGCTCCTCGCCCCGCACCGAGATCGGCGACCACATCTACACCGCCACCGACCACCCGGCCGACCAGCCCATCGCGCTGCACAACGAGAACTCCTACCAACGGGAGTTCCCGGCCACCCTGGCGTTCTGCTGCGCGGTCGCGGCCGAGAGCGGCGGGGCGACCCCGGTCGCGGACACCCGCCGGATCCTGGCCCGTCTCGATCCCGGGGTGGTGCGCGACTTCGCGCGCGTCGGCGTGCGGTACGTCCGCAACTACGGGGAGGGCGTCGGCCTGCCGTGGCCGGAGGTGTTCCAGACCGACAACCGGGACGAGGTGGCCGCGTACTGCCAGGAGCGGGGCATCGACCTGGAGTGGAAACCCGACGGCGGGCTGCGCACCAGCCATGTCCGGCCGGCGCTCGCCGAACACCCCGTGACCGGTGAGCGGGTCTGGTTCAATCACGCCATTTTCTTTCATGTCACGAGTTTGCTGCCCGAGGTGCGCGACGCTGTGCTCCGGCAGTTCGCGGAGGAGGACCTGCCGAGCAACACCTACTACGGCGACGGCCGGCCGATCGAACCGGATGTGCTCGACCACCTCCGGGACGCCTACCGGTCGGAGCTGGTCGCGCTGCCCTGGGAGCCCGGTGACGTGATGGTCGTGGACAACCTCCTCTCCGCCCACGGGCGGGAGCCGTTCACCGGGGCGCGTCGCGTCCTGGTGGGCATGGCGGGGACGGTGCGCTGGGACGACGTGCGGGTCACGGGGGAGACACCATGA	MSVHRGPVSGQRRAIALATTDWVRPGGTPPGRELPLVLRPSHDDVDLAAWAGTHGGRVRSWLHRYGALLFRDFHVAQEDFGEVVRALAGEPLAYVERSSPRTEIGDHIYTATDHPADQPIALHNENSYQREFPATLAFCCAVAAESGGATPVADTRRILARLDPGVVRDFARVGVRYVRNYGEGVGLPWPEVFQTDNRDEVAAYCQERGIDLEWKPDGGLRTSHVRPALAEHPVTGERVWFNHAIFFHVTSLLPEVRDAVLRQFAEEDLPSNTYYGDGRPIEPDVLDHLRDAYRSELVALPWEPGDVMVVDNLLSAHGREPFTGARRVLVGMAGTVRWDDVRVTGETP	MKKPELTATSVEKFLIEKFDSVSDLMQLSEGEESRAFSFDVGGRGYVLRVNSCADGFYKDRYVYRHFASAALPIPEVLDIGEFSESLTYCISRRAQGVTLQDLPETELPAVLQPVAEAMDAIAAADLSQTSGFGPFGPQGIGQYTTWRDFICAIADPHVYHWQTVMDDTVSASVAQALDELMLWAEDCPEVRHLVHADFGSNNVLTDNGRITAVIDWSEAMFGDSQYEVANIFFWRPWLACMEQQTRYFERRHPELAGSPRLRAYMLRIGLDQLYQSLVDGNFDDAAWAQGRCDAIVRSGAGTVGRTQIARRSAAVWTDGCVEVLADSGNRRPSTRPRAKE	102.05	gnl|BL_ORD_ID|187|hsp_num:0	205			180	324	hygromycin B
BGC0001048.1|Tallysomycin_26 # 60123 # 61595 # 1 # ID=1_26;partial=00;start_type=ATG;rbs_motif=GGGGGA;rbs_spacer=6bp;gc_cont=0.733	BGC0001048.1|Tallysomycin_26 	60123	61595	+	Loose	500	26.9498	OXA-549	28.57	3005773	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGACATCGCTCTCCTCGCGACCGGGACTGCGCCGAGCCTCGTTCCTCCAGCGAGGGGCGTGGCGGTGGCTGCGGGAGGCTCCGCCCGCGGCCGCCTTCGCCGCGCGCGGTCTGCTGGGCAGCGGGCGGATCGATGACGACCGGCTCGCGGCGGCGGCGGACGAGGTGCTGGACGCCTTTCCCCTGCTCCGCGTGAACTTCGTGGACGACGACGGCCTGTGGATGCGCACCAGGGAGAACGCCGACGCGCTGGTGCGGTCCGACCTGCGCGGCCACCCTGATCCGCAGGCGCGGTGCGTCGAGTTGTTGCGGGCGGACCGGGACCGGCCCACGGACCCGGAGCGCGATCCGCTGGTCCGCCTGCACCTGGTCCGCCTCTCCGAGACGGACGTGGTGCTCGGCGTCGTCGCCCACCAGATGCTCCTCGACGCCCGGTCCCGCTACATGGTGCTGGGCGCGGTGTGGCAGGCCTACTACGGCCGGTTCCGCCCCGCCCAGTACCGGGACTTCGCCGAGGTCGCGGACTTCCACCCGCTGGACAGGGAGACCGTGCGGGTGGCCCGGCACCGCTGGTGGTCCCGCCGGTTGCCGGCACTGCCGGTGCGGGGCGGGGACGGCGGTCCGGTCGGGCCACCGGAGACCTCGCGGTTGCGGGTGCCCGGGTCGCGCTGGCAGGCGCTGACCGAGCCGGGCGGACCGTTGGGCGGCAACGGATCGCTGGCCATGGCCGCGCTGACCGCGTGGTGGTTGTGGACACAGGGCGCCGGCACGGGAACGGATACCGGCGCTGGCACTGGCACTGGGAAGGACAGCCTTTACCTGAGCACGGAGGTCGACCTGCGGGACCACCTCCAGCTCGGCTCGGTGGTCGGCCCGCTGACCGACCGCGTCGTGTTCGGCGTCGACCTGACCGGCCTGCGCGAGCCGTCGTTCCGCGACCTGATGTCGCGGACCCAGGCGGGTTTCCTCGACGCGGTCGTGCACTACCTGCCCTACCACGACGTCGTCGACCTCGCGGTGGACCTGGGCGTGGTGACGCCGCCCCGGGTCGCCGCGCGGTGGGACGTGGCCGTGCACCTGTGCCGCAACGCGCCCAGCAGCTCGCTGACCCGGGGCGAGCGGACGCTGGCCGAGCTCGGGGTCTCCATCGAGCTGTTCCGGGAGGCGGACCTCATCGGCGGCGACACCAGGTCCGCCACCGACACCTGGGACGGCACCGACACCTGGGACGGCACCACGACGGACCTCAGCGTCGGCGAACTGGGCGAGGACATGGTGATCGTGCTCGACCAGCGCCGAACCCACCCGGCCGGCGGGGGCTCCGCCCTGCTCGACGGGCTCGACGCCGCCATGGCGCAGGCCGTCGCCGACCCGTCGGCCCCACTGCCGCACTCGACCGTCGACACCACCACACAGTCCACTGTGGACAAGGACACTGTGGACAGGAACACCGCGCACGAGAACGAGGAGTGA	MTSLSSRPGLRRASFLQRGAWRWLREAPPAAAFAARGLLGSGRIDDDRLAAAADEVLDAFPLLRVNFVDDDGLWMRTRENADALVRSDLRGHPDPQARCVELLRADRDRPTDPERDPLVRLHLVRLSETDVVLGVVAHQMLLDARSRYMVLGAVWQAYYGRFRPAQYRDFAEVADFHPLDRETVRVARHRWWSRRLPALPVRGGDGGPVGPPETSRLRVPGSRWQALTEPGGPLGGNGSLAMAALTAWWLWTQGAGTGTDTGAGTGTGKDSLYLSTEVDLRDHLQLGSVVGPLTDRVVFGVDLTGLREPSFRDLMSRTQAGFLDAVVHYLPYHDVVDLAVDLGVVTPPRVAARWDVAVHLCRNAPSSSLTRGERTLAELGVSIELFREADLIGGDTRSATDTWDGTDTWDGTTTDLSVGELGEDMVIVLDQRRTHPAGGGSALLDGLDAAMAQAVADPSAPLPHSTVDTTTQSTVDKDTVDRNTAHENEE	MRSFAISTVLGMSSLLASSIIAAPTFASTAVKKEWQETRSWDAIFTQHQVEPQQAKLQKTKLQQTSGVVALWNENKQQGYTNNLKRANQGFLPASTFKIPNSLIALDLGVVKDEHQVFKWDGKSRDIATWNRDHNLITGMKYSVVPVYQEFARQIGEARMSKMIASFDYGNETISGNLDSFWLDGGIRISATEQIDFLRRLYHNKVHASERSQRIVKQAMLTEANSDYIIRAKTGYAVRAEPSIGWWVGWVELDDNVWFFAMNMDIPDAAGLPLRQAITKEVLKLEHVIP	168.97	gnl|BL_ORD_ID|3808|hsp_num:0	4878			225	363	cloxacillin; oxacillin; cefalotin
BGC0001048.1|Tallysomycin_27 # 61599 # 62168 # 1 # ID=1_27;partial=00;start_type=GTG;rbs_motif=AGTGA;rbs_spacer=3bp;gc_cont=0.740	BGC0001048.1|Tallysomycin_27 	61599	62168	+	Loose	700	26.5646	ADC-127	23.38	3006302	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	ADC beta-lactamases pending classification for carbapenemase activity	GTGACCGAGACGACCCAGGCGACCGAGCCCACCTACCACGTGGTGGTCAACGACGAGGAGCAGTACTCGATCTGGCCCACCGAGCAGGACATCCCGCTCGGCTGGAAGGCCGTGGGCCGCACCGGCACCAAGGAGGAGTGCCTGGCCCACATCGAGGAGGTCTGGACGGACATGCGGCCGCGTAGCCTGCGCGAGCACATGGCCGCCACCGCCGACGCCGAGCCGGAGGAGGTGCCGGCCGACCCGACCCCGAGCCTGGTCGAGCGGCTCAGCGCCGCCGAGCAGCCGATCGAGGCCAGCCTGCGGCCCGAGCGCACCGCCTCGGCGCTGCGCGCGGCGATCGACGAGGGCTACGTGATCGTCCGCTTCACCGAGACCCGCGGCGGCACCGAGCTGGGCATCCAGCTCGACCAGGGCGCGACCGACCTCGCCGGCGCGGACTTCGCGGCCGGCAGCGGCGAGGTGACGCTCGTGGGCACCCTCACGCTCGACTTCGAGCCGGTGCGCTGCGTCGCCCGGATCGACCTGGCGACGCTGGCCGGCCAGGGCCGCCTGGAGCGGGTGGCCTGA	MTETTQATEPTYHVVVNDEEQYSIWPTEQDIPLGWKAVGRTGTKEECLAHIEEVWTDMRPRSLREHMAATADAEPEEVPADPTPSLVERLSAAEQPIEASLRPERTASALRAAIDEGYVIVRFTETRGGTELGIQLDQGATDLAGADFAAGSGEVTLVGTLTLDFEPVRCVARIDLATLAGQGRLERVA	MRFKKISYLILPSLFIFNTSIYAGNTSKEQDIKKVVDQNFKPLLEKYDVPGMAVGVIQNNKKYEMYYGLQSVQDKKSVNGNTIFELGSVSKLFTATAGGYAKTKGKISFNDTPGKYWKELKNTPIDRVNLLQLATYTSGNLGLQFPDEVQTDQQVLTFFKDWKPKNQIGEYRQYSNPSIGLFGKVVGLSMNQPFSQVLENTIFPSLHLKHSYVNVPKTQMQNYAFGYNQENQPIRVTPGPLDAPAYGVKSTLPDMLSFIDANLNPQKYPADIRRAIDETHKGFYQVGTMYQALGWEEFSYPAPLQTLLDSNSEQIVMKPNKVTAISKEPSIKMFHKTGSTNGFGTYVVFIPKENIGLVMLTNKRIPNEERIKAAYAVLNAIKK	49.35	gnl|BL_ORD_ID|3160|hsp_num:0	4198			618	834	
BGC0001048.1|Tallysomycin_28 # 62204 # 63352 # 1 # ID=1_28;partial=00;start_type=ATG;rbs_motif=AGGGGA;rbs_spacer=6bp;gc_cont=0.748	BGC0001048.1|Tallysomycin_28 	62204	63352	+	Loose	600	25.409	clbB	33.33	3002815	protein homolog model	n/a	n/a	lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; oxazolidinone antibiotic; phenicol antibiotic; pleuromutilin antibiotic	antibiotic target alteration	Cfr 23S ribosomal RNA methyltransferase	ATGACCGACAACCCGGCGATCCGGCGGATCGCGGTGTTCGCCCGGCTCCGGGGACCCGGCCTCGGTGACCTCGTCCAGCGGAACATCCTGCTGTCGTTGCTGCGCAGGGCCCACCCGCTGGCCGAGGTCAGCGTCGTGGCCGGGTCGGAGTTGGTCGACCGCTTCTCCGAACTGCTGACCGGCCACAGCTACGCCACGGACGTGCTGCGCTGCCCCGCCGTCGGGGACACCGATCCCGGGCGGTGGCGGGAGTTCCGGCGCGTTCTGGCCGAGCGGGGCTTCCAGATGTGCGTGGTGGACCCGGACAGCAGGGACCTCGACGCGCGGGAGGCGCGCGCCGCGGGGATCCCGGTCCGGGTCGCCCTGCCCACCGGAGGCCCGGGGGACACCGCGATCACGCACCCGATCCGGCTGCCACCCTCGTTGCGCGGACGGCCCGACCTGTACGACTACGCCCGCGGCGCCGCCGCCGCGCTCGGCCTGCCCGCGCCCCGCTCCGGCGAGGTCGTTCCGGTGCTGCCGAAACGTCCGGAGTGGACACCGGAGCTGGACGCCCCGGCGCCCAGGATCGCGGTGCACCCCGGCGGCGCGCGGCTCTGGAACCGCCGGTGGCCGTTGCGGCACTTCGCGCGGTTGTGCGTCCGGCTGGTCGACGAGCTCGACGCGAGCCTCTACCTGCTCGGGGCCGAGCAGGAACGGGCGGAACTGGCCGTGTTGAGCCGGGACGTGCTCGCCCAGCGGCCGGACGCGCGCGTCCACGTCGCGGTCGGCGAGTCCCTCAACCGGACGGCCAACCTCCTGGCGGGCGTGGAACTCCTGGTGGGCAACGACTCCGCGCCCGCCCACCTCGCCGCGGCGCTGCGCACGCCGACCGTGGTGCTGTACGGGCCGACGGGAACCGAGTTCCTGTGGGCCAGGGTCTACCCCCGGCACCGCGGGGTGTCCCTGCGGTACCCCTGCCAGGACATCCGGCACGCGGCCGAGGACGTCGCCACCCGGCGGTGCGAGCACGCCTGCCCGGTGGCCTACGAGTCGCCGGAGGGTCCGTACCCGAGATGCCTGACCGACCTTCCGGTGGACGAGGTGTGGCGAGCGGTGACCCGGCAGCTCCCCGCCACCTCCGCACGACCGAACGGGAGCCCGAGATGA	MTDNPAIRRIAVFARLRGPGLGDLVQRNILLSLLRRAHPLAEVSVVAGSELVDRFSELLTGHSYATDVLRCPAVGDTDPGRWREFRRVLAERGFQMCVVDPDSRDLDAREARAAGIPVRVALPTGGPGDTAITHPIRLPPSLRGRPDLYDYARGAAAALGLPAPRSGEVVPVLPKRPEWTPELDAPAPRIAVHPGGARLWNRRWPLRHFARLCVRLVDELDASLYLLGAEQERAELAVLSRDVLAQRPDARVHVAVGESLNRTANLLAGVELLVGNDSAPAHLAAALRTPTVVLYGPTGTEFLWARVYPRHRGVSLRYPCQDIRHAAEDVATRRCEHACPVAYESPEGPYPRCLTDLPVDEVWRAVTRQLPATSARPNGSPR	MKLTSKYETIRRILSECKQPEYRYAQIMDAIFKQNIGEYERMTILPKFLRDELNRILGPNVCSIAPVKELTSKQVSKVLFAIPGDEQVEAVRLTYERGWKSYCISTQCGCGFRCKFCATGTIGLKRNLTADEITDQLLYFRLNGHSLDSISFMGMGEALANPHIFEAMTILTDPYLFGLGHRRITISTIGLLPGIDKLTREFPQVNLTFSLHSPFDDQRSELMPINDRFPVRDVLIALDRHIRETGRKVYIAYILLRGVNDSTAHAEAVAELLRGRGAWEHLYHVNLIPFNSTEVTPDSYRQSDPSRIKAFVRILKSRGISVTVRTQFGSDINAACGQLYRSE	111.37	gnl|BL_ORD_ID|109|hsp_num:0	127			903	1002	lincomycin; clindamycin; azidamfenicol; chloramphenicol; thiamphenicol; virginiamycin M1; tiamulin; madumycin II; griseoviridin; dalfopristin
BGC0001048.1|Tallysomycin_30 # 64965 # 65234 # 1 # ID=1_30;partial=00;start_type=ATG;rbs_motif=GGGGGG;rbs_spacer=4bp;gc_cont=0.722	BGC0001048.1|Tallysomycin_30 	64965	65234	+	Loose	550	25.0238	R39	33.93	3003565	protein homolog model	n/a	n/a	penam	antibiotic inactivation	R39 beta-lactamase	ATGGTCAGGGGCTGGCTGCGCTCCCGGCGGCAGCGCCGGCTGCTGGACGAGGTCACCGCGATCTGGTGCGAGGTGCTGGGCCGCGAGCACGTGGGGCCGCACGAGGACTTCCTGGAGCTGGGCGGGGACTCGGTGGCCGCCATCCAGATCATCAGCAGGGCCGAGGAGCTGACCGGCGCCGAGCTGTCGATCCAGTTGCTGATGGAGAACCGCACGGTGGCCGCGATGGCCGGGGAGCTGGAGCGCGTGCTGGCGGGGGAGGCGACGTGA	MVRGWLRSRRQRRLLDEVTAIWCEVLGREHVGPHEDFLELGGDSVAAIQIISRAEELTGAELSIQLLMENRTVAAMAGELERVLAGEAT	MLFPTARRTGFAALAALALVPAAACSGSAAPAEAEPASAEVTAEDLSGEFERLESEFDARLGVYAVDTGTGEEVFHRADERFGYASTHKAFTAALVLGQNTPEELEEVVTYTEEDLVDYSPITEQHVDTGMTLLEVADAAVRHSDNTAANLLFEELGGPEGFEEDMRELGDDVISADRIETELNEVPPGETRDTSTPRAMAGSLEAFVLGDVLEEGPRDVLTEMLLNNTTGDELIRAGVPEDWRVGDKTGGGSHGSRNDIAVVWPPEDDPIVIAVMSTREQEDAEFDNALVSGATEVVVEALAP	29.28	gnl|BL_ORD_ID|4671|hsp_num:0	332			480	633	
BGC0001048.1|Tallysomycin_31 # 65231 # 66727 # 1 # ID=1_31;partial=00;start_type=GTG;rbs_motif=GGGAGG;rbs_spacer=4bp;gc_cont=0.757	BGC0001048.1|Tallysomycin_31 	65231	66727	+	Loose	800	28.1054	adeG	28.16	3000778	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGAACACCGACCTGGTCGGTCTGCTGGACGCGGTCGCCGGACTCCGGGTGCTCGTGGTCGGCGACGCCATCCTCGACCGGTACACCTACGGCCGGTCGGAGCGGATGTGCCGGGAGGCCCCGGTGCCGGCCATCGCGGTGGAGTCCGACGTGGACCAGGCGGGGGGCGCGGCGAACGCGGCGGTCAACGCCCGCGCCCTCGGCGCGCGGGCCACGCTGCTGTCGGTGCTGGGCCGGGACGTCGAGGCGGACCGGCTGTCGTCGGTGCTGACGGCCTCCGGGGTCGAGATCTCCGGCCTGTCGCGCGAGCGGGACCGGACGACGCCGGTGCGGCAGCGCGTGTTGGCCGACGGGCAGATGCTGCTGCGGGTCGACCGGGGCGAGGCCAGGCCGATCTCGGACGCCAGCGCGCGCGAGCTGGTCCGACGCCTCGACGAGAATCTGTCCACAGTGGACGTCCTGGTCGTCTCCGACAACGCGGCGGGGGTGGTGACCCCCGGCCTGATCGCCGAGCTGGCCGCCCGCCGGGGGCGGGGACCGTCCACAGTGGTGGTGGATGCCCGCGACCCGATGGCGTTCCGCGACCTGCGGGCGAGCGCGATCAAACCGAACTACGCCGAGGCGTTGCGGGTGGTCGGCGCTCCGGACCGGCCGGCGGGCGACCGCACCCGGCACTTCCACGACCTCGGCGACGAGCTGCTCGCCCGCACCGGGGCCGGCCTGGTCGCGTTGACCCTGGACGCCGAGGGCGCCCTGGTGTTCCAGCCCGGCCGGCCGCCCGTCCGCACCTACGCCAGGGGCGGCACGGCGACCTCGACGGTCGGGGCCGGCGACACGTTCGCCGTCGCGCTGGCGCTGGCGCTGGCCGCCGAGGCCGACGGCGGCGCGGCGGCGGAGTTCGCCTCGGCCGCGGCCGGAGCCGCCGTCGCCAGCACCGGAACGGCCGTCTGCGACGCCGACGAGCTCCGCCGCGGGCTCACCGGGACGATCAAGATCGGCAGCCGCGACGGGCTGGCCGACTGGCGCGCCGAGGCCACCCGCCGCCGACGGCGGGTGGTGTTCACCAACGGCTGCTTCGACATCCTGCACGGCGGCCACGTCTCGCTCCTCAGCCGCGCCAAGGAACTCGGCGACGTGCTGGTCGTGGGCGTCAACTCCGACGAGAGCGTGCGCCGCCTCAAGGGGCCCACCCGGCCGGTGAACGCCCTGGCCGACCGCCTGCGCGTGCTGGCCGCGCTGAGCTGCGTGGACCTCGTCGTCCCCTTCACCGGCGACAGCCCGACCGACCTGATGGAGCTCCTGCGACCGGACGTCTACGTCAAGGGCGCGGACTACACCCTCCAGACGTTGCCCGAGGCGCCGCTGGTGGAGCGGTGGGGCGGCGCGGTGCGCCTGCTCCCGCTCGTCGACGACGCGTCCACCACCCGCATCATCCGGCGCATCCACGACCTGGCCGCGGCCGGACCCGTCGAGCCGACACCGGGAGGCAGCCGGTGA	MNTDLVGLLDAVAGLRVLVVGDAILDRYTYGRSERMCREAPVPAIAVESDVDQAGGAANAAVNARALGARATLLSVLGRDVEADRLSSVLTASGVEISGLSRERDRTTPVRQRVLADGQMLLRVDRGEARPISDASARELVRRLDENLSTVDVLVVSDNAAGVVTPGLIAELAARRGRGPSTVVVDARDPMAFRDLRASAIKPNYAEALRVVGAPDRPAGDRTRHFHDLGDELLARTGAGLVALTLDAEGALVFQPGRPPVRTYARGGTATSTVGAGDTFAVALALALAAEADGGAAAEFASAAAGAAVASTGTAVCDADELRRGLTGTIKIGSRDGLADWRAEATRRRRRVVFTNGCFDILHGGHVSLLSRAKELGDVLVVGVNSDESVRRLKGPTRPVNALADRLRVLAALSCVDLVVPFTGDSPTDLMELLRPDVYVKGADYTLQTLPEAPLVERWGGAVRLLPLVDDASTTRIIRRIHDLAAAGPVEPTPGGSR	MSFSRKQFALSAIFVAILATGGSFMLLHENADAKAAPTAAQQAATVDVAPVVSKTITDWQEYSGRLEAIDQVDIRPQVSGKLIAVHFKDGSLVKKGDLLFTIDPRPFEAELNRAKAQLASAEAQVTYTASNLSRIQRLIQSNAVSRQELDLAENDARSANANLQAARAAVQSARLNLEYTRITAPVSGRISRAEVTVGNVVSAGNGAQVLTSLVSVSRLYASFDVDEQTYLKYISNQRNSAQVPVYMGLANETGFTREGTINSIDNNLNTTSGTIRVRATFDNPNGVLLPGLYARIRLGGGQPRPAILISPTAVGVDQDKRFVVVVDAKNQTAYREVKLGAQQDGLQIVNSGLQAGDRIVVNGLQRIRPGDPVTPHLVPMPNSQITASATPPQPQPTDKTSTPAKG	122.66	gnl|BL_ORD_ID|1125|hsp_num:0	1226			780	1074	tetracycline
BGC0001048.1|Tallysomycin_32 # 66724 # 67998 # 1 # ID=1_32;partial=00;start_type=GTG;rbs_motif=GGGAG;rbs_spacer=7bp;gc_cont=0.675	BGC0001048.1|Tallysomycin_32 	66724	67998	+	Loose	500	27.7202	bcr-1	34.88	3003801	protein homolog model	n/a	n/a	bicyclomycin-like antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGAACCACCCCATCAGTCCCCAACAACTGCTCACCGCGATCTCCGAGGTGGTCAGGAACCACCCGAACAAGAAGCTCGCGGTGTACGTGCACATCCCGTTCTGCTCGTCGAAGTGCCACTTCTGCGACTGGGTCACCGACATCCCGGTGCGGCGGCTGCGCAGCGGCCCCGAGGGCAGGGCGTCCTATGTGGACGCCCTGTGCGACCAGATCCGCTTCTACGGCCCGCAGTTGACCCGCTTCGGCTACCGGCCGAAGGTGATGTACTGGGGCGGCGGCACCCCGACCCGGTTGGCTCCGGAGGAGATGCGGGCCATCAGGGCCGCGCTGGACGACTCGTTCGACTTCTCCGACCTCGTCCAGTGGACGGTGGAGACCACGCCCAACGACCTCGACGCGGAGAAGCTCGCGGCGATGCGGGAGATCGGCGTCGACCGGGTCAGCGTGGGCGTGCAGTCGCTCAACCCCTACCAGCTCCGCAAGGCCGGTCGCGCGCACAGCAGGGAGCAGGCGCTGGCCGCCTTCCCCCTGTTGCGGCAGGCCGGGATCACCAACTTCAACGTGGACCTGATCTCCAGTTTCCCCGGCGAGGACCAGGAGTCCTTCCGCCGCACGGTGGAGGACATCCTCGCGCTGGACCCGCCGCACGTCTCCGTCTACCCCTACCGCGCCACGCCGAAGACGGTGATGGCCATGCAGCTCGACCGCGAGTTCCTCGAAGCCCACCAACAACACGACATGGTCGCCACCTACGAGATGGCGATGGAGATGTTGGGGCAGGCGGGGTACCACGAGTACTGCCACGGGTACTGGGTGCGCGACGCCGCCCACGAGGACCACGACGGCAACTTCAAGTACGACCTCGAAGGCGACAAGATCGGCTTCGGCAGCGGCGCCGAGTCCATCATCGGGCACCACCTGCTGTGGAGCGAGAACACCAAGTACGAGGAGTACCTCGACGACCCGCGCACCTTCTCCATGGCGCACCGGTTCACCCTCGACGACCCGGAACGGCTCACCGCTCCCGTGGGCGGCGCGCTGATGACCAGGGAGGGCGTGGACTTCGCCCGGTTCCACCGGCTGACCGGGGTGTCCTTCGCCGACCTGCGCGCCACGCCCTACTTCACCCGCTGGTTCCAGGTCCTGGAGGAGTGCGGCGCGCGGTTCCTGGAGAGCGACACCAACTTCCGCATGGACCCGACCGTGATCCACAAGGCCTACATCACCCATCTCGCCCACTCCACGGCCAACGGCCTGGCCCCGCAACGGGCGTGA	MNHPISPQQLLTAISEVVRNHPNKKLAVYVHIPFCSSKCHFCDWVTDIPVRRLRSGPEGRASYVDALCDQIRFYGPQLTRFGYRPKVMYWGGGTPTRLAPEEMRAIRAALDDSFDFSDLVQWTVETTPNDLDAEKLAAMREIGVDRVSVGVQSLNPYQLRKAGRAHSREQALAAFPLLRQAGITNFNVDLISSFPGEDQESFRRTVEDILALDPPHVSVYPYRATPKTVMAMQLDREFLEAHQQHDMVATYEMAMEMLGQAGYHEYCHGYWVRDAAHEDHDGNFKYDLEGDKIGFGSGAESIIGHHLLWSENTKYEEYLDDPRTFSMAHRFTLDDPERLTAPVGGALMTREGVDFARFHRLTGVSFADLRATPYFTRWFQVLEECGARFLESDTNFRMDPTVIHKAYITHLAHSTANGLAPQRA	MPASASRIQVGSGERRLLLLLSALVAFGPLSIDMYLPSLPAIAADLGASDAQVQRSISGFLVGFCVGMLFYGPLSDRFGRRPVLLAGIALYLFSSLACALADSAGQLVLLRVLQALGGGAASVLARAMVRDLYPLGEAARMLALMHMVTMLAPLAAPLLGGYLMLWAGWRALFVVLALFAGLCLLAVWRVAESHPPERRGGSLAQAFLAYGRLLGDRRALGYVLCMGLAFAGMFAYISAAPFVFIEHFGVRAERFGWFFGLNILGVMLATWCSARLVRRHGPRPLLRAGSLLACVSGLFLLGYAALGERGGLWALVPGLLCFVSVTGLLGANCIASLLALYPGQAGAASAVAVSGQFGLGCLASLAVGWLALPGVLPMALVMAVCGVGSLLALGLALHGGNR	105.47	gnl|BL_ORD_ID|2332|hsp_num:0	2303			144	255	bicyclomycin
BGC0001048.1|Tallysomycin_33 # 68022 # 68948 # 1 # ID=1_33;partial=00;start_type=ATG;rbs_motif=GGGAG;rbs_spacer=7bp;gc_cont=0.701	BGC0001048.1|Tallysomycin_33 	68022	68948	+	Loose	890	26.9498	cpxA	46.43	3000830	protein homolog model	n/a	n/a	aminoglycoside antibiotic; aminocoumarin antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGGAGCGGACCCGACACGGCGTCGATCCGACGACGTGCGTCGACACTATTCCGAGCTCGTCAACGCCCTGCGGGCGGACGGTGACGCGGAGGCCGCGCGCCAGGTCGCCGACCTGGCGGTGGACCACGGGGTGTGGCGACACCCGCTCCAGCGCCCCACGCACTACGTGCCCTCCTTCGACCCGGTGCCGGTGCACGACCCCGCGGACTTCTGGTTCACCAGCTACCTGGAGGAGAACTACGAGAAGATCCGCGCCGAGCTGGACGCGGTGACCCGGCCGACCGAGCAGGGTTTCCTGCCGGTGGAGGAGCCGCTGCTCGGCCGGGGTCGCTGGGAGCAGGTCACGTTCTACGAGACCGGCGTCCGGTTTGACGACGCCTGCGCCCGGTTCCCGGTCACCGCCAGCGTCATCGACGGCATTCCCGAGGCCGCCGCGGCCGGCCCGGGCGTGGTGACCCTGTCCTGGCTGTACCCGGGAACGCACATCGTCCCGCACTGCGGCGGGTCCAACGCGCGGCTGCGGGTCCACCTCGGCCTGCGGGTGCCCGACGGCCCCCGCATCCGCGTGGGGGACGAGGTGCTGACCTGGCGTGAGGGCGGCTGCATGGTGTTCGACGACTCGTTCGAGCACGAGGTGTGGCACGACGGCGACGAGCCGAGGATCATCCTCCTGCTGGACGTCTGCCACCCGGCGCTGGACGCGGGGACCCGCGAGTGGATGTTGTCCGGCCGCGCTTCCTTCGACGACCGGATGACCGCCTACATGCGGGATCGGGGTATCGAACGGGTGGAAATCCACGGGGACGAGGTCACTCTTTCGCCGAATACCGGCGCGGTGAGCCTGGTGCGTCGCCACCTTCGGGAAGTGGGCGCGACCGCGGTGGAACTCCGCGATGGTAGGTTGCGGTACGAGAAGATCAACTGA	MGADPTRRRSDDVRRHYSELVNALRADGDAEAARQVADLAVDHGVWRHPLQRPTHYVPSFDPVPVHDPADFWFTSYLEENYEKIRAELDAVTRPTEQGFLPVEEPLLGRGRWEQVTFYETGVRFDDACARFPVTASVIDGIPEAAAAGPGVVTLSWLYPGTHIVPHCGGSNARLRVHLGLRVPDGPRIRVGDEVLTWREGGCMVFDDSFEHEVWHDGDEPRIILLLDVCHPALDAGTREWMLSGRASFDDRMTAYMRDRGIERVEIHGDEVTLSPNTGAVSLVRRHLREVGATAVELRDGRLRYEKIN	MIGSLTARIFAIFWLTLALVLMLVLMLPKLDSRQMTELLDSEQRQGLMIEQHVEAELANDPPNDLMWWRRLFRAIDKWAPPGQRLLLVTTEGRVIGAERSEMQIIRNFIGQADNADHPQKKKYGRVELVGPFSVRDGEDNYQLYLIRPASSSQSDFINLLFDRPLLLLIVTMLVSTPLLLWLAWSLAKPARKLKNAADEVAQGNLRQHPELEAGPQEFLAAGASFNQMVTALERMMTSQQRLLSDISHELRTPLTRLQLGTALLRRRSGESKELERIETEAQRLDSMINDLLVMSRNQQKNALVSETIKANQLWSEVLDNAAFEAEQMGKSLTVNFPPGPWPLYGNPNALESALENIVRNALRYSHTKIEVGFAVDKDGITITVDDDGPGVSPEDREQIFRPFYRTDEARDRESGGTGLGLAIVETAIQQHRGWVKAEDSPLGGLRLVIWLPLYKRS	67.40	gnl|BL_ORD_ID|131|hsp_num:0	152			621	702	novobiocin
BGC0001048.1|Tallysomycin_34 # 69009 # 69383 # 1 # ID=1_34;partial=00;start_type=ATG;rbs_motif=GGAAG;rbs_spacer=5bp;gc_cont=0.699	BGC0001048.1|Tallysomycin_34 	69009	69383	+	Loose	350	25.7942	catB11	34.78	3004660	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic inactivation	chloramphenicol acetyltransferase (CAT)	ATGGCCAAGTTGACCAGTGCCGTTCCGGTGCTCACCGCGCGCGACGTCGCCGGAGCGGTCGAGTTCTGGACCGACCGGCTCGGGTTCTCCCGGGACTTCGTGGAGGACGACTTCGCCGGTGTGGTCCGGGACGACGTGACCCTGTTCATCAGCGCGGTCCAGGACCAGGTGGTGCCGGACAACACCCTGGCCTGGGTGTGGGTGCGCGGCCTGGACGAGCTGTACGCCGAGTGGTCGGAGGTCGTGTCCACGAACTTCCGGGACGCCTCCGGGCCGGCCATGACCGAGATCGGCGAGCAGCCGTGGGGGCGGGAGTTCGCCCTGCGCGACCCGGCCGGCAACTGCGTGCACTTCGTGGCCGAGGAGCAGGACTGA	MAKLTSAVPVLTARDVAGAVEFWTDRLGFSRDFVEDDFAGVVRDDVTLFISAVQDQVVPDNTLAWVWVRGLDELYAEWSEVVSTNFRDASGPAMTEIGEQPWGREFALRDPAGNCVHFVAEEQD	MKNYFESPFKGKPLVEQVKNPNIKVGRYSYYSGYYHGHSFDDCARYLLPDRDDVDKLIIGSFCSIGTGASFIMAGNQGHRYDWVTSFPFFYMNEEPAFSESVDAFQAAGNTVIGSDVWIGSEAMIMPGVKVGHGAVIGSRALVTKDIEPYTIVGGNPAKEIKKRFSEQEISMLLDMKWWDWPLEQIKEAMPLLCSSDIAGLYHFWQRSSA	59.05	gnl|BL_ORD_ID|2201|hsp_num:0	3360			546	615	chloramphenicol
BGC0001048.1|Tallysomycin_35 # 69485 # 70045 # 1 # ID=1_35;partial=00;start_type=ATG;rbs_motif=AGGAGG;rbs_spacer=5bp;gc_cont=0.750	BGC0001048.1|Tallysomycin_35 	69485	70045	+	Loose	500	24.2534	OXA-669	42.31	3005880	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGACGAGGACACCGAGTCTCGTCGCCGCCGTGCGCGACGGCGACGCGGAAGCCCTCCGCGCCGCCCTGGGCCGGGGCGAGGACCCGGCCGAGCGCGACGAGCGGGGCTGGGCCGCGTTGGACTGGGCGGCCGGGCGCGGTGACGTCCCGGCGGTGCGGGCGCTGCTGGACGCCGGGGCCGACCCGCGGGCGCGCGGTCCCGAGGGCCGCTCGCCCTACGAGATCGCCGTGGCAGCCGGGAAGGTCGACGCCGCCAGGGTGTTGCGGGAGGTCACCGGGGAGGGCGCGGACGGCTGGCGCCCGTACTGCAAGGCCTATCTCGTGGCCGCCCTCAGGGCGTTCCCCGACTGGTCTACTGTGGACGGTGAGGGTCTGACCGCCGAGACCGTGGTCTACCTCCACCACGACCTCACGGTGACGCGCTCCATCTGGCACGGCGAGGACGTGCTGTGGTCCCACTCCTCGCCGGAGTGGGCGGAGTTCTGCCGGGAGGACCTGGGATTCAGGGTGCCGGACGACCTGGAGCTGGTCCCCGGCGGGAGCGGAACGGGGCGGCGATGA	MTRTPSLVAAVRDGDAEALRAALGRGEDPAERDERGWAALDWAAGRGDVPAVRALLDAGADPRARGPEGRSPYEIAVAAGKVDAARVLREVTGEGADGWRPYCKAYLVAALRAFPDWSTVDGEGLTAETVVYLHHDLTVTRSIWHGEDVLWSHSSPEWAEFCREDLGFRVPDDLELVPGGSGTGRR	MSNNIFKIKSSVLIILSSLAFSGCVSKLNLYDPASSQRTSEIPLLFNYAQTQAVFVTYDGTQFKRYGNDLNRAKTAYIPASTFKMLNALIGLQHAKTTNTEVFKWNGEKRSFPAWEKDMTLAGAMQASAVPVYQELARRIGLDLMSQEVKRVGFGNTQIGQQVDNFWLVGPLKITPEQEAKFAYQLAKKTLPFDDAVQQQVKDMLYVERRGDSKLYAKSGWGMDVEPQVGWYTGWIEQPNGQITAFALNMHMQTGDDPAERKQLTLSILDKLGLFFYLR	66.67	gnl|BL_ORD_ID|3915|hsp_num:0	4985			732	810	cloxacillin; oxacillin; cefalotin
BGC0001048.1|Tallysomycin_36 # 70042 # 70431 # 1 # ID=1_36;partial=00;start_type=ATG;rbs_motif=GGGG;rbs_spacer=5bp;gc_cont=0.764	BGC0001048.1|Tallysomycin_36 	70042	70431	+	Loose	500	23.483	APH(3'')-Ib	39.53	3002639	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(3'')	ATGACGACGGACGAGCGGACCGTGCGGGTCGAGGTGGTCTGGCGCGAGCCGGTGGACGAGGGGGAGGTCGGCCTCCAGGACAAGTCGGGCGAGCTCGTCGCGGGCACGCCCCAGTCGGACGGGTCGGTGCGGTACGAGGTCGACGTCCCGGTGCGCCCGCGCCGGGGTGGCGGCGGGCTCGACTTCGCCGGCCCCCACGTGCACGGCTCGGCCGGCGAGCGGTTCCTGTACCTGAGCTTCCGGCGGCCGGGCGAGGCCGCCTGGTTCCGCCGCAGCAAGATCCTGCTCCCGGAGTCCGCGCCGGAGTCGGCCGCCACGCTGCGGGCCACCGTGGTGGACGTCTCCGGCAGCCGGGCCGGTCTGGACCCGGCCGGCTGGGTCGAGGCGTAG	MTTDERTVRVEVVWREPVDEGEVGLQDKSGELVAGTPQSDGSVRYEVDVPVRPRRGGGGLDFAGPHVHGSAGERFLYLSFRRPGEAAWFRRSKILLPESAPESAATLRATVVDVSGSRAGLDPAGWVEA	MNRTNIFFGESHSDWLPVRGGESGDFVFRRGDGHAFAKIAPASRRGELAGERDRLIWLKGRGVACPEVINWQEEQEGACLVITAIPGVPAADLSGADLLKAWPSMGQQLGAVHSLLVDQCPFERRLSRMFGRAVDVVSRNAVNPDFLPDEDKSTPQLDLLARVERELPVRLDQERTDMVVCHGDPCMPNFMVDPKTLQCTGLIDLGRLGTADRYADLALMIANAEENWAAPDEAERAFAVLFNVLGIEAPDRERLAFYLRLDPLTWG	48.31	gnl|BL_ORD_ID|1690|hsp_num:0	1830			399	510	streptomycin
BGC0001048.1|Tallysomycin_37 # 70887 # 71861 # 1 # ID=1_37;partial=00;start_type=ATG;rbs_motif=GGAAGG;rbs_spacer=6bp;gc_cont=0.706	BGC0001048.1|Tallysomycin_37 	70887	71861	+	Loose	2110	26.1794	MexF	30.91	3000804	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGCCGGGGAGCAGGGGAACGGTGCGAGCGAGGGCGTCGGAACGCGCGCGTACCTCATGCAGATGGTGCGCCGGTACTACGGCAACCTGATCGACGCCTGGCACTACTCCGGGCAGCCGGAGCGGGCGTGGGAATGCGCCGAGCAGGCCGTGCGGCAGGGCGTGTGGGAGCAGCCGATGCAGCGGGCGCGGGAGCACATTCCCGGCCTCGCCGCGCAGCCGGTGCACGACCCGTCCCAGTTCTGGTTCATCTCCTACCTGGAGGAGAACTACGCCCGCATCCGGGCCGAGGTCGAGCAGGTGCTCGACCAGCCGCTGGACCCCGTGCGCCCGACGGTCGAGGACCGCGCGCTCATCCGCAAAGGCTCCTGGAAGCAGGCCCACCTCTTCCGCGACGGGCGGTGGCGTGACGAGGTGTGCGCCCGGTTCCCCGTGACCGCCAGCATCCTGGAGCAGGTGCCCGAGGTGACCACGCTCAGCCCGGGCGTGATCACCATGTCCCGGGTGTCGCCGGGGACGCACATCATGCCGCACTGCGGACCGACGAACGCCGTGCTGCGCATCCACCTCCCGCTGATCATCCCGGCCGGGCTGACGCTGCGGGTCGCCGGTCAGGACCTGCGGTGGGTGGAGGGGAAGTGCCTGATCTTCGACGACTCGTTCGAGCACGAGGTCCGGCACGACGGGACCGAGGACCGCGTCGTGCTGATCCTCGACATGCTGCACCCCGACCTCGGCGGTGACCAGCGGGAGCGGTTGTTGCAGCGGCGGCTGACCTTCGAGGAGCAGATGGTCGACTTCCTCAAGGAGCACGGCATGGACCGGATGGAGACCCGGGACGACGGGGTCGTCTTCCGGCCGAACCCGACCGTGCGGGACGAGCTGGCCTACTACATGGCCGTCACCGGGGTCACCGGCGCCGAGCTGCGGGGCAACGAGGTGGTCTGGCACCGGTCGGAGGAGCGGCCCGCCTGA	MAGEQGNGASEGVGTRAYLMQMVRRYYGNLIDAWHYSGQPERAWECAEQAVRQGVWEQPMQRAREHIPGLAAQPVHDPSQFWFISYLEENYARIRAEVEQVLDQPLDPVRPTVEDRALIRKGSWKQAHLFRDGRWRDEVCARFPVTASILEQVPEVTTLSPGVITMSRVSPGTHIMPHCGPTNAVLRIHLPLIIPAGLTLRVAGQDLRWVEGKCLIFDDSFEHEVRHDGTEDRVVLILDMLHPDLGGDQRERLLQRRLTFEEQMVDFLKEHGMDRMETRDDGVVFRPNPTVRDELAYYMAVTGVTGAELRGNEVVWHRSEERPA	MNFSQFFIQRPIFAAVLSLLILIGGAISLFQLPISEYPEVVPPTVVVRANFPGANPKVIGETVASPLEQAITGVENMLYMSSQSTSDGKLTLTITFALGTDLDNAQVQVQNRVTRTEPKLPEEVTRLGITVDKASPDLTMVVHLTSPDNRYDMLYLSNYAVLNVKDELARLDGVGDVQLFGLGDYSLRVWLDPNKVASRNLTATDVVNAIREQNRQVAAGTLGAPPAPSDTSFQLSINTQGRLVTEEEFENIIIRAGANGEITRLRDIARVELGSNQYALRSLLNNKPAVAIPIFQRPGSNAIEISNLVREKMAELKHSFPQGMDYSIVYDPTIFVRGSIEAVVHTLFEALVLVVLVVILFLQTWRASIIPLAAVPVSLIGTFAVMHMLGFSLNALSLFGLVLAIGIVVDDAIVVVENVERNIGLGLKPVEATKRAMREVTGPIIATALVLCAVFIPTAFISGLTGQFYRQFALTIAISTVISAFNSLTLSPALAAVLLKGHHEPKDRFSVFLDKLLGSWLFRPFNRFFDRASHGYVGTVNRVLRGSSIALLVYGGLMVLTYFGFSSTPTGFVPQQDKQYLVAFAQLPDAASLDRTEAVIKQMSEIALAQPGVADSVAFPGLSINGFTNSPNSGIVFTPLKPFDERKDPSQSAGAIAAALNAKYADIQDAYIAIFPPPPVQGLGTIGGFRLQIEDRGNQGYEELFKQTQNIITKARALPELEPSSVFSSYQVNVPQIDADIDREKAKTHGVAISDIFDTLQVYLGSLYANDFNRFGRTYQVNVQAEQQFRLEPEQIGQLKVRNNLGEMVPLASFIKVSDTSGPDRVMHYNGFITAELNGAPAAGYSSGQAQAAIEKLLKEELPNGMTYEWTELTYQQILAGNTALFVFPLCVLLAFLVLAAQYESWSLPLAVILIVPMTLLSAITGVILAGSDNNIFTQIGLIVLVGLACKNAILIVEFAKDKQEEGMDRVAAVLEACRLRLRPILMTSIAFIMGVVPLVISTGAGAEMRHAMGVAVFSGMIGVTFFGLLLTPVFYVLIRRFVENREARRAANDKGLPEVHA	30.51	gnl|BL_ORD_ID|2353|hsp_num:0	1300			2865	3030	ciprofloxacin; trimethoprim; chloramphenicol; norfloxacin
BGC0001048.1|Tallysomycin_38 # 71889 # 73088 # 1 # ID=1_38;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=7bp;gc_cont=0.713	BGC0001048.1|Tallysomycin_38 	71889	73088	+	Loose	750	25.7942	pmrA	41.18	3000822	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGGGCATGATCAACGTCTTCCAACCCACGCTCGGCGAGGCGGAACTGGCCGCCGTTCGCGAGGTGTTCGCGAGCGGCTGGCTCGGTCGCGGCCCGCGGACGAAGGTGTTCGAGGCGGACTTCGCCGAGCACCTGGGCGTCGGCGCGGAGCAGGTCGTCTCGGTGAGCTGCTGCACCGAGGGGCTCTTCCTGTCCATGGAGCTGCTGGGAGTCGGCCCCGGCGACGAGGTCGTGCTCCCCTCGATCTCCTTCGTCGGCGCGGCGAACGCGATCGCCGCGCGCGGCGCCCGACCCGTGTTCTGCGACGTGGACCCGGCGACCCTGAACCCCACCGCCGACCACGTCGCGGAGAAGCTTGGCCCGCGCACGAAAGCCGTGGTGGTGCTGCACTACGGCGGCTACCCCGGCGACCTGGTGGCCATCGCGGAACTGTGCCGGGAGCGCGGTGTGCCGCTGGTGGAGGACAGCGCGTGCGCTGTCGCGTCCCAAGTGGACGGTCGGGCCTGCGGAACCCTCGGCGACGTCGGGGTGTGGAGCTTCGACGCGATGAAGATCCTGGTCACCGGGGACGGCGGGATGCTGTGCTTCCGGGACCCGGAGCTCGCGGAGCGGGCGCGGAAGCTCGCGTCCCTGGGAATGGCGCAGAGCAGCGGGTTCGCCAACGCCACCGCCGACGCGGAGGCGCGCTGGTGGGAGTTCGAGGTCACCGCGTTCGGCCGTCGCTCCATCAGCAACGACGTCGCGGCCAGCATCGGCAGCGTGCAGCTCCGCCGACTCCCGGAGTTCGTGCGACGCCGCCGCGAGATCGCCGAGCGCTACGACCAAGGTCTGTCCACTGTGGATGGTCTTCGGTGCCCGCCCCCGCTGCCCGCCGGGCACACGTCCTCCTACTACTTCTACTGGGTGCGGATGGACGCGTCGGTGCGGGACGCGATGGCTCGGCGGCTGTACGACCGCGGTGTCTACACGACGTTCCGGTACGCGCCACTGCACCTCGTGTCGGCCTACGGGCACGAAGGATCTCTGCCCGGCGCGGAACGCGCCGCGGAGGAGACGCTGTGCCTGCCGCTGCACCAGGCGTTGAGCGACAGCGACGTCGAGACCGTCATCGGCGAGGTGCGCGCCGGGCTCGCCGCGCTGACAGCGCCGTCTGGGTCGTCGGTGCCGACTGTTTCGTCCTTTCCGGCCTCGCGGCCCTGA	MGMINVFQPTLGEAELAAVREVFASGWLGRGPRTKVFEADFAEHLGVGAEQVVSVSCCTEGLFLSMELLGVGPGDEVVLPSISFVGAANAIAARGARPVFCDVDPATLNPTADHVAEKLGPRTKAVVVLHYGGYPGDLVAIAELCRERGVPLVEDSACAVASQVDGRACGTLGDVGVWSFDAMKILVTGDGGMLCFRDPELAERARKLASLGMAQSSGFANATADAEARWWEFEVTAFGRRSISNDVAASIGSVQLRRLPEFVRRRREIAERYDQGLSTVDGLRCPPPLPAGHTSSYYFYWVRMDASVRDAMARRLYDRGVYTTFRYAPLHLVSAYGHEGSLPGAERAAEETLCLPLHQALSDSDVETVIGEVRAGLAALTAPSGSSVPTVSSFPASRP	MTEINWKDNLRIAWFGNFLTGASISLVVPFMPIFVENLGVGSQQVAFYAGLAISVSAISAALFSPIWGILADKYGRKPMMIRAGLAMTITMGGLAFVPNIYWLIFLRLLNGVFAGFVPNATALIASQVPKEKSGSALGTLSTGVVAGTLTGPFIGGFIAELFGIRTVFLLVGSFLFLAAILTICFIKEDFQPVAKEKAIPTKELFTSVKYPYLLLNLFLTSFVIQFSAQSIGPILALYVRDLGQTENLLFVSGLIVSSMGFSSMMSAGVMGKLGDKVGNHRLLVVAQFYSVIIYLLCANASSPLQLGLYRFLFGLGTGALIPGVNALLSKMTPKAGISRVFAFNQVFFYLGGVVGPMAGSAVAGQFGYHAVFYATSLCVAFSCLFNLIQFRTLLKVKEI	100.00	gnl|BL_ORD_ID|1925|hsp_num:0	2003			87	189	ciprofloxacin; norfloxacin
BGC0001048.1|Tallysomycin_39 # 73120 # 74682 # 1 # ID=1_39;partial=00;start_type=ATG;rbs_motif=GGAAGG;rbs_spacer=9bp;gc_cont=0.711	BGC0001048.1|Tallysomycin_39 	73120	74682	+	Loose	500	32.7278	fexA	31.88	3002704	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGGGCCAGTCCTGGTGGTCGTTGAGCGGGGCCATGGGCGTGCCCTGCCTCCTCGTGGGCGACCTGCGCCGCGCCGCCGAGTACTACCGGGAGGTCCTCGGCTTCGACGTCGTCGAGCCGCTGGGCGACCCGACCACCGCGGTCCTCGCCCGCCGGGCGGAGGGGGCCGTGCTGCTCCAGCTCGCGCCGGACGACGAGGAGGGCTTCTCCCACCGGGAGTTCGCCGACCGGGCATGGGACGCGTTGTTCCTGGTCGACGACATCGGCCGCGTCGCGTCGCAGTTGCGCTCCCGCCGGGCCAACATCGAGTTCGGCATCGGGATCACCGAGGTCTCCGACCGGACGTTGGAGGTGCGGGACGAGTGGGGCAACATCCTCGCCTTCGCCGCCACGTATGACGGTCTGCGTCCGGCGGTGCGCCAGCTCGTGGAGCGAACCGTGCCGGGCAGCGTGCGCACCGCGTGGCGCAACCACCGCTTCGCCCGCGAGGAGCGACCGGAACTCGCCGCGTTCCAACGCTTCTACCAGCGGTTGGAGAGCAAGCGCGCCCCCGTGTACATGTACTTCACCACCGGCCTGCTGCACTGGGTGATCGCCGCGGAGCGGCACGTTCCCGCCGACGTCAACCTGGTGCTGATCGGCTCCGGCCTGTCCGCGGTGGAGCAGCGGTGGATCAGGGAGAACCTGGCCCGTCCGTTCCACAACATCGCGCTGGAGGTCGACGACAACACGGTGTGGGAGTTCCTCTTCGCCACCAACCAGTTCGACTTCGCCTACATGGACATCGACTGCTTCGTGCTGGAACCCGCCGTGTTCGCCGACATGATGCGGTTCCCGCGCGACGCCGCGGTGAACGCGATCTGGACCTACGAGGCCGCGCCGGGAACTCCCATCGGCTGCACGCACTTCGTGGCCATCAACGTCGAGGCCGCGCGCGATCTGCGCCGCCGCGGCCGCTACATGAGCCCCACCAACTACGACTGGGACGGCTCGATGGTGCACACCCTGCACCACCGGACCTACTGCCGGGTCCCGACGCCCCGGCAGACCCGGCTGCTGCTCCAGGTGCTGCCCGCCGACGAGCGGGGGCGGCCGCTGCCGCCCGGCGACTCGCCGTTCTTCGACACCCTCGTCGCCTACCAGATCGCGGCGGCGACCGCCGGCTACCGGACGAACCCGGTCCGCCCGATGGCCCACCGGACCCAGGCCACGTTCGCGGAGCAGAACGCGTCCGACGAGCGGGTGTGGCAGCAGGACATGACCGACGAGCTGTTGCACGTGGGCGGCATCTCCTACTACGGCCGCGTGTTCCACGCCTCCGACCTGCGCCGGCTCTACCTGTCCGCCGAGCACACCCTGCTGAGCGGCTCGGTGGATCGGCTGCCCACGCCCTACGCCGACCGGCTCCGGACGATCTCGCGCCGGCTGGAGCACCTGGGGGTGGACCCCGGGGACGCGGCCAAGCTGATCTTCCACCACCTCGTGTCGGACCGCGGGCTGGCCGTGCGGACCGCCGAACGGGTGCTCGCCCAGCCCGCACCCGATCTCCCCGCCGGGGCCTGA	MGQSWWSLSGAMGVPCLLVGDLRRAAEYYREVLGFDVVEPLGDPTTAVLARRAEGAVLLQLAPDDEEGFSHREFADRAWDALFLVDDIGRVASQLRSRRANIEFGIGITEVSDRTLEVRDEWGNILAFAATYDGLRPAVRQLVERTVPGSVRTAWRNHRFAREERPELAAFQRFYQRLESKRAPVYMYFTTGLLHWVIAAERHVPADVNLVLIGSGLSAVEQRWIRENLARPFHNIALEVDDNTVWEFLFATNQFDFAYMDIDCFVLEPAVFADMMRFPRDAAVNAIWTYEAAPGTPIGCTHFVAINVEAARDLRRRGRYMSPTNYDWDGSMVHTLHHRTYCRVPTPRQTRLLLQVLPADERGRPLPPGDSPFFDTLVAYQIAAATAGYRTNPVRPMAHRTQATFAEQNASDERVWQQDMTDELLHVGGISYYGRVFHASDLRRLYLSAEHTLLSGSVDRLPTPYADRLRTISRRLEHLGVDPGDAAKLIFHHLVSDRGLAVRTAERVLAQPAPDLPAGA	MKKDSKSKEMIQSEKRGSTRLLMMVLSLSVLVGAITADLVNPVLPLISKDLEASKSQVSWIVSGIALVLAIGVPIYGRISDFFELRKLYIFAIMILASGSLLCAIAPNLPLLVLGRMVQGAGMSAIPVLSIIAISKVFPQGKRGGALGIIAGSIGVGTAAGPIFGGVVGQYLGWNALFWFTFLLAIMIVIGAYYALPTIKPAESVGSNKNFDFIGGLFLGLTVGLLLFGITQGETSGFSSFSSLTSLIGSVVALVGFIWRIVTAENPFVPPVLFNNKDYVNTVIIAFFSMFAYFAVLVFVPLLVVEVNGLSSGQAGMILLPGGVAVAILSPFVGRLSDRFGDKRLIITGMTLMGLSTLFLSTYASGASPLLVSVGVLGVGIAFAFTNSPANNAAVSALDADKVGVGMGIFQGALYLGAGTGAGMIGALLSARRDATEPINPLYILDAMSYSDAFLAATGAILIALIAGLGLKKRG	109.47	gnl|BL_ORD_ID|835|hsp_num:0	907			117	303	chloramphenicol; florfenicol
BGC0001048.1|Tallysomycin_40 # 74732 # 75610 # 1 # ID=1_40;partial=00;start_type=GTG;rbs_motif=AGGGGA;rbs_spacer=6bp;gc_cont=0.751	BGC0001048.1|Tallysomycin_40 	74732	75610	+	Loose	125	32.7278	vanXY gene in vanC cluster	29.23	3002966	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanXY	GTGGAACTGAGGACGCCCAGGCTGCGCCTGATCCCGTTGGACCCGGACCGCGACGCGTCCGGCCTGCACGCCGCGTTCGGCGATCCCGAGGTCATGCGCTGGTGGAACCACGTGGTGTGCGCCGACGTGGCGGAGACCCGCGAACGCCTGCGGGAGAGCGTCGACCGCGACGGCGCCCACCTCTGGGTGATCCGCCGGGGCGAGGCGTGCGAGCCGGCGGGGATGGTCGGGTTGCTGGGCGAGGTCGACGTCCCCGGCCTGACCTGGTTGCTGTGCAAGGACGCCTGGGGGAGGGGCCTGGCGACCGAGGCGGCCGGAGCGGTGGTGGAGCACGCGCTCGGCCCGTTGGACCTGCCCCGCGTGGAGGCGTGGGTGGAGGCCACCAACGAGCGCTCCCTGGCGGTGGCCCGCCGCGTCGGCCTCACCGAACGCGGCCGCCTGGCGCAGCGGTACCCGCACCGCGAGCGCCCCCACGAGATGGTCGTGCTCGGCAGGGCGCGGGACCACGAGCCCACCCCGATGCTCAACGCCGAGGTCGCCCTGCCCGTGCGCGACGTCGCGGCCACCCTCACCCTCCTCAGGGAGGCCCTGGGCGGCCGGACGCTGTTCAGCGTCGGCGACCCGCCCGAGGTGGCGGGCGTGAGCTTCGGGCCGTGGAGCGTCGGACCCCGGCTCCAGCTCGTCTCGACGCGCCGCTGGCGCATCGCCCGGGTCACCCTCTACCTCGACGTCGGCGTCGAGCTGGAGGCGCTGCACGACCGCGCGGTCGACGCGGGCGCGGACGTCGTCCAACGGCCGACCGAACAACCCTGGGGCATGCGCGAGTGCGTCGTGCAACTCCCCGAAGGCCACCACATCGTGCTGACCGCCCCCGCCTGA	MELRTPRLRLIPLDPDRDASGLHAAFGDPEVMRWWNHVVCADVAETRERLRESVDRDGAHLWVIRRGEACEPAGMVGLLGEVDVPGLTWLLCKDAWGRGLATEAAGAVVEHALGPLDLPRVEAWVEATNERSLAVARRVGLTERGRLAQRYPHRERPHEMVVLGRARDHEPTPMLNAEVALPVRDVAATLTLLREALGGRTLFSVGDPPEVAGVSFGPWSVGPRLQLVSTRRWRIARVTLYLDVGVELEALHDRAVDAGADVVQRPTEQPWGMRECVVQLPEGHHIVLTAPA	MNTLQLINKNHPLKKNQEPPHLVLAPFSDHDVYLQPEVAKQWERLVRATGLEKDIRLVDGYRTEKEQRRLWEYSLKENGLAYTKQFVALPGCSEHQIGLAIDVGLKKQEDDDLICPHFRDSAAADLFMQQMMNYGFILRYPEDKQEITGISYEPWHFRYVGLPHSQVITAQKWTLEEYHDYLAQTVRQFA	153.68	gnl|BL_ORD_ID|4668|hsp_num:0	97			351	546	vancomycin
BGC0001048.1|Tallysomycin_41 # 75700 # 76899 # -1 # ID=1_41;partial=00;start_type=ATG;rbs_motif=GAGGAG;rbs_spacer=6bp;gc_cont=0.736	BGC0001048.1|Tallysomycin_41 	75700	76899	-	Loose	960	25.7942	cmeC	38.89	3000785	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; cephalosporin; fusidane antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCCGCTGGACGACGACACGCACATCGGCCGCACCATCGCCAGGTTCCGCAAGGCGGCCGGCCTCAACCAACACCAACTCGCCGCTCGCGCCAACATCTCCCTGAGCCTGCTCCAGAAGGTCGAGATCGGCGACCGGGCCGCCAACCACTCCACCATCGCCGGCGTCGCCCGCGCCCTGCACCTCCCGCCCGAGAAGCTGACCGGCCAGCCCTACGTCGACCACCACGGCGACGAGGCCAGCCGCCGCCACGTCGACGCCATCCGCGCGGTCCTGCGCCGCTACGACCTTCCCTCCGACTCCCCCGTCCGCCCCGTGACCGACCTGGCCGCCGACGTCGCCGAGATCTCCCGGCTGCGCCGCGACGCCGACTACAACCGCCTCGTGGTGCGCCTGCCCGCCCTGCTGGACGAGCTCACCACCGCCGCCCACCACCAACCCGACGCCTCCGAGCCGTGGCGGCTGTTGTGCCAGGGCTACTTCGTCGCCCACAACCTGCTGCACCGCCTCGGTCACGGCGACCTGGCCGAGGTCAGCCAGGACCGGCTCGACTGGGCCGCCCAGCGGGCCAGCGACCCGCTCGCCCGCGCGGTGACGGCCTGGGCGCGCTGCACCGCCTTCCAGGCCGCCGGCGACTACACCCACGGGCTGCGACTGATGGACACCGCCCGCACCGAGTTGGATGACGAACTCCGCGGCCAGCCGTCCCCGGAGGTGTTGACCGTCTACGGCAGCCTGCACCTGCGGGCGGTCACCCTCGCCTCCCGCGCCGGGGACGCCGACACCACCCGCGCCCACCTGCGGGCAGCCCGGGATCTCGCCACCCAACTCGGCAACGGCGACCAGGTGCACTACGGACTCACCTTCGGCCCTGCCAACACCCTGACCCACGAAGTCGCCGCGCACGTCGAACTCGGCGACGCCCCCGCCGCGCTGGAGGCCGCCCGGTCCTGGACCCCACCACAGGGCATGCCGCGCACCCGTCGGGGACACCACCACATCGACCTCGCCCGCGCCCACCTCGCCGTCGGTGACCGCGCCGGCACACTGTCGGCTCTGCGGGAGGCCAAGAGGATCGCCCCGCAGCAGACCCGCCTCCACCCGATGGTCCGGGAGACCACCGCGGTCCTGGTCAGCCTGCACCGGCGCGCGGTTCCCGAGCTGAGCCGCTACGCCACCTGGCTCGGGCTCACGAGCTGA	MPLDDDTHIGRTIARFRKAAGLNQHQLAARANISLSLLQKVEIGDRAANHSTIAGVARALHLPPEKLTGQPYVDHHGDEASRRHVDAIRAVLRRYDLPSDSPVRPVTDLAADVAEISRLRRDADYNRLVVRLPALLDELTTAAHHQPDASEPWRLLCQGYFVAHNLLHRLGHGDLAEVSQDRLDWAAQRASDPLARAVTAWARCTAFQAAGDYTHGLRLMDTARTELDDELRGQPSPEVLTVYGSLHLRAVTLASRAGDADTTRAHLRAARDLATQLGNGDQVHYGLTFGPANTLTHEVAAHVELGDAPAALEAARSWTPPQGMPRTRRGHHHIDLARAHLAVGDRAGTLSALREAKRIAPQQTRLHPMVRETTAVLVSLHRRAVPELSRYATWLGLTS	MNKIISISAIASFTLLISACSLSPNLNIPEANYSIDNKLGALSWEKENNSSITKNWWKDFDDENLNKVVDLALKNNNDLKLAFIHMEQAAAQLGIDFSSLLPKFDGSASGSRAKTAINAPSNRTGEVSYGNDFKMGLNLSYEIDLWGKYRDTYRASKSSFKASEYDYEAARLSVISNTVQTYFNLVNAYENENALKEAYESAKEIYRINDEKFQVGAVGEYELAQARANLESMALQYNEAKLNKENYLKALKILTSNDLNDILYKNQSYQVFNLKEFDIPTGISSTILLQRPDIGSSLEKLTQQNYLVGVARTAFLPSLSLTGLLGFESGDLDTLVKGGSKTWNIGGNFTLPIFHWGEIYQNVNLAKLNKDEAFVNYQNTLITAFGEIRYALVARKTIRLQYDNAQASEQSYKRIYEIAKERYDIGEMSLQDYLEARQNWLNAAVAFNNTKYSYANSIIDVIKAFGGGFEQSEDTSKNIKEESKNLDMSFRE	81.10	gnl|BL_ORD_ID|731|hsp_num:0	798			861	969	erythromycin; cefotaxime; fusidic acid
BGC0001048.1|Tallysomycin_42 # 77145 # 77513 # -1 # ID=1_42;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.683	BGC0001048.1|Tallysomycin_42 	77145	77513	-	Loose	650	23.8682	ALG6-1	41.38	3006893	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	ALG6 beta-lactamases	GTGCCGGACTTCAAGGAGCTCGTGGCCCTGTTGGTGCTGTCCATTGAGGACAGTGTGTCCATGGAGGACACAGGCGAGGCCAGGCCGAGCGATGCCGAGCTGGTGCGGCACACCGCCACCGTCGTCTCGGAACTCGTGCGCCGCGGCGTCATCCTCGCGGGACGCTACAGCCGGGACGACCCGGACTTCGTGCCGTGGAAGACAACCCCCGAAGAGGCCGCCAGGAGAACCGAACACGAGGCCGAGGTGTTCGCGGCGGCGGATCGACTCCCGGACCTGGGAGACATCTGCGCCATCGGACTTCCTCCGGGGTCGCGGAAGGCGCTCTCCCCCAGAAGGCATGGCGTCGGGGGTGCGCTGGACGGGTGA	MPDFKELVALLVLSIEDSVSMEDTGEARPSDAELVRHTATVVSELVRRGVILAGRYSRDDPDFVPWKTTPEEAARRTEHEAEVFAAADRLPDLGDICAIGLPPGSRKALSPRRHGVGGALDG	MSHGIPCAPSSRMETQMVSKMAMAAILLLAGPTAAAEVTPTTPIVCSMCEGWNRPQKPFKIYGNTWYVGTNDLSALLVTSPNGHVLLDGALPQSAPLIEANIQALGFKLKDVKLILNSHEHFDHAGGIPALQRASGATVAASIRGAKVLRAGTVGKDDPQFDPVKPFFLAKLEKVREVADGETLTAGDLRITAHYTPGHTPGGTSWTWTSCENGRCLNMVYADSLTPVSSEGFRFSGGNGAPDISSAFQATIDKVAALKCDVMVSNHPGFSQVMEKLAARTDANNTFIDPTGCRKYAAAASKRLANRLATEAKQKAAR	38.36	gnl|BL_ORD_ID|3290|hsp_num:0	4359			408	495	
BGC0001048.1|Tallysomycin_43 # 77602 # 77964 # 1 # ID=1_43;partial=00;start_type=ATG;rbs_motif=GGGAGG;rbs_spacer=4bp;gc_cont=0.705	BGC0001048.1|Tallysomycin_43 	77602	77964	+	Loose	300	23.483	tet(O)	38.46	3000190	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	ATGGCGGACGATCGTCTTTCTCGGGTGTTCGCGGCCCTCGCGGACCCGACCCGGCGCGACATCGTGGCCCGGCTCTCGCTGGGGGACGCCACGGTCGGGGAGCTCGCCGAGCCCTACGACGTCTCGGTCCAGGCCGTCTCCAAGCACCTCAGGGTCCTGGAGGGCGCCGGGCTGGTGAGCAGGAGCCGGGACGCGCAGCGTCGGCCCTGCCACCTGGAGGCCGAGGTGTTCGACCTGATGACCAAGTGGATCGAGAGGTACCGCCGGCAGGCCGAGGAGCGGTTCCACCGACTCGACGCCGTGCTGGCGGACATGGACGAGAACCAGGACAGCGACCACCAGCAGCGAGGAGCCGCGTCATGA	MADDRLSRVFAALADPTRRDIVARLSLGDATVGELAEPYDVSVQAVSKHLRVLEGAGLVSRSRDAQRRPCHLEAEVFDLMTKWIERYRRQAEERFHRLDAVLADMDENQDSDHQQRGAAS	MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAVTSFQWEDVKVNIIDTPGHMDFLAEVYRSLSVLDGAVLLVSAKDGIQAQTRILFHALQIMKIPTIFFINKIDQEGIDLPMVYREMKAKLSSEIIVKQKVGQHPHINVTDNDDMEQWDAVIMGNDELLEKYMSGKPFKMSELEQEENRRFQNGTLFPVYHGSAKNNLGTRQLIEVIASKFYSSTPEGQSELCGQVFKIEYSEKRRRFVYVRIYSGTLHLRDVIRISEKEKIKITEMYVPTNGELYSSDTACSGDIVILPNDVLQLNSILGNEILLPQRKFIENPLPMIQTTIAVKKSEQREILLGALTEISDCDPLLKYYVDTTTHEIILSFLGNVQMEVICAILEEKYHVEAEIKEPTVIYMERPLRKAEYTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAVMEGVLYGCEQGLYGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYLHFEIYAPQEYLSRAYHDAPRYCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTYFTNGQGVCLTELKGYQPAIGKFICQPRRPNSRIDKVRHMFHKLA	18.78	gnl|BL_ORD_ID|1953|hsp_num:0	2020			1221	1299	tetracycline; doxycycline; minocycline; chlortetracycline; demeclocycline; oxytetracycline
BGC0001048.1|Tallysomycin_44 # 77961 # 78443 # 1 # ID=1_44;partial=00;start_type=ATG;rbs_motif=GAGGAG;rbs_spacer=7bp;gc_cont=0.712	BGC0001048.1|Tallysomycin_44 	77961	78443	+	Loose	350	28.4906	BcI	38.71	3002877	protein homolog model	n/a	n/a	cephalosporin; penem	antibiotic inactivation	class A Bacillus cereus Bc beta-lactamase	ATGACCACGACCGGGAACCGGACCAGCATCGAGGCCGACCCCGTCCTGCCGACGATCCGCGTCGTCCGCGAGTTCGACGCGCCGCCCGCCAGGGTGTACCGCGCCTGGACCGACCCGGCGCTGGTCGTCCGCTGGATGGGGGCGAACGACCTCACCCTCCGGCTCGACACCTGGGACGCGCGCACCGGGGGCAGCTACCGCTACGCCGCGCCGCGGGACGGTGCGGAGGTCGCGGCCTTCTACGGTTCGTTCCACGAGCTGCGGCCCAACGAGCGCCTGGTGCAGACCATGACCTACGAGGGCCTGCCCGACGGCGTCTGCCTGGAGACCATCACCTTCGAGGACCTTGGCGACGGCCGTACGCGCACCACTTCCGTCACGGTCGTCGACACCATGGAGGCGCGCGACGGGTTGCTCGTGAGCACGGAGCACGGCGTGGTCGAGGGCTTCGCGCGCATGGACAGTCTTCTCGCCGAGGGGTGA	MTTTGNRTSIEADPVLPTIRVVREFDAPPARVYRAWTDPALVVRWMGANDLTLRLDTWDARTGGSYRYAAPRDGAEVAAFYGSFHELRPNERLVQTMTYEGLPDGVCLETITFEDLGDGRTRTTSVTVVDTMEARDGLLVSTEHGVVEGFARMDSLLAEG	MKNKRMLKIGICVGILGLSITSLEAFTGESLQVEAKEKTGQVKHKNQATHKEFSQLEKKFDARLGVYAIDTGTNQTISYRPNERFAFASTYKALAAGVLLQQNSIDSLNEVITYTKEDLVDYSPVTEKHVDTGMKLGEIAEAAVRSSDNTAGNILFNKIGGPKGYEKALRHMGDRITMSNRFETELNEAIPGDIRDTSTAKAIATNLKAFTVGNALPAEKRKILTEWMKGNATGDKLIRAGIPTDWVVGDKSGAGSYGTRNDIAVVWPPNRAPIIIAILSSKDEKEAIYDNQLIAEATKVIVKALR	52.29	gnl|BL_ORD_ID|665|hsp_num:0	720			237	330	
BGC0001048.1|Tallysomycin_45 # 78810 # 80111 # 1 # ID=1_45;partial=00;start_type=ATG;rbs_motif=GGGAG;rbs_spacer=5bp;gc_cont=0.727	BGC0001048.1|Tallysomycin_45 	78810	80111	+	Loose	1050	29.261	carA	25.17	3002817	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic target protection	Miscellaneous ABC-F subfamily ATP-binding cassette ribosomal protection proteins	ATGGTCTCTCGTGTTCTGGCCGCCAACCTGTCCCGGCACGCCGGCGCCGTCGTGCGCGTCGCCGGCTGGGTGCACCGCCGGCGGCGTCTCAAGTCCGTCACCTTCGTCGTCGTCCGGGACCGGTCCGGGCTGGCGCAGGTCGTGCTTCCCGCGTCGGCGGAACCCGCCGTGGCCGAGCTGCCCGAGGAAACCGTGGTCGAGGTCCGCGGCCGCGTGACCGCCAACCCGCAGGCCCCCGGAGGAGCGGAGATCACCGAACCGGTGATCTCGGCGCTCTCCGAGCCGGCGGCCGCGCCGCCGTTCGACCTCTACCGGCCGGCGGTGACCGCGACACTGCCCACGATCCTGGACCACGCGCCCGTCACGCTGCGGCACCCGCGGCTGCGGGCGGGGTTCGAGGTCGCCTCGGCCAGCGTCGCCGGGTTCCGGGCCGCCCTGGACGACCTCGGCTTCACCGAGGTGCGCACCCCGAAGATCGTCGGGTCGGTCACCGAGTCCGGCGCGAACGTCTTCGGCATCGACTACTTCGGCCGCCGGGCCTACCTCGCCCAGTCCCCGCAACTGTTCAAGCAGGCCCTGGTCGGGGTGTTCGAGCGGGTCTACGAGGTCGGGCCGGTGTTCCGCGCCGAGCCGCACGACACCACCCGCCACCTCGCGCAGTACACCAGCCTGGACGCCGAGCTCGGCTTCGTCGCCGACCACCACGACGTCATGGCGGTGCTGCGGGACGTGGTGGCGCGGATGGTCGACGCGGTCGCCGAGCGGGCGGCCGGGGCCGTCGACCTGCTGGGGGCCCGCCTGCCCCGGGTTCCGCACTCGATCCCGGCGATCCACTTCGCCGAGGCCCAGGAGCTGCTGGCCCGCCACACGGCGGAGGACCCCCGGGGCGAACCCGACCTGGCGCCGGCCCACGAACGGTGGCTGTCGGAGTGGGCCGAGCGCACCCACGACTCGGAGTTCCTGTTCGTCACCGGGTACCCGATGGCGAAACGCCCCTTCTACACCCACCCGGACCCGGAACGCCCCGGGTACTCCAACAGCTTCGACCTGCTCTTCCGCGGGCTGGAGCTGGTGACCGGAGGCCAACGGTTGCACCGGAGGGTTGACTACCTCGCCGCGCTCGCGGAACGCGGTGAGAGCCCGGAGCCGTACCAGTCCTATGTGGACGTCTTCGCGCACGGAATGCCGCCGCACGGCGGTTTCGCGATCGGGCTCGAACGGTGGACCGCCCGCCTGCTCGGGGTGTCCAACATCCGCGAGGTGACCCTGTTCCCCAGGGACCTGCACCGCCTCGAACCCTGA	MVSRVLAANLSRHAGAVVRVAGWVHRRRRLKSVTFVVVRDRSGLAQVVLPASAEPAVAELPEETVVEVRGRVTANPQAPGGAEITEPVISALSEPAAAPPFDLYRPAVTATLPTILDHAPVTLRHPRLRAGFEVASASVAGFRAALDDLGFTEVRTPKIVGSVTESGANVFGIDYFGRRAYLAQSPQLFKQALVGVFERVYEVGPVFRAEPHDTTRHLAQYTSLDAELGFVADHHDVMAVLRDVVARMVDAVAERAAGAVDLLGARLPRVPHSIPAIHFAEAQELLARHTAEDPRGEPDLAPAHERWLSEWAERTHDSEFLFVTGYPMAKRPFYTHPDPERPGYSNSFDLLFRGLELVTGGQRLHRRVDYLAALAERGESPEPYQSYVDVFAHGMPPHGGFAIGLERWTARLLGVSNIREVTLFPRDLHRLEP	MSTAQLALHDITKRYQDHVVLDRIGFTIKPGEKVGVIGDNGSGKSTLIKLIAGREQPDNGAVTVVAPGGVGYLAQTLELPLEATVQDAVDLALADLRELEEGMRRTEAELAERPYQTGQDPELAGLLESYAALVDRYQARGGYEADSRVEIALHGLGLPGLERGRRLGTLSGGERSRLALAATLASEPELLLLDEPTNDLDDRAVDWLEEHLRKHKGTVVAVTHDRLFLDRLTTTILEIDSGKVMRYGNGYEGYLAAKAAERQRRLLEYEQWRAELDRSRDLIASNVARLDAIPRKLPFAVFGAGQFRMRGRGHGAMVRIRNAKERVARLTENPVAPPPEPLTFTAEITTEAAQSRETVAELTGVRVGDRLSVDSLHLGPGERLLVTGPNGAGKTTLLRVLSGELEPDSGSLLVSGRVGHLRQEQTPWRPGMTVLQAFSSGRAGDIDEHTEALLSLGLFSPDDLRQRVQDLSYGQRRRIELARLVTEPVDLLLLDEPTNHLSPALVEELEEALTGYQGTVVVVTHDRRMRSRFNGAHLTLQDGRVAEFTAA	78.58	gnl|BL_ORD_ID|853|hsp_num:0	928			24	390	carbomycin
